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I.  Progress in the Field of Unactivated, Aliphatic C–H Functionalization 
The site-selective transformation of unactivated, aliphatic C–H bonds is a challenging 
goal to achieve in the field of C–H functionalization. Major contributions in C–H oxidation, 
halogenation, and amination are presented, with a particular focus on systems that enable control 
in selectivity. 
II.  C–H Xanthylation: A Synthetic Platform for Alkane Functionalization 
 
Intermolecular functionalizations of aliphatic C−H bonds offer unique strategies for the 
synthesis and late-stage derivatization of complex molecules, but the chemical space accessible 
remains limited. A strategy for significantly expanding the chemotypes accessible was addressed 
via C−H xanthylation. A one-pot xanthate to hydroxy functional group transformation was 
developed and implemented in the context of a C–H xanthylation reaction to achieve a formal C–
H hydroxylation. The utility of the C–H xanthylation in late-stage derivatization for accessing a 
wide array of functionalities is further demonstrated.   
 
iv 
III.  Investigations into Different Dithiocarbonyl Groups for Nitrogen-Tolerant C–H 
Functionalizations   
 
Nitrogen-containing heterocycles are of considerable interest in medicinal chemistry. 
Therefore, efforts toward effecting a nitrogen-tolerant variant of the C–H xanthylation reaction 
were pursued using dithiocarbamates. Although unsuccessful, important insights were made with 
regards to dithiocarbamate amide synthesis and dithiocarbonyl transfer.  




A key advantage to intramolecular C–H functionalization reactions is the ability to obtain 
products site-specifically. A method for site‐specific, intramolecular C−H functionalization was 
developed using N-dithiocarbamate amides. The convergent synthesis of substrates enables high 
functional group tolerance, with a diversity of products available via the dithiocarbamate.  
V.  Chemo- and Regioselective Functionalization of Isotactic Polypropylene: A 
Mechanistic and Structure-Property Study 
 
 
Post-polymerization modification of polyolefins via C–H functionalization is an 
attractive method for transforming inexpensive polyolefins already produced on industrial scale 
into functionalized materials. Thermal conditions were developed for the C–H xanthylation of 
v 
branched polyolefins to enable reaction scale-up, and two new thiocarbonylthio amides were 
successfully synthesized to explore structure-reactivity properties involved in thiocarbonylthio 
group transfer. These studies allowed translation of the reaction onto a twin-screw extruder for a 
decagram production of 1% xanthylated polypropylene. 




Carboxylic acids make up a ubiquitous class of organic starting materials, and in recent 
years have been featured heavily as radical precursors in the context of decarboxylative 
functionalization. A method for direct decarboxylative xanthylation of aliphatic carboxylic acids 
using N-xanthylamides is described. Mechanistic studies support a radical pathway involving a 
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CHAPTER ONE: PROGRESS IN THE FIELD OF UNACTIVATED, ALIPHATIC C–H 
FUNCTIONALIZATION 
1.1 Introduction 
While synthesis is traditionally guided by the functional groups present in a molecule, the 
direct reaction of carbon-hydrogen (C–H) bonds offers several distinct advantages to synthetic 
chemistry. C–H bonds, which are ubiquitous in starting materials, provide points of 
diversification from a single structure. Late-stage functionalizations of drug-like molecules 
provide opportunities for furnishing products with direct biological relevance. The ability to 
derive analogues without having to rely on de novo synthesis holds tremendous value in drug 
discovery and development, allowing for rapid exploration of structure-activity relationships 
(SAR) and other physiochemical properties.1 Additionally, consideration of the C–H bond as a 
functional group provides opportunities for novel disconnects during retrosynthetic analysis, 
thereby expanding the number of approaches for efficient syntheses of complex molecules.2 
Finally, C–H functionalization has been utilized in polymer synthesis as a strategy for accessing 
next-generation materials from commodity polyolefins through post-polymerization 
modification.3 
The earliest examples of C–H functionalization can be traced back to nature, where 
certain enzymes have evolved to catalyze C–H functionalization reactions with exquisite levels 
of site- and stereoselectivity. Cytochrome P450s are famous examples of enzymes responsible 
for C–H oxidations processes for preparing oxidized metabolites, and haloperoxidase enzymes 
catalyze C–H halogenation reactions responsible for halogenated secondary metabolites. Wel05 
2 
is a notable example of a halogenase that stereoselectively installs a chlorine atom on an 
unactivated position of 12-epi-fischerindole G (Figure 1.1).4 Enzymatic reactivity, however, is 
often limited to very specific substrates, as enzyme activity relies on specific substrate-enzyme 
binding interactions in the enzyme’s active site. Enzymatic evolution has made one approach to 
conferring the high regio- and stereoselectivity observed with enzymatic C–H functionalization 
reaction onto a broader scope of substrates.5 In addition, the development of operationally 
simpler, chemical systems for achieving selective C–H functionalizations has served as an active 
area of interest for the past few decades. This chapter will serve as an introduction to some of the 
major contributions in the field of unactivated, aliphatic C–H functionalizations, with a particular 
focus on systems that enable control in selectivity.  
 
Figure 1.1. Examples of enzymatic C–H functionalizations. 
1.2  Intramolecular C–H Functionalizations 
 The Hofmann-Löffler-Freytag (HLF) reaction is a quintessential example of an 
intramolecular C–H functionalization. Early HLF reactions involved the use of N-haloamines 
(e.g. 1.3, Figure 1.2) which under strongly acidic conditions and either thermolytic or photolytic 
conditions, generate amine cation radicals (1.7) that can perform a kinetically favorable 
3 
intramolecular hydrogen atom transfer (HAT).6 Selectivity in this reaction is governed by a 
chair-like transition state (1.4) that favors a 1,5-HAT. The resulting carbon-centered radical (1.8) 
can abstract a halogen atom, which propagates the radical chain. Basic workup leads to 
substitution to provide pyrrolidine products (1.5) via a net intramolecular C–H amination. 
 
Figure 1.2. The Hofmann-Löffler-Freytag reaction and mechanism. 
While classical HLF chemistry traditionally required strongly acidic conditions, 
numerous variations of the reaction have enabled reactivity under milder conditions. In 
particular, the Suarez modification marked an important advancement in HLF chemistry, 
whereby the use of an electron withdrawing group on the nitrogen allows for initiation under 
neutral conditions. Suarez’s initial report showed the conversion of iodonitroamides, generated 
in situ with acetyl hypoiodite, to C–H amination products (e.g. 1.11, Figure 1.3) in good yields 
under neutral conditions with visible light.7 Additional electron withdrawing groups on nitrogen, 
including N-cyanamides, N-phosphoramidates, N-sulfonamides, and N-carbamates, have made 
up other variations of HLF chemistry.8–11  
4 
 
Figure 1.3. The Suarez modification for HLF reactivity under neutral conditions. 
The installation of strongly electron withdrawing groups, such as trifluoroacetamides and 
sulfonamides, can prevent cyclization for isolating C–H halogenation products.12 In some 
instances, 1,6-functionalized products can be achieved. Baran demonstrated 1,6-HAT processes 
facilitated by the abstraction of a weaker benzylic or tertiary C–H bond by a carbamyl radical to 
access 1,3-diol products (Figure 1.4).13 Roizen used sulfamate esters for 1,6-HAT resulting from 
favorable seven-membered transition states due to longer N–S and S–O bond lengths of the 
sulfamate ester (Figure 1.4).14   
 
 
Figure 1.4. Examples of 1,6-functionalizations via HLF-like reactivity. 
Despite the advances that have been made in HLF chemistry, some general limitations 
remain: namely, the requirement for pre-functionalization of the directing nitrogen. This pre-
functionalization step typically requires a strong oxidant, such as acetyl hypoiodite or 
hypobromite, that limits the functionalities that can be present on the substrate. Another general 
limitation of HLF reactions is that functionalization is limited to halogenation and amination 
5 
products. Recently, photoredox catalysis has presented a method for bypassing these limitations. 
In 2015, Knowles and Rovis independently published reports of using an iridium catalyst and 
phosphate base to generate an N-centered radical that undergoes a 1,5-HAT (Figure 1.5). The 
resulting carbon-centered radical adds to a Michael acceptor, which is reduced to provide C–H 
alkylation products 1.18 and 1.20 (Figure 1.5).15,16 The 1,5-HAT, however, is notably limited to 
the abstraction of tertiary C–H bonds.  
 
 
Figure 1.5. Intramolecular C–H alkylation by photoredox catalysis.  
While most examples of intramolecular functionalization provide predictable 1,5- or 1,6- 
functionalization products, remote functionalizations afford opportunities for accessing products 
of different selectivities. Breslow’s studies on biomimetic control showed that selective C–H 
chlorinations of steroids were possible using a hypervalent iodine(III) aryl tether (e.g. 1.21, 
Figure 1.6).17 Regioselectivity could be controlled by varying the substitutional position of 
iodine on the arene and by adjusting the length of the tether to strategically position the reactive 
iodanyl radical in proximity to specific C–H bonds of the steroid.  
6 
 
Figure 1.6. Remote C–H chlorination of a steroid. 
It becomes apparent with all of these cases that intramolecular C–H functionalizations 
have the advantage of inherent conformational biases to afford products with high levels of 
selectivity for a particular site. In contrast, intermolecular reactions typically lack the kinetic 
advantage, and consequently, specificity in the C–H abstraction or activation. 
1.3  Intermolecular, Aliphatic C–H functionalizations 
The main challenges of intermolecular C–H functionalizations lie in the inertness and 
ubiquity of C–H bonds. The general inertness of C–H bonds requires the use of high-energy 
intermediates to cleave the C–H bond with enough control to selectively functionalize one out of 
many C–H bonds. 
The majority of C–H functionalization systems provide products based on substrate-
controlled selectivity, where a combination of electronic and steric factors influences the site of 
functionalization. Functionalizations of activated positions, such as benzylic, allylic, and alpha 
heteroatom positions are commonly observed due to the lower bond dissociation free energy 
(BDFE) associated with those positions (Figure 1.7). Accordingly, among unactivated aliphatic 
C–H bonds, functionalizations of electron-rich tertiary C–H bonds are observed over secondary 




Figure 1.7. Bond strengths of representative C–H bonds. 
Recent studies have addressed difficulties in reactivity and site selectivity commonly 
associated with C–H functionalizations to make intermolecular C–H functionalization a viable 
tool for synthetic chemists. Methods for achieving reagent-controlled selectivities, as opposed to 
substrate-controlled, have emerged as a way for accessing products functionalized at different 
sites.  
1.3.1  Unactivated Aliphatic C–H Oxidations  
Examples of selective, C–H oxidations come as early as the 1980s with Curci’s reports of 
C–H oxidations using dioxirane reagents.18 The strain present in these 3-membered rings result in 
a highly reactive species that can react with a C–H bond in what is believed to involve a 
concerted, asynchronous oxidation. C–H oxidations with dioxiranes are selective for the most 
electron-rich, tertiary carbon centers (Figure 1.8). In the absence of any tertiary C–H bonds, the 
reaction yields a ketone through oxidation of the alcohol intermediate. Reactions with the 
electronically-poor methyl(trifluoromethyl)dioxirane furnish products in high yields (Figure 1.8), 
but must be run at cryogenic temperatures due to the instability of the reagent.  
The concept of using a strained, electrophilic oxaziridine for achieving selective, tertiary 
C–H functionalizations was further developed by Du Bois in 2009 with the use of a 
benzoxathiazine organocatalyst and hydrogen peroxide oxidant.19 More recently, systems 
involving the in situ generation of dioxiranes using trifluoroacetophenones as organocatalysts 
have been developed.20  
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Figure 1.8. C–H oxidations with strained, electrophilic reagents. 
Hypervalent iodine reagents have also been used for achieving C–H oxidations. In 2010, 
Yeung reported a protocol involving diacetoxyiodobenzene (DIB) and tert-butylhydroperoxide 
(TBHP) for allylic and benzylic oxidations (Figure 1.9).21 The use of an ester solvent proved 
critical for the reaction, and solvent-coordination was hypothesized for stabilization of the 
iodine(III) center (e.g. 1.29). Further investigations into the role of the solvent resulted in 
identification of the isolated, C3-oxidation of n-butyl ester to afford 1.30 (Figure 1.9).22 The 
reaction conditions could be applied on a number of different cyclic and aliphatic esters and 
amides, although yields were generally modest. Once again, a carbonyl-coordinated hypervalent 
iodine species (e.g. 1.29) was proposed for enabling the site-selective oxidation of the 




Figure 1.9. C–H oxidations with (diacetoxyiodo)benzene. 
In 2003, Maruoka designed various (diphenylphosphinoyl)oxy hypervalent iodine(III) 
reagents tuned with an electron-withdrawing triflate group to increase the reactivity of the 
iodine-centered radical and enable the site-selective oxidation of unactivated secondary C–H 
bonds (Figure 1.10).23 While increasing the steric bulk on the diarylphosphinic groups with 
reagent 1.34 led to no appreciable differences in selectivities, an increase in the steric bulk 
around the iodine center with 1.35 provided a marked increase in selectivity in the reaction of 
tert-butylcyclohexane for the C3-oxidized product. These results suggest the intermediacy of an 




Figure 1.10. Site-selective C–H oxidations by hypervalent iodine(III). 
 
10 
In terms of metal-based catalysis, early examples involved Fe Gif-type systems consisting 
of an iron complex (FeII/III), reducing agent (Fe or Zn), and molecular oxygen to oxidize 
saturated hydrocarbons to ketones.24 Further studies by White improved upon the system with 
the development of different biomimetic, iron-based catalysts for achieving reagent-controlled 
oxidation.25 Adding steric bulk around the iron center with larger ligands favors methylene C–H 
functionalization (Figure 1.11).26  
 
Figure 1.11. C–H oxidation by iron catalysis. 
Subsequent work by Costas showed that the chirality of the iron catalyst can also play a 
role in site-selectivity.27 More recently, Costas reported the regioselective C–H oxidation of 1-
decylamine using a Mn complex with a crown ether tethered to the ligand of the catalyst (Figure 
1.12).28 Substrate binding between the ammonium group of the protonated amine and the crown 
ether placed the C–H bonds at the C8 and C9 positions in close proximity to the metal center to 
provide the oxidized products in an 81% selectivity.  
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Figure 1.12. Mn-catalyzed, regioselective C–H oxidation by substrate recognition. 
In 2017, Baran presented an electrochemical method for the C–H oxidation of alkanes 
under air using quinuclidine as a redox mediator.29 The oxidation of quinuclidine provides an 
amine cation radical capable of abstracting an electron-rich secondary or tertiary C–H bond, and 
the resulting carbon-centered radical is trapped by molecular oxygen to provide product. This 
system is easily scalable and was used to functionalize 50 grams of sclareolide for the synthesis 
of 2-oxo-yahuzunone. (Figure 1.13).  
 
 
Figure 1.13. Electrochemical C–H oxidation of (+)-sclareolide. 
Over-oxidation is an inherent problem with the majority of these C–H oxidation systems. 
A rare example of a secondary-selective C–H hydroxylation reaction was reported by Mizuno 
involving a polyoxometalate catalyst and hydrogen peroxide (Figure 1.14).30 The steric bulk 
surrounding the divanadium-substituted phosphotungstate catalyst suppresses tertiary 
functionalization, and overoxidation is not observed. Despite the advances made, substrate scope 
is limited to simple alkanes with no examples demonstrating any functional group tolerance. 
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Figure 1.14. Polyoxometalate-catalyzed C–H hydroxylation of methylene C–H bonds.  
1.3.2  Unactivated Aliphatic C–H Halogenations  
 Compared to C–H oxidations, there are fewer examples of practical C–H halogenations.  
Free radical chlorination is one of the oldest synthetic reactions and is still used today 
industrially in the chlorination of methane. The highly reactive chlorine radicals that are formed 
react indiscriminately to provide statistical mixtures of primary, secondary, and tertiary alkyl 
halide products.  
 
Figure 1.15. Early C–H chlorinations by nitrogen-centered radicals. 
Minisci explored the use of nitrogen-centered cation radicals for alkane halogenation 
with dimethylamine in what can be considered as essentially an intermolecular version of the 
HLF reaction (Figure 1.15).31 Concentrated sulfuric acid was necessary for high levels of 
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selectivity, and diluted concentrations had adverse effects on the selectivity of the reaction. Deno 
further studied the effect of modulating the alkyl group on the haloamine as a means for altering 
site-selectivity.32 Similar to the development of HLF chemistry, the use of amides and 
sulfonamides instead of amines eventually obviated the requirement for acidic conditions to 
activate the nitrogen.33 
 
Figure 1.16. Highly selective C–H bromination with N-bromoamide. 
The Alexanian group further developed the concept of using electron-poor amidyl 
radicals for C–H halogenation with the development of prefunctionalized haloamides to enable 
selective, C–H halogenation reactions, beginning with C–H bromination in 2014. C–H 
bromination with bromoamide 1.48 proceeded with visible light initiation to furnish products in 
high yields and excellent levels of selectivity (Figure 1.16).34 Selectivity is dictated in part by the 
tert-butyl group on the amide providing a sterically hindered environment around the N-centered 
radical, favoring abstraction of the most accessible hydrogen. Consequently, C–H 
functionalization occurs at secondary over tertiary centers, despite the higher bond dissociation 
energies associated with secondary C–H bonds (e.g. 1.49 and 1.50). With adamantane, which has 
C–H bonds of similar BDFEs, C–H functionalization is selective for the tertiary C–H bond based 
solely on steric accessibility. The mechanism is believed to involve N–Br bond homolysis by 
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visible light to produce amidyl radical 1.54 for selective, intermolecular hydrogen abstraction 
(Figure 1.17). The alkyl radical can then abstract a bromine atom from another equivalent of 




Figure 1.17. Mechanism of the C–H bromination with N-bromoamide. 
Shortly after, the C–H chlorination of unactivated alkanes was developed using N-
chloroamide 1.58, providing similar site selectivities as observed with the C–H bromination.35 
The addition of cesium carbonate was critical for maintaining good selectivities, as trace acid 
could react with 1.58 to produce molecular chlorine and generate nonselective background 
chlorination. The C–H chlorination of (+)-sclareolide provided 1.59 in 82% yield on multigram 
scale, which was further elaborated to (+)-chlorolissoclimide, an antiproliferative diterpenoid, in 
collaboration with the Vanderwal group (Figure 1.18). 
 
Figure 1.18. Synthesis of (+)-chlorolissoclimide.   
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 Increasing the steric environment around nitrogen further improved selectivity, and high 
levels of reagent-dictated site selectivity could be obtained with N-chloroamide 1.61 (Figure 
1.19).36 Notably, reactions of substrates containing chain branching provided high levels of 
primary functionalization, and artemisinin was chlorinated at the methyl group of the cyclohexyl 
ring in a 65% selectivity. An X-ray crystal structure of 1.61 confirmed that the ortho 
trifluoromethyl groups cause significant twisting in the structure and shield the nitrogen atom, 
leading to an increased selectivity for sterically less hindered C–H sites. 
 
 
Figure 1.19. Reagent-dictated C–H chlorination of artemisinin. 
Groves developed a series of C–H halogenation reactions through manganese porphyrin 
catalysis. The reactions are believed to proceed via a manganese (V) oxo species capable of 
abstracting C–H bonds, with a putative manganese (IV) hypohalite complex formed from either 
sodium hypochlorite or hypobromite to provide the C–H chlorination and bromination products, 
respectively.37 Porphyrin systems with bulky mesityl substituents on the ligand enable 
functionalizations at the most electron-rich and sterically accessible methylene site. The bulkier 
tetramesitylporphyrin (TMP) catalyst favors chlorination of trans-decalin at the β position rather 
than the α position in a 4:1 selectivity (Figure 1.20).  
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Figure 1.20. C–H chlorination by Mn porphyrin catalysis. 
Groves later reported a method for aliphatic C–H fluorination using Mn(TMP)Cl with 
AgF/TBAF as fluoride sources to generate a manganese (IV) fluoride complex in situ,38 and also 
a methodology for C–H azidation using sodium azide.39 Other methods of C–H fluorination have 
been disclosed involving UV irradiation or transition metal catalysis.40–42 
1.3.3 Unactivated Aliphatic C–H Amination 
Practical methods of intermolecular C–H amination have only been disclosed in the past 
decade. In 2012, Baran reported a Ritter-type amination of unactivated aliphatic C–H bonds 
using a copper catalyst and Selectfluor.43 An unstable Cu(III)–Selectfluor complex is 
hypothesized to be the C–H abstracting species. Subsequent oxidation of the carbon-centered 
radical to the carbocation followed by addition of acetonitrile and basic hydrolysis delivers the 
acetamide (Figure 1.21). Substrates with alcohol or ketone functionality provided directed 





Figure 1.21. A Ritter-type C–H amination. 
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Du Bois reported a method for C–H amination via C–H insertion by a rhodium nitrenoid 
species generated from a dirhodium tetracarboxylate catalyst and sulfamate ester. Selectivity is 
generally observed for the most electron-rich tertiary site, but benzylic functionalization can also 
occur. A model for evaluating product selectivity was developed in a collaboration with Sigman, 
which was used to identify a new sulfamate ester for improved benzylic-to-tertiary site 
selectivity.44 An updated protocol was recently disclosed providing improvements in catalyst 
turnover and reaction scope of the C–H amination largely attributed to the use of tBuCN as the 
solvent (Figure 1.22).45  
 
 
Figure 1.22. C–H amination by nitrene insertion. 
In 2015, Hartwig reported an intermolecular azidation of tertiary C–H bonds using an 
iron(II) catalyst, tridentate bis(oxazoline) ligand, and an azidoiodinane reagent (Figure 1.23).46,47 
Functionalization occurred at tertiary sites distal from electron-withdrawing moieties, although 
yields were generally modest. Chen was able to achieve a similar azidation reaction using a Ru 
photocatalyst (Figure 1.23).48 Chlorinated and brominated products could be accessed with the 




Figure 1.23. C–H azidation reactions using an azidoiodinane reagent. 
 A recent collaboration between the Alexanian and Nicewicz groups resulted in a modular 
strategy for aliphatic C–H functionalization through photoredox catalysis using an acridinium 
catalyst and phosphate base.49 Mechanistic studies suggest that single-electron transfer from 
excited state acridinium generates an oxygen-centered radical from the phosphate base that is 
responsible for the C–H abstraction. A number of substrates underwent efficient C–H azidation 
using a sulfonyl azide trap, and different transformations could be accessed by changing the 










1.4  Outlook 
 The field of C–H functionalization has progressed rapidly in the past few decades with 
the development of a number of systems to enable a variety of C–H functionalizations. Although 
the chemical space available through C–H functionalization has expanded significantly, systems 
for accessing different selectivities, especially among methylene positions, are still lacking. With 
few exceptions, most systems that offer reagent-controlled selectivities are limited to steric-




CHAPTER TWO: C–H XANTHYLATION: A SYNTHETIC PLATFORM FOR 
ALKANE FUNCTIONALIZATION 
2.1 Introduction 
Significant progress has been made in the field of C–H functionalization. Studies 
targeting the reactivity of unactivated, aliphatic C–H bonds have resulted in a number of site-
selective C–H oxidations, halogenations, and azidations, with practical applications in the late-
stage derivatization of natural products and drug derivatives (see Chapter 1). Despite these 
advances, the functionalities available through alkane C–H functionalization remain limited, with 
examples of C–C bond-forming reactions particularly lacking. We sought to take advantage of 
the high methylene selectivity observed with our functionalized amides, and conceived of an 
alternate strategy that would enable access to a wide array of functional groups through the 
reactivity of a single intermediate. We identified the xanthate as a prime candidate for group 
transfer given the number of functional group manipulations known, including vinylation, 
allylation, thiolation, and deuteration, that would significantly expand the chemical space 
accessible via C–H functionalization. 
2.2 Background 
Alkyl xanthates make convenient sources of carbon-centered radicals.50 The high 
radicophilicity of the xanthate stems from the discrepancy between the sizes of the carbon and 
sulfur atoms that result in poor overlap between the p orbitals compared to the carbon and 
oxygen atoms of the carbonyl. Consequently, the thiocarbonyl has a weaker π bond compared to 
the carbonyl, which is characterized by both a longer bond (1.6 A vs 1.25 A) and weaker bond 
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strength by 40-50 kcal/mol, and makes the dithiocarbonyl susceptible to nucleophilic radical 
addition on sulfur.  
 
Figure 2.1. The two-step addition-fragmentation reactivity of xanthates. 
The xanthate group reacts via a two-step addition-fragmentation sequence, and 
establishes an equilibrium with a captodatively stabilized radical species (2.3, Figure 2.1) that 
increases the effective lifetime of the radical (2.2) in solution. The xanthate is not susceptible to 
displacement by nucleophilic substitution, and is generally compatible with a range of 
functionalities with a key exception of nucleophilic nitrogen, which will promote rapid 
aminolysis to give the thiocarbamate (e.g. 2.5, Figure 2.2) and thiol products.51  
 
 
Figure 2.2. Polar aminolysis pathway of xanthates.  
A variety of functional group transformations are known for xanthates. For instance, 
allylation, vinylation, and azidation products are possible through radical coupling from sulfones 
as demonstrated by Zard and Renaud, and conditions for the reduction of the xanthate to the 
deuterated product was developed by Boivin (Figure 2.3).52–55 Therefore, a C–H xanthylation 
reaction would provide access to net C–C, C–N, C–D, and C–S bond constructions from a single 
C–H bond. Despite the vast array of known transformations possible from the xanthate group, 
there was no xanthate to alcohol functional group conversion known in the literature. 
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Considering the value of the hydroxy group in late stage functionalization for preparing oxidized 
metabolites and increasing hydrophilicity of potential drug molecules, we reasoned that the 
development of these functional group transformations would greatly enhance the utility of the 
C–H xanthylation reaction.  
 
 






2.3  Method for a Formal C–H Hydroxylation 
2.3.1 Reaction Development  
We envisioned a xanthate to alcohol functional group conversion using TEMPO (2,2,6,6-
tetramethylpiperidin-1-yl)oxyl) as the oxygen source to give an alkoxyamine intermediate which 
could be converted to either an alcohol or ketone under appropriate reductive or oxidative 
conditions, respectively (Figure 2.4).  
 
Figure 2.4. Approach to accessing the hydroxy and ketone oxidation states via the xanthate. 
We considered two different methods for the reduction of the xanthate group using either 
photochemical or thermal conditions. In the case of the former, Grainger demonstrated in the 
total synthesis of (–)-aphanorphine the reduction of dithiocarbamate 2.15 using a Hg arc lamp to 
photolytically cleave the π-bond of the thiocarbonyl group (Figure 2.5).56 Addition of TEMPO 
and subsequent fragmentation of the dithiocarbamate group generated the alkyl radical, which 
was trapped by another equivalent of TEMPO to give 2.16 in good yield. 
 
Figure 2.5. Photolytic TEMPO-trapping from dithiocarbamates. 
Alternatively, reagents such as tributyltin hydride are known to abstract xanthates through 
an addition-fragmentation sequence upon thermal initiation to give the alkyl radical, which could 
be trapped by TEMPO instead of propagating the chain by hydrogen abstraction. In this regard, 
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Boger and Studer have reported successful TEMPO-trappings of alkyl radicals generated from 
alkyl iodides with tributyltin hydride as well as tris(trimethylsilyl)silane (TTMSS), a nontoxic 
alternative to  tributyltin hydride (Figure 2.6).57,58 
 
Figure 2.6. TEMPO-trapping from alkyl iodides. 
2.3.2 Results & Discussion 
TEMPO-trapping under different photolytic conditions was examined by irradiating 
xanthate 2.21 with UV-A light with 4 equivalents of TEMPO. Although the analogous 
diethyldithiocarbamate 2.22 afforded some product after 48 h under UV irradiation, no reaction 
was observed with the xanthate, suggesting that the C=S of the dithiocarbamate group is 
photolytically more labile than that of the xanthate (Figure 2.7).  
 
Figure 2.7. Initial TEMPO-trapping attempts under photolytic conditions. 
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We therefore focused efforts on using TTMSS for xanthate reduction. Optimized 
conditions centered on xanthate 2.24 and involved two sequential additions of TTMSS and 
TEMPO over 48 hours at 100 °C in chlorobenzene to provide alkoxyamine 2.25 in 83% yield 
(Entry 1, Table 2.1). 
 
Table 2.1. TEMPO-Trapping Optimization 
 
Entry Deviations from standard conditionsa 
Conversion (%)b Yield (brsm)b,c 
(%) 
1 None 84 83 (98) 
2 TEMPO and TTMSS added over 32 h by syringe pump 84 81 (96) 
3 TEMPO and TTMSS added in one portion 85 51 (64) 
4 2 equiv TEMPO and 1 equiv TTMSS added in one portion 50 46 (92) 
5 2 equiv TEMPO and 1.5 equiv TTMSS added in one 
portion 
70 41 (59) 
6 1 equiv TEMPO and 1 equiv TTMSS added in one portion 48 28 (57) 
7d [0.5 M] PhCl 89 57 (64) 
8 120 °C 88 71 (81) 
9 80 °C 55 37 (67) 
10 No silane added 0 - 
a TTMSS = tris(trimethylsilyl)silane; b 1H NMR yields based on trimethoxybenzene internal standard;  




The two addition sequence proved to be necessary to maintain high yields; addition of the 
reagents in one portion gave a similar conversion but a significantly diminished yield of 51% 
(Entry 3). In general, the conversion of 2.24 proved to be dependent on the total amount of 
TTMSS used; 1 equivalent of silane corresponded to 50% conversion (Entries 4, 6), and no 
silane resulted in no reaction (Entry 10). Increasing concentration proved to be deleterious to 
product yield although led to increased conversion (Entry 7). Likewise, increasing temperature 
improved conversion while slightly decreasing yield (Entry 8), and decreasing temperature 
corresponded to decreased conversion (Entry 9). The ratio of reagents used in the reaction 
proved to be key in maximizing yield, and a 2:1 stoichiometric ratio of TEMPO to TTMSS was 
determined to furnish the highest yield based on recovered starting material (Entries 4–6). In 
addition, different silanes were considered including triethylsilane and triphenylsilane; however, 
TTMSS was the only reagent that led to any product. 
The optimized conditions were applied to cycloheptane and cyclooctane xanthates to 
provide 2.26 and 2.27 in good yields (Figure 2.9). With the terpenoid (+)-sclareolide derived 
xanthate, yields dropped to 58%, and another addition of TEMPO (2 equiv) and TTMSS (1 
equiv) slightly raised the yield to 65%. Only one diastereomer was observed in the reaction, with 
the TEMPO group combining with the carbon centered radical to give the equatorial product 
2.28.  
 
Figure 2.8. TEMPO-trapped products from cyclic substrates. 
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2.3.3 Mechanistic Considerations  
There were two key background reactions to consider during reaction optimization: 
complete reduction of the xanthate to alkane 2.30 and spontaneous reaction between TEMPO 
and TTMSS (Figure 2.8).   
The reactivity between TEMPO and TTMSS has been reported by Pedulli.59 
Tris(trimethylsilyl)silyl radical 2.31 reacts with TEMPO to form adduct 2.32 that fragments by 
N–O bond homolysis to give the aminyl and silanoxy radicals. Aminyl radical 2.33 can abstract a 
hydrogen from the starting silane or combine with alkyl radical 2.29 to give tertiary amine 2.35.  
 
 
Figure 2.9. Background reactions from TEMPO and TTMSS. 
Indeed, some amount of the trapped tertiary amine product were observed, especially at higher, 
0.5 M concentrations (Table 2.2, Entries 1–2). Increasing the ratio of silane to TEMPO led to some 
















[ ] M 2.25 (%)b 2.35 (%)b 2.30 (%)b 
1 4 1.2 0.5 27 46 - 
2 2 4 0.5 <5 22 28 
3 2 4 0.1 46 9 6 
a TTMSS added in 3 portions every 60 min; b 1H NMR yields based on trimethoxybenzene internal standard. 
 
2.4 Implementation in the C–H Xanthylation 
The C–H xanthylation reaction was developed by Will Czaplyski, who identified blue 
LEDs as an effective mode of initiation for the C–H xanthylation of a number of substrates using 
xanthylamide 2.36 (Figure 2.10).  
Functionalization is generally observed for the most sterically accessible, electron-rich 
secondary C–H bond. The terpenoid (+)-sclareolide was xanthylated at the C2 position in 55% 
yield to provide 2.37, with functionalization occurring away from the electron-withdrawing 
lactone at the most sterically accessible secondary C–H bond. The terpenoid (+)-longifolene 
provided xanthate 2.38 in 54% yield under neat conditions (i.e. 1 equivalent 2.36 in 1 equivalent 
liquid (+)-longifolene), resulting from C–H abstraction on the less hindered cycloheptyl core 
away from the quaternary centers and xanthate transfer occurring away from the polycyclic 
system to provide a single diastereomer. Functionalization of the adamantyl core in the differin 
precursor provided derivative 2.39 in 51% yield, occurring at the sterically most accessible 
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tertiary C–H bond. The xanthylation of (–)-ambroxide provided 2.40 in 80% yield with 
functionalization occurring at the hyperconjugatively activated site α to oxygen. 
 
Figure 2.10. Complex substrate scope of the C–H xanthylation. 
The steroid trans-androsterone acetate underwent xanthylation to give a 1:1 mixture of 
the C2 and C6 products in 56% combined yield, each as a single diastereomer (2.41). C2 
functionalization of trans-androsterone acetate was somewhat surprising to observe, as the 
acetate group was expected to electronically deactivate the A ring. Complete deactivation of the 
A-ring was accomplished with 5α-androstanedione with xanthylation only observed at the C6 
position on the B-ring in 44% yield (2.42, Figure 2.10). 
The regioselectivities of the steroid products 2.41 and 2.42 were determined by 
converting the xanthates to the corresponding ketones and matching the spectroscopic data of the 
oxidized products with literature values. Xanthate 2.41 was converted to ketone 2.45 with m-
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CPBA oxidation of the in situ generated alkoxyamine intermediate 2.43 in an overall one-pot 
procedure (Figure 2.11). Additionally, xanthate 2.41 could be taken to hydroxy product 2.44 in a 
net C–H hydroxylation reaction by treating the crude mixture with Zn and acetic acid. In contrast 
to most other C–H oxidation methods, this procedure allows for absolute control on the final 
oxidation state to access either hydroxy or ketone products, with selectivity of the oxidized 
product set by the C–H xanthylation.  
 
Figure 2.11. Controlled oxidation products from the xanthate intermediate.  
While a one-pot procedure starting from the alkane to the TEMPO-trapped product would 
be ideal, initial attempts provided little to none of the alkoxyamine intermediate. The presence of 
bis(xanthate) dimer, a byproduct of the C–H xanthylation reaction, severely diminished the yield 
in the subsequent TEMPO-trapping reaction, most likely reacting with the silane reductant to 
give off-pathway products.  
2.5  Method for a Formal C–H Trifluoromethylthiolation  
The trifluoromethylthiol group has become invaluable in the preparation of bioactive 
compounds owing to its high electronegativity and ability to modulate the lipophilicity of drug 
molecules.60 Therefore, a method for trifluoromethylthiolation was devised using dilauroyl 
peroxide (DLP) as a reductant and a SCF3 trap. The SCF3 transfer reagent developed by Shen, 
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which had precedent in radical trifluoromethylthiolation, was particularly apt for our purposes,61 
and was used to provide 2.46 in 71% yield. In general, higher yields were obtained at more dilute 
conditions, although these dilute conditions also necessitated higher loadings of initiator to react 
with the xanthate (Table 2.3). This strategy allowed for net C–H trifluoromethylthiolation of 
unactivated secondary C–H bonds, which is complementary to the existing methods in the 
literature and is suitable for late-stage complex molecule functionalization. 
 
Table 2.3. Xanthate to Trifluoromethylthiol Optimization 
 
Entry Deviations from standard conditions Conversion (%) Yield (%)a 
1 None Full 86 (71)b 
2 DLP (10 mol % x 3) 0 - 
3 DLP (50 mol % x 3) 50 45 
4 DLP (10 mol % x 10), 0.5 M PhCl Full 40 
5b DLP (30 mol % x 3), 0.5 M DCE, 80 °C Full 28 
a 1H NMR yields based on 2,5-dimethyl furan internal standard; b Isolated yield; c DLP additions made every 4 h. 
 
 
2.6 C–H Diversification via the Xanthate 
To illustrate the applicability of the C–H xanthylation for achieving late-stage 
derivatization, we performed seven different transformations on sclareolide xanthate 2.37 (Figure 
2.12). Through this approach, we were able to access products of formal C–H allylation, 
vinylation, azidation, deuteration, hydroxylation, thiolation, and trifluoromethylthiolation 
reactions. All the products maintained functionalization at the same position, highlighting the 
utility of our amidyl radical-mediated strategy in delivering complex molecule derivatives with 
consistent site selectivity via a common intermediate.  
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Figure 2.12. Product diversification of sclareolide xanthate.  
 
2.7  Conclusions 
A one-pot xanthate to hydroxy functional group transformation was developed by first 
reducing the xanthate with TTMSS and trapping the alkyl radical with the persistent radical 
TEMPO before reducing the alkoxyamine with Zn and acetic acid. The reaction gives moderate 
to high yields for a variety of simple to complex substrates. Reaction conditions were optimized 
for the TEMPO-trapping chemistry to maximize yield and minimize off-pathway products, in 
which the stoichiometry of reagents played a critical role. An advantage to this methodology is 
the ability to control the final oxidation state, although lengthy reaction times as well as excess 
reagents are required at times for high yields.   
This methodology was successfully implemented in the context of a C–H xanthylation 
reaction to achieve formal C–H hydroxylation products. The direct xanthylation of unactivated 
aliphatic C–H bonds was achieved using alkane substrate as the limiting reagent in all cases. 
Selectivity in general favors the most electron-rich secondary C–H site, and the reaction occurs 
under extremely mild, visible light-mediated conditions. Due to the utility of alkyl xanthates in 
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synthesis, the C–H xanthylation serves as a two-step strategy to achieve the net diversification of 
alkane substrates, accessing a wide variety of late-stage functionalization products with common 
site selectivity. Despite the utility of the transformation, one major drawback remains: nitrogen is 
not well-tolerated overall, which we attempted to address through the use of nitrogen-tolerant 





CHAPTER THREE: INVESTIGATIONS INTO DIFFERENT DITHIOCARBONYL 
GROUPS FOR NITROGEN-TOLERANT C–H FUNCTIONALIZATIONS 
3.1 Introduction 
Nitrogen-containing heterocycles are of considerable interest in medicinal chemistry, 
often responsible for key non-bonding interactions that contribute to a molecule’s overall 
pharmacological activity (Figure 3.1). As of 2014, 84 percent of all drugs approved by the FDA 
contain at least one nitrogen in their structures, with 59 percent containing some sort of nitrogen 
heterocycle.62  
 
Figure 3.1. Examples of FDA-approved nitrogen-containing drugs. 
Previously, we demonstrated C–H xanthylations of a variety of substrates, including 
complex natural products and drug derivatives, using blue light irradiation (Chapter 2). However, 
the methodology is only applicable to a small subset of nitrogen containing compounds: mainly 
weakly nucleophilic heterocycles such as pyridines and pyrroles. We attribute the inherent 
incompatibility of xanthates and amines to the high electrophilicity of the dithiocarbonyl, which 
results in fast aminolysis of the xanthate to yield the thiol and carbamothioate (Figure 3.2). 
Furthermore, most protecting groups were ineffective for the C–H xanthylation of substrates 
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with primary and secondary amines, including acetate, trifluoroacetate, carbamate, and 
sulfonamide protecting groups, with phthalimide protected primary amines making a notable 
exception: rapid decomposition of xanthylamide was observed within minutes with these 
substrates under the photochemical conditions. we realized that the nitrogen intolerance of the 
C–H xanthylation would severely limit its applicability in the late-stage functionalization of 
drug-like molecules. 
 
Figure 3.2. Generation of thiols from xanthates with amines.  
3.2 Approach 
 Nitrogen intolerance in other C–H functionalization systems, particularly metal-based 
catalysis, can stem from catalyst deactivation via nitrogen binding and direct N-oxidation.  
 
Figure 3.3. Remote functionalization of N-containing substrates by ammonium ion deactivation. 
In 2015, White presented a strategy for circumventing these problems in high valent 
metal-oxo catalysis through Lewis acid complexation or strong Brønsted acid protonation to 
form pre-complexed amine substrates using stoichiometric quantities of acid (Figure 3.3).63 
Remote functionalization is observed, instead of hyperconjugative activation α to the nitrogen, 
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due to the strong inductive effect on adjacent C–H bonds exerted by the ammonium cation. 
Similarly, Sanford achieved distal C–H oxidations of alkyl amines with a Pt(II) catalyst and 
Cu(II) oxidant through in situ ammonium ion formation from sulfuric acid (Figure 3.3).64 
Attempts by other members of the group to use amine complexation for effecting 
nitrogen tolerance with the C–H xanthylation by examining a broad range of Lewis and Brønsted 
acids were largely unsuccessful. We therefore considered an alternative method of replacing the 
xanthate with a less electrophilic dithiocarbonyl group, capable of performing the same set of 
post-reactions as the xanthate yet also resistant to amine addition.  
 
Figure 3.4. N-tolerance of various dithiocarbonyl groups.  
We first examined neopentyl O-xanthate 3.7 (Figure 3.4), hypothesizing that the added 
electron density and steric bulk would make a less electrophilic thiocarbonyl; however, 
decomposition was still observed with the addition of one equivalent of piperidine. We next 
considered the trithiocarbonate and dithiocarbamate groups as potential dithiocarbonyl 
alternatives. Of the groups examined, only dithiocarbamate 3.11 was found to resist aminolysis 
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from primary, secondary, tertiary amines as well as different N-heterocycles. We therefore 
focused our attention on dithiocarbamate transfer via amidyl radical chemistry.  
 
 
Figure 3.5. Initial synthesis attempt of N-dithiocarbamate amide from N-chloroamide. 
Initial attempts of synthesizing dithiocarbamate amide 3.13 similarly to the xanthylamide 
by reacting N-chloroamide 3.12 with the dithiocarbamate salt were unsuccessful, generating the 
desired product 3.13 in low yield (Figure 3.5). When optimization efforts of the reaction proved 
unfruitful, we considered an alternate synthesis consisting of an amide coupling between 
thiocarbamylsulfenamide 3.15 and carboxylic acid 3.14 (Figure 3.6). In 1949, Smith reported the 
synthesis of a wide variety of thiocarbamylsulfenamides in good yields by reacting in situ 
generated chloroamines (e.g., 3.16, Figure 3.6) with a sodium dithiocarbamate salt.65 
Accordingly, reagent 3.15 was prepared in good yield by treating tert-butylamine with sodium 
hypochlorite, followed by sodium diethyldithiocarbamate salt, and engaged in amide coupling to 
generate the desired reagent 3.13 in excellent yield. In general, we found the 
thiocarbamylsulfenamide reagents to be stable to silica gel chromatography with a shelf life of at 
least 2 years when stored at -20 °C.  
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Figure 3.6. Alternate synthesis of N-dithiocarbamate amide with a thiocarbamylsulfenamide reagent. 
 
3.3 Reaction Optimization 
With dithiocarbamate amide 3.13 in hand, a variety of initiation methods were examined, 
including different light sources and radical initiators, using cyclooctane as the model substrate 
(Table 3.1).  
Table 3.1. C–H Dithiocarbamation Optimization 
 
Entry Initiationa T (° C) 3.13 conversion (%) NMR yield (%)b 
1 450 nm LEDs Ambient 81 11 
2 UV-A Ambient 60 26 
3 AIBN (10 mol %) 80 0 0 
4 BPO (10 mol %) 100 27 0 
5 ABCN (10 mol %) 100 27 21 
6 DCP (10 mol %) 130 70 42 
a AIBN = azobisisobutyronitrile, BPO = benzoyl peroxide,  
ABCN = azobis(cyclohexanecarbonitrile), DCP = dicumyl peroxide;  
b 1H NMR yields based on hexamethyldisiloxane internal standard. 
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Applying identical conditions of the C–H xanthylation reaction (Entry 1, Table 3.2) using 
blue LED light initiation on cyclooctane resulted in a much lower yield of functionalized product 
3.17. UV-A light initiation provided a slight increase to the yield. Overall, radical initiators 
provided more efficient reactions, with increasing conversions and yields obtained with 
increasing temperatures (Entries 3–6). Functionalization of cyclooctane was achieved up to 40% 
yield at 130 °C using dicumyl peroxide (DCP; Entry 6).  
 
Figure 3.7. Dithiocarbamate versus xanthate transfer using radical initiators. 
However, when applying these reaction conditions to (+)-sclareolide, no product was 
observed, accompanied with a much lower conversion of dithiocarbamate amide 3.13 (Figure 
3.7). This discrepancy in yields between the reactivity of cyclooctane and (+)-sclareolide was 
also observed with C–H xanthylation when using radical initiation (Figure 3.7), altogether 
suggesting that the propagating chains with these dithiocarbonyl groups are inefficient with 
substrates with stereoelectronically non-equivalent C–H bonds. The benefit of using light 
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irradiation is that a steady rate of initiation is ensured throughout the course of the reaction. In 
comparison to the xanthate, the dithiocarbamate was a more difficult group to transfer, which can 
be rationalized by the delocalization of the lone pairs on the nitrogen reducing the C=S double 
bond character of the thiocarbonyl bond (Figure 3.8). This resonance contributes to the increased 
stability of the dithiocarbamate compared to the xanthate group that reduces the electrophilicity 
of the carbonyl center for polar addition, but also reduces the radicophilicity, rendering the 
dithiocarbonyl less reactive for radical addition. This observation is consistent with reversible-
addition-fragmentation transfer (RAFT) literature in polymer science, in which 
dialkyldithiocarbamates are considered to have the slowest transfer rates.66,67 
 
Figure 3.8. Dithiocarbamate resonance structures. 
We hypothesized that higher C–H functionalization yields could be obtained by 
increasing the radicophilicity of the thiocarbonyl with electron-withdrawing substituents on 
nitrogen, and dithiocarbamate reagents 3.23 and 3.24 were prepared to study the effect of 
different N-substitutions on the functionalization of cyclooctane using photoinitiation conditions 
(Figure 3.9). However, differences in N-substitutions also influenced the photophysical 
properties of the reagents, which complicated comparisons in reagent reactivity. Dimethyl 
derivative 3.22 was the least reactive of the reagents studied, providing no product and 
incomplete conversion of the reagent despite similarities in electronics with reagent 3.13. 
Fluorine atoms on the dialkyl substituents of the dithiocarbamate caused a red-shift in the 
absorbance spectra of 3.23, which was isolated as blue crystals, and visible light initiation 
provided low yields of functionalization. Finally, using N-methylaniline derived dithiocarbamate 
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3.24 provided a modest increase in yield, but was still less efficient compared to the C–H 
xanthylation (85% yield). Further efforts in optimization were ultimately unsuccessful.  
 
Figure 3.9. Functionalization of cyclooctane with different dithiocarbamate derivatives.  
3.4 Conclusion 
Dithiocarbamates were identified as a promising alternative to the xanthate for effecting a 
nitrogen-tolerant variant of the C–H xanthylation reaction. However, transfer of the more 
electron rich group was deemed inefficient for the intermolecular functionalization of complex 
small molecules, although space for further exploration of other dithiocarbamate derivatives 
remains. Despite the apparent failure of the project, some important discoveries and insights 
were made. The development of a reliable, convergent method of generating dithiocarbamate 
amides, for instance, led to a general approach for achieving site-selective, intramolecular C–H 
dithiocarbamation (Chapter 4). Furthermore, a part of these studies contributed to understanding 
the mechanism of dithiocarbonyl transfer via amidyl radical chemistry, which was studied in the 





CHAPTER FOUR: A GENERAL APPROACH TO SITE-SPECIFIC, 
INTRAMOLECULAR C–H FUNCTIONALIZATIONS USING DITHIOCARBAMATES 
4.1 Introduction  
A key advantage to intramolecular C–H functionalization reactions is the ability to obtain 
products site-specifically. The facile preparation of stable, isolable N‐dithiocarbonyl reagents by 
amide coupling provided an opportunity for implementing a practical, intramolecular C–H 
functionalization with dithiocarbamates (Figure 4.1). In particular, we anticipated this method to 
have a major advantage in applications involving the late stage derivatization of highly 
functionalized, bioactive small molecules on which classical Hofmann-Löffler-Freytag (HLF) 
reaction conditions cannot be applied due to the strong oxidants necessary for pre-
functionalization of the directing nitrogen (see Chapter 1.1). 
 
 
Figure 4.1. General approach for an HLF-like C–H dithiocarbamation. 
The ability to achieve product diversification marked another significant advantage of the 
intramolecular C–H dithiocarbamation reaction over standard HLF‐type reactions, which is 
largely limited to C–H halogenation and subsequent cyclized products. Although the versatility 
of the dithiocarbamate was not as well-established as they were for the xanthate, examples of 
transformations from the dithiocarbamate, such as deuteration and oxidation from Grainger,56,68 
led us to hypothesize that a range of derivatives could be accessed via polar and radical processes 
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similarly to the xanthate. The dithiocarbamate moiety is itself a useful pharmacophore with roles 
in enzyme catalysis, protein folding, and redox signaling and regulation, and collectively 
possesses anti-tumor, antibacterial, antioxidation, and insecticidal activities.69 These properties 
make C−H dithiocarbamation a reaction of considerable interest in the pharmaceutical and 
pesticide industries.  
4.2 Reaction Optimization 
Table 4.1. Optimization of an HLF-Type C–H Dithiocarbamation 
 
Entry Z = Initiatorc T (°C) Solvent Conversion (%) Yield (%)b 
1 NEt2 ABCN 100 PhCF3 <5 - 
2 NEt2 DCP 130 PhCl 60 55 
3 NMe2 DCP 130 PhCl 95 66 
4 NMe2 Blue LED Ambient PhCF3 >95 54 
5 NMePh DLP 80 PhCF3 56 41 
6 NMePh DCP 120 PhCl >95 81 
7 NMePh Blue LED Ambient PhCF3 >95 84 
a ABCN = azobis(cyclohexanecarbonitrile); DCP = dicumyl peroxide; DLP = dilauroyl peroxide;  
b 1H NMR yields based on hexamethyldisiloxane (HMDS) internal standard 
 
 
We focused on three different dithiocarbamates derived from dimethylamine, 
diethylamine, and N-methylaniline due to the convenience and practicality of their large-scale 
preparations from inexpensive amines. Initial results with N-diethyldithiocarbamate 4.1 (Entries 
1–2, Table 4.1) indicated that higher temperatures of 130 °C were necessary to induce any 
reactivity.  The use of dimethyldithiocarbamates compared to diethyldithiocarbamates led to a 
marked increase in conversion, with nearly full conversion of 4.3 observed under the same 
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conditions with improved product yield (Entry 3). Blue LEDs also made a viable method for 
initiation (Entry 4). Overall, N-methylaniline derived 4.5 provided the highest yields with both 
radical and photoinitiation methods (Entries 6–7), and subsequent studies were carried out using 
this particular dithiocarbamate. The differences observed between the reactivities of the 
intermolecular (cf. Table 3.1) and intramolecular C–H dithiocarbamation are striking, and the 
improved reactivities observed with the intramolecular functionalization is certainly a testament 
to the kinetic advantage of the C–H abstraction step.   
4.3 Substrate Scope 
Table 4.2. Intramolecular C–H Dithiocarbamation of N-Alkyl Hexanamides 







tBu (4.6) 61 56 – 













We began by examining simple substrates derived from straight chain carboxylic acids 
using both photo- and radical initiation methods. A variety of other N-alkyl substituted 
hexanamides made competent substrates and proceeded in good yields (Table 4.2), although 
among those examined, perfect site-specificity was only observed with the tBu and iPr amides.  
A 3:1 product mixture was observed with the nPr amide, with minor regioisomer 4.9 resulting 
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from a 1,6-HAT process, suggesting that some steric bulk around nitrogen is necessary to 
enforce a rigid transition state for the 1,5-HAT step. With the nHex amide, where 
functionalization could occur on either the N- or C- termini of the substrate, functionalization on 
the carboxy side chain was slightly favored.  
Table 4.3. Site-Specific C–H Dithiocarbamylation of Simple Substrates 







1 4.12: R = Ph 82 82 
























Substrates derived from simple amines proceeded smoothly (Entries 1–2, Table 4.3) with 
both benzamides and trifluoroacetamides providing similar yields. Primary C–H 
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functionalization was also successful in moderate to good yields (Entries 3–4). 
Functionalizations of cyclic substrates generated 1,2- or 1,3-substituted products in good yields 




Figure 4.2. Potential mechanism for dehydrogenation with attempted tertiary C–H functionalization. 
While C–H functionalizations of unactivated primary and secondary C–H bonds were 
successful, attempts to obtain tertiary functionalized products with N-dithiocarbamate 4.18 
instead resulted in a mixture of alkenes, with a preference for terminal olefin 4.19 in a 4.3:1 
selectivity (Figure 4.2). We hypothesized that the mixture of olefins resulted from elimination of 
tertiary cation 4.25, generated from oxidation of tertiary radical 4.21 by substrate 4.18 (Figure 
4.2). We speculated that this reactivity was only observed with the C–H functionalization of 
tertiary C–H bonds due to the relative stability of tertiary radical species 4.21. While secondary 
and primary radicals would favor fragmentation of the captodatively-stabilized species (e.g. 
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4.22) to generate the desired product, the equilibrium would be shifted to favor tertiary radical 
4.21, resulting in off-pathway products 4.19 and 4.20.  
Attempts to trap tertiary radical 4.21 with an exogenous allylating trap were met with 
limited success (Figure 4.3), providing the quaternary carbon products 4.26 and 4.27 in low 
yields. In contrast, no trapped products were observed in an analogous reaction involving 




Figure 4.3. Tertiary radical trapping experiments.  
Substrates were prepared from various natural products and drug derivatives to 
demonstrate the practicality of the C–H dithiocarbamation for late-stage derivatization (Figure 
4.4). Reaction of the N‐dithiocarbamate derived from rimantadine delivered 4.28 in good yield. 
The C−H functionalization of substrates prepared from the amino acids norleucine and valine 
provided products 4.29 and 4.30, respectively, in good yields, with functionalization at either the 
secondary or primary C−H site. Reaction of the N‐dithiocarbamate derived from the clotting 
agent tranexamic acid proceeded in high yield to deliver the trisubstituted cyclohexane core of 
4.31.  
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More complex carboxylic acids were examined to further probe the functional group 
compatibility of the intramolecular C–H dithiocarbamation. The electron-rich arene of 
gemfibrozil was tolerated in a reaction affording 4.32 in moderate yield. Pyridine functionality 
was tolerated, as demonstrated by the reaction of the N-dithiocarbamate nicotinamide delivering 
4.33 in good yield. The enone functionality of progesterone was also tolerated to provide primary 
C−H functionalization of the C18 methyl group (4.34). The N‐dithiocarbamate derivative of 
NSAID etodolac provided 4.35, with 1,6‐functionalization adjacent to the oxygen atom of the 
tetrahydropyran ring preferred instead of 1,5‐functionalization of the pendant ethyl group. 
Finally, the site‐specific functionalization of an unsaturated sidechain containing a skipped diene 
derived from linoleic acid was successful (4.36). 
 
 
Figure 4.4. Complex substrate scope.  
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4.4 Dithiocarbamate Post-Transformations  
Dithiocarbamates have relatively fewer literature precedence demonstrating their 
chemical versatility compared to xanthates. Therefore, we performed several post-
transformations on nicotinamide 4.33 to exemplify the utility of the dithiocarbamate as a 
synthetic intermediate. Reduction with deuterated hypophosphorous acid initiated by AIBN 
provided deuterated product 4.37 in good yield. Azide and allyl functionalities were similarly 
transferred in good yields using bis(tributyltin) and di-tert-butyl hyponitrite (DTBHN) initiation 
with the appropriate sulfone traps. While reduction of the dithiocarbamate was also possible with 
the more benign dilauroyl peroxide (DLP) to provide products 4.38 and 4.39, the complex 
reaction mixtures that ensued complicated purification.  
 
Figure 4.5. Dithiocarbamate post-functionalization reactions.  
Thiol 4.40 was accessed using hydrazine hydrate to cleave the dithiocarbamate. Finally, 
under refluxing diphenyl ether (258 °C), elimination of the dithiocarbamate in a Chugaev-like 




Figure 4.6. Dehydrogenation via Chugaev-like elimination of dithiocarbamates. 
4.5 Conclusion 
A general approach to site‐specific, intramolecular C−H functionalization was made 
possible by the convergent synthesis of N‐dithiocarbamate amides from carboxylic acids and 
thiocarbamylsulfenamides. HLF-type reactivity of N‐dithiocarbamates derived from N-
methylaniline was achieved using photo- and radical initiation, and was applicable to the 
diversification of both primary and secondary C−H sites in a number of complex natural 
products and drug derivatives. In particular, the successful functionalization of substrates 
containing electron-rich arenes, Lewis basic functionalities, and unsaturation, which would 
otherwise be problematic with other C–H functionalization methods, highlights the high 
functional group compatibility of the methodology. Overall, the products available via the 
intramolecular C–H dithiocarbamation offers opportunities for parallel functionalization and 




CHAPTER FIVE: CHEMO- AND REGIOSELECTIVE FUNCTIONALIZATION OF 
ISOTACTIC POLYPROPYLENE: A MECHANISTIC AND STRUCTURE-PROPERTY 
STUDY 
5.1 Introduction  
Polyolefins make up a high-volume class of polymers. Their widespread use in packaging 
and coatings is in large part due to their desirable physical properties, including high tensile 
strength, low density, resistance to chemical degradation, and processability.71 Some of the most 
common polyolefins include polyethylene (PE) and polypropylene (PP), which are 
semicrystalline materials that become pliable above their melting temperature (Tm) and solidify 
upon cooling. This property allows molding of the material into a variety of useful shapes. 
However, due to their inherent lack of functionality, polyolefins do not interface well with other 
materials, which limit their ability to form composites, adhesives, or blends.72 The ability to 
incorporate functionality into polyolefins, therefore, has the potential to generate new 
thermoplastics with unique properties for high-performance engineering applications. 
5.2.  Background 
There are the two main approaches for accessing polar polyolefins: copolymerization and 
post-polymerization modification (PPM). In copolymerization, monomers containing 
functionalities are used with α-olefins in the polymerization process, resulting in direct 
incorporation of the desired functionality into the polymer from simple and often commercially-
available monomers.73 However, these Lewis basic monomers poison the early transition-metal 
catalysts typically used in polyolefin polymerization processes, resulting in low molecular 
weight materials. Additionally, nonrandom incorporation of the polar comonomer is often 
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observed, resulting in materials with unevenly distributed polar functionalities. While significant 
advances have been made with the development of late transition-metals to minimize Lewis 
acid/base complex formation and reaction inhibition as pioneered by Brookhart with DuPont 
(Figure 5.1),74–76 the high costs associated with these specialized catalysts ultimately make them 
unviable for practical implementation.  
 
Figure 5.1. Copolymerization to introduce functionalities to polyolefins. 
 
Another strategy for accessing polar olefins involves the copolymerization of an α-olefin with a 
monomer containing a masked functionality that can be further manipulated to install the desired 
functionality in a second step (Figure 5.2).77 Certain monomers, including those containing 
borane, p-methylstyrene, and divinylbenzene, allow the copolymerization reaction to proceed 
without catalyst deactivation. However, the types of functionalities that can be incorporated into 
the final product are inherently limited with this approach. 
 
Figure 5.2. Copolymerization of a borane-containing monomer with ethylene. 
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On the other hand, post-polymerization modification (PPM) is a strategy for accessing 
new polymers from existing materials.3,72 The direct PPM of polyolefins via C–H 
functionalization is particularly attractive for transforming inexpensive polyolefins already 
produced on industrial scale into functionalized materials. Ideally, PPM also enables modulation 
of functional group density in the polymer, which can be challenging with existing 
copolymerization strategies. Significant macroscopic changes in the polymer’s physical 
properties are observed with minor changes in the polymer’s chemical structure. Unlike for small 
molecules, the high stability of polyolefins allows the use of harsh and non-selective reagents.  
Post-polymerization modification is practiced commercially with maleic anhydride 
grafting to polyethylene (PE) and isotactic polypropylene (iPP) by reactive extrusion, a process 
in which reactivity occurs in the melt phase at high temperatures inside an extruder.78 The 
thermal decomposition of a peroxide forms a radical species that can abstract a C–H bond, 
generating a carbon-centered radical (e.g. 5.1, Figure 5.3) that can add into maleic anhydride. 
With branched polyolefins, the C–H abstraction of weaker, tertiary C–H bonds is observed, 
resulting in tertiary carbon-centered radicals that are prone to β-scission processes. Chain 
scission events have deleterious effects on the properties of the polymer, resulting in low 
molecular weight species (5.3) with minimal incorporation of polar functionalities.79 
 
Figure 5.3. Maleic anhydride grafting to iPP. 
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A number of transition metal-catalyzed C–H functionalizations have been successfully 
applied on polymeric samples, most notably the rhodium-catalyzed hydroxylation of branched 
polyolefins by Hartwig and Hillmyer (Figure 5.4).80,81 The presence of trace metal, however, can 
catalyze auto-oxidation processes causing polymer degradation.82 Due to challenges associated 
with purification and fully eliminating metal from the product, strategies for post-polymerization 
modification that avoid the use of transition metals or Lewis acidic compounds are highly 
desirable. 
 
Figure 5.4. Rh-catalyzed C–H hydroxylation of polypropylene. 
 
Relatively few strategies for metal-free PPM have been reported. In 2017, Liu and 
Bielawski reported the azidation of isotactic polypropylene (iPP) with an azidoiodinane reagent 
(Figure 5.5).83 Up to 3.5% azidation could be achieved, which occurred only at tertiary sites. As 
a result, the functionalized iPP showed a significant decrease in the average molar mass (Mn) of 
polymer chains, indicative of chain cleavage in the reaction, as well as a decrease in dispersity 
(Đ).  
 
Figure 5.5. C–H azidation of polypropylene.  
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Also in 2017, Sun and Chen disclosed the C–H amination of polyethylene (Mn =7.9 
kg/mol, Đ = 1.83) using NHPI as a C–H abstracting reagent and dialkyl azodicarboxylates as the 
radical trap (Figure 5.6).84 Up to 15 mol % amination was observed using a di-tert-butyl 
azodicarboxylate radical trap with no evidence of chain scission or coupling occurring under the 
reaction conditions. Unlike with unfunctionalized PE, blends could be obtained of the 
functionalized PE with poly(methyl methacrylate) (PMMA).  
 
 
Figure 5.6. C–H amination of polyethylene. 
 
Recently, the C–H xanthylation was applied onto polyolefins in a collaboration between 
the Alexanian and Leibfarth groups (Figure 5.7).85 This initial report represented an important 
advancement in the field of PPM as a metal-free method with tunable degrees of 
functionalizations available by adjusting the amount of xanthylamide 5.5 present in the system 
relative to repeat unit of the polymer. Importantly, due to the high methylene site-selectivity 
observed with xanthylamide, no chain scission was observed, and the versatility of the alkyl 
xanthate group enabled access to a diverse number of polyolefins containing useful 
functionalities. The photoinitiation conditions used, however, was a limitation that we 
recognized would make practical large-scale implementation by reactive extrusion difficult. 
Therefore, we set out to develop thermal conditions to enable large-scale C–H xanthylations of 




Figure 5.7. Photoinitiated C–H xanthylation of hyperbranched polyethylene. 
5.3 Thermally-Initiated C–H Xanthylations  
5.3.1 Small Molecule Studies 
Thermal reaction conditions for C–H xanthylation were developed using cyclooctane as a 
model small-molecule substrate for optimization due to its relatively high boiling point (149 °C) 
and the symmetry of functionalized product 5.6 enabling facile analysis.  
Table 5.1 Optimization of a Thermally-Initiated Xanthylation on Cyclooctane 
 
Entry Initiatora Solvent T (° C) 5.5 conversion (%) Yield (%) 
1 AIBN PhH 80 24 22 
2 DLP PhH 80 36 25 
3 BPO PhH 80 26 17 
4 BPO PhCl 100 63 39 
5 (tBuO)2 PhCl 130 37 23 
6 DCP PhCl 110 56 37 
7 DCP PhCl 130 100 66 
a AIBN = azobisisobutyronitrile, DLP = dilauroyl peroxide, BPO = benzoyl peroxide, DCP = dicumylperoxide 
 
A range of common initiators were evaluated (Table 5.1). The use of radical initiators 
azobisisobutyronitrile (AIBN), dilauroyl peroxide (DLP), and benzoyl peroxide (BPO) provided 
similarly low yields of functionalized product (17–25%) at 80 °C with 1 equivalent of 
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xanthylamide 5.5 (Entries 1–3, Table 5.1). Increasing the reaction temperature generally 
corresponded to an increase in yield, with the highest yield obtained with dicumyl peroxide 
(DCP) initiation at 130 °C (Entry 7).  
We synthesized reagents 5.7 and 5.8 to probe the structure-reactivity properties of amidyl 
reagents with different thiocarbonylthio groups. Trithiocarbonylamide 5.7 was synthesized 
similarly to xanthylamide through reaction of the N-chloroamide in a low but synthetically useful 
yield (25% yield), while dithiocarbamylamide 5.8 was synthesized via the amide coupling 
approach described in Chapter 3. Despite differing only in the heteroatom in the thiocarbonylthio 
group, reagents 5.7 and 5.8 provided lower yields of functionalized cyclooctane under analogous 
conditions to those of 5.5 (Figure 5.8). Complete conversion of trithiocarbonylamide 5.7 was 
observed, but only a 47% yield of functionalized cyclooctane 5.9 was obtained. Reaction with 
dithiocarbamylamide 5.8 resulted in incomplete conversion but demonstrated a similar yield to 
that of reagent 5.7. 
 
Figure 5.8. Cyclooctane functionalization by various thiocarbonylthio amides. 
5.3.2 Application to Polyolefins  
All polymer studies were performed by Jill Williamson unless otherwise noted, and a 
brief summary of the results are presented herein. 
Thermal conditions developed for C–H dithiocarbonylation were applied on 
hyperbranched polyethylene (HBPE). HBPE with 10 methyl branches per 100 carbons was 
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synthesized using a previously reported Pd(II) α-diimine catalyst,86 and polymers of different 
number-average molar mass (Mn) and narrow dispersities (Đ) were synthesized to determine the 
influence of reaction conditions on molecular weight and MWD.  
Table 5.2. Functionalization of HBPE 
 
Entry Z Theoretical mol % 
funct 





Mn Đ Mn Đ 
1 OEt 10 4 80 35 1.03 48 1.11 
2 OEt 20 5 82 35 1.03 51 1.07 
3 OEt 50 7 69 35 1.03 53 1.09 
4 OEt 100 7 54 35 1.03 40 1.07 
5 SEt 10 3 50 42 1.05 45 1.12 
6 SEt 20 3 35 42 1.05 45 1.08 
7 SEt 50 3 39 42 1.05 45 1.06 
8 SEt 100 3 32 42 1.05 43 1.10 
9 NEt2 10 1 24 35 1.17 35 1.22 
10 NEt2 20 1 22 35 1.17 35 1.28 
11 NEt2 50 1 21 35 1.17 35 1.27 
12 NEt2 100 1 18 35 1.17 35 1.24 
a Determined by 1H NMR in CDCl3. b Determined by SEC against polystyrene standards in THF. 
The reaction of HBPE with xanthylamide 5.5 with 10 mol % DCP in chlorobenzene at 
130 °C resulted in 4 mol % polymer xanthylation (Entry 1, Table 5.2) at a theoretical maximum 
functionalization of 10 mol % (i.e., addition of 1 equiv of reagent per 10 repeat units). C–H 
functionalization of HBPE could be tuned to 1–7 mol % by varying the loading of reagent 5.5 
with xanthylation plateauing around 8 mol %. Reagents 5.7 and 5.8 also successfully 
functionalized HBPE, but the plateau of functionalization appeared at much lower values of 3 
and 1 mol %, respectively. Changes in the molecular weight distribution (MWD) as analyzed by 
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size exclusion chromatography (SEC; Figure 5.9) showed that 1 mol % xanthylated (from 5.5) 
and trithiocarbonylated (from 5.7) HBPE demonstrate MWD similar to that of the parent 
polymer, but dithiocarbamylated (from 5.8) HBPE shows evidence of polymer-chain coupling.  
 
Figure 5.9. SEC trace of 1 mol % functionalized HBPE. 
The 1 mol % functionalized variants of the polymers demonstrated thermal stability up to 250 °C 
as determined by thermal gravimetric analysis (TGA), at which point a partial mass loss was 
observed before reaching a plateau and fully degrading at >400 °C (Figure 5.10). The magnitude 
of mass loss for each of the functional polymers in TGA correlates to the loss of the entire 
thiocarbonylthio functional group, which we hypothesize is the result of a [1,5]-sigmatropic 
Chugaev-type elimination to yield an olefin on the polymer backbone. Mass spectrometric 
analysis of the volatile compounds by TGA/MS indicated a prominent peak in all of the samples 
with a mass to charge (m/z) of 76.1, which would be consistent with the expulsion of CS2.  
 
Figure 5.10. TGA-MS of HPBE. 
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5.4 Mechanistic Insights 
The differences observed in the reactivities with the three thiocarbonylthio groups can be 
rationalized with what is known from reversible-additional fragmentation transfer (RAFT) 
polymerization.66,67,87,88 In RAFT polymerization, the choice of Z groups has pronounced effects 
on the rates of radical addition to thiocarbonylthio functional groups and the rate of 
fragmentation of the captodatively stabilized species (Figure 5.11). The rate of radical addition 
for the Z groups decreases in the series SEt > OEt > NEt2, whereas the rate of radical 
fragmentation decreases in the series NEt2 > OEt > SEt.  
 
Figure 5.11. The influence of the Z group on the rates of addition and fragmentation. 
For the dithiocarbamate functional group in 5.8, a slower rate of radical addition leads to 
a longer lifetime of the polymer-centered radical 5.11 and an increased potential for radical–
radical coupling (Figure 5.12). Significant chain coupling observed in the SEC traces (Figure 
5.9) supports this hypothesis. Conversely, the faster rate of radical addition into the 
trithiocarbonate leads to better control over the MWD of the functionalized polyolefin. The faster 
rate of addition, however, results in a lower amount of overall polymer functionalization 
than 5.13 even at high reagent loadings, presumably due to a faster rate for k-2 even after 5.13 is 
formed. We hypothesize that the relatively higher functionalizations observed for xanthylation is 
due to the balance in rates of addition and fragmentation. 
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Figure 5.12. Chain propagation.  
Further evidence of reversible functionalization comes from crossover experiments using 
xanthylated polymer samples and reagents 5.7 and 5.8, resulting in a loss of mol % xanthylation 
in the product (e.g. Figure 5.13), with both Z groups observed on the functionalized polymer. 
Furthermore, xanthylated polymer samples that were heated in the presence of DCP as an 
initiator with no additional reagent showed a decrease in functionalization. 
 
Figure 5.13. Evidence of reversible functionalization with functionalized HBPE.  
5.5 Functionalization of Semicrystalline Polyolefins 
The thermal functionalization of several commercially available semicrystalline branched 
polyolefins was achieved, including linear low-density PE (LLDPE), low density PE (LDPE), 




Table 5.3. Functionalization of Semicrystalline Polyolefins 
 
Polyolefin Entry Z Ratio of 
1 : repeat unit 
Mol % functa  Mn (kg/mol)
b Đ b Tm (°C)
c 
 
Linear low density PE 
Tm = 122 °C 
Mn = 22 kg/mol 
Đ = 3.37 
1 OEt 1:20 3 28 7.66 95 
2 OEt 1:10 7 15 6.17 75 
3 SEt 1:10 3 23 3.84 100 
4 NEt2 1:10 0 – – – 
 
Low density PE 
Tm = 105 C 
Mn = 41 kg/mol 
Đ = 9.54 
5 OEt 1:20 3 41 23.35 84 
6 OEt 1:10 5 39 13.15 73 
7 SEt 1:10 3 43 17.94 85 
8 NEt2 1:10 0 – – – 
 
Isotactic PP 
Tm = 155 C 
Mn = 64 kg/mol 
Đ =4.84 
9 OEt 1:20 0 – – – 
10 OEt 1:10 1 84 4.03 144 
11d OEt 1:20 1 63 9.72 137 
12d OEt 1:10 2 79 7.34 130 
a Determined by 1H NMR at 110 °C; b Determined by SEC at 120 °C;  
c Determined by DSC in the second heating cycle; d Neat conditions. 
 
Xanthylation of Dow DNDA-1081 NT 7 linear low density polyethylene resin (LLDPE, 
19 branches per 100 carbons) using reagent 5.5 resulted in 3 mol % functionalization upon 
addition of 5 mol % of the reagent. At higher equivalents of reagent 5.5, mol % functionalization 
increased along with an observed increase in MWD. With trithiocarbonate reagent 5.7, which has 
a faster rate of radical addition, the amount of deleterious chain coupling and chain scission side 
reactions decreased and led to moderate functionalization of LLDPE without significantly 
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altering Mn or Đ. Functionalization of Dow polyethylene 4012 low density (LDPE, 49 branches 
per 100 carbons) with reagents 5.5 and 5.7 provided efficient functionalization. However, no 
functionalization was imparted using reagent 5.8. Finally, Basell Profax 6301 polypropylene 
homopolymer (iPP) was functionalized with reagent 5.5 only under neat conditions (i.e. without 
solvent) at 1 mol % at a theoretical maximum functionalization of 5 mol %. High-temperature 1H 
NMR spectroscopy indicated that functionalization occurred only at the primary C–H bonds 
on iPP. 
Reaction scale-up by reactive extrusion using a twin-screw extruder was performed by 
Jill Williamson and William Daniel of iPP and reagent 5.5 with 10 mol % DCP at a 
stoichiometry corresponding to a theoretical maximum functionalization of 5 mol % at 180 °C. 
The extrusion process was circulated for 30 min and resulted in 1 mol % xanthylation of iPP 
with 1 mol % xanthate groups and no observed β-scission.  
 
Figure 5.14. SEC of 1 mol % xanthylated polypropylene from reactive extrusion. 
Overall, the xanthylated iPP retained desirable thermomechanical properties. Slight 
decreases in melting point (137 °C) and percent crystallinity (28%) were observed compared to 
the commercial Profax 6301 material (Tm = 155 °C, 41% crystalline). Tensile testing of 
xanthylated iPP and regular iPP similarly showed plastic deformation behavior consistent with 
semicrystalline thermoplastics (Figure 5.15, left). Xanthylated iPP exhibited significantly 
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improved adhesive properties compared to iPP even at 1 mol % functionalization (Figure 5.15, 
right): a comparison of lap shear strengths between iPP and xanthylated iPP showed that 
xanthylated iPP (120 ± 30 MPa) had twice the adhesion strength to glass than did the iPP 
material (48 ± 4 MPa).  
              
Figure 5.15. Comparison of tensile and lap shear strengths. 
5.6 Conclusions  
 Thermal conditions were developed for the C–H xanthylation of branched polyolefins, 
and two new thiocarbonylthio amides were successfully synthesized to explore structure-
reactivity properties involved in thiocarbonylthio group transfer. Ultimately, these studies 
allowed translation of the reaction onto a twin-screw extruder for a decagram production of 1% 
xanthylated iPP. This material displayed more than double the adhesive properties of commercial 
iPP while maintaining similar tensile properties. As dithiocarbonyl groups are already used by 
polymer chemists as a technique for providing controlled polymerizations using RAFT 
(reversible addition-fragmentation chain transfer) chemistry, the functionalized products provide 





CHAPTER SIX: DIRECT DECARBOXYLATIVE FUNCTIONALIZATION OF 
CARBOXYLIC ACIDS VIA O–H HYDROGEN ATOM TRANSFER 
6.1  Introduction 
Achieving site-selectivity in C–H functionalization remains a major challenge, especially 
for unactivated methylene C–H bonds where bonds are typically characterized by similar steric 
environments and bond strengths. One approach to addressing this challenge is to leverage the 
functionalities present on the substrate molecule and fix substrate orientation to the reagent 
through non-covalent interactions. By positioning the reagent in close proximity to a single C–H 
bond in the substrate, high levels of site-selectivity can be achieved. While transition-metal 
catalysis relies heavily on directing groups for controlling selectivity in aryl C–H activation,89 
considerably less work has been done in the context of aliphatic methylene functionalization.  
 
 
Figure 6.1. Ion pairing coordination for directed C–H chlorination. 
An early example of directed selectivity through non-covalent interactions can be found 
in Breslow’s work on templating strategies for the selective C–H functionalizations of various 
steroid scaffolds.90 Ion-pair coordinated complex 6.1 afforded chlorination in good yields with a 
3.5:1 preference for halogenation at C9 over C14 under visible light irradiation using 
iodobenzene dichloride as a chlorinating agent (Figure 6.1). No chlorination was observed in a 
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system without the ion-paired aryl iodide, demonstrating the importance of the template for 
directing C–H abstraction.   
White showed that carboxylates could be used as directing groups with iron complexes.25 
The C–H oxidation of tetra-hydrogibberellic acid (6.3, Figure 6.2) furnished lactone 6.4 as a 
single diastereomer in 52% yield (recycled once), formed upon C–H hydroxylation of the C15α 
C–H bond and subsequent lactonization.  
 
 
Figure 6.2. Carboxylate-directed C–H lactonization. 
A recent collaboration between Costas and Bietti also used carboxylates as directing 
groups for the enantioselective C–H oxidation of various adamantaneacetic acids by manganese 
catalysis.91 The functionalization of adamantaneacetic acid 6.5 by a chiral Mn catalyst resulted in 
lactone 6.7 from the C–H hydroxylation of the secondary γ C–H bonds; the corresponding 
methyl ester 6.6 provided functionalization at the tertiary C–H bond with 6.8 (Figure 6.3). 
 
 
Figure 6.3. Carboxylate-directed enantioselective C–H lactonization. 
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We similarly considered using substrate-reagent non-bonding interactions to position an 
amidyl radical by a specific C–H bond in a substrate molecule to obtain unique selectivities. We 
hypothesized that hydrogen bonding between the carboxylic acid moiety of the substrate and the 
pyridyl nitrogen of a reagent derived from nicotinic acid could be used to direct selectivity 
(Figure 6.4). Dithiocarbamate amide 6.10 was prepared for this purpose, which was synthesized 
easily by amide coupling. 
 
 
Figure 6.4. Strategy for directed functionalization by hydrogen bonding.  
Despite concerns of the poor reactivity observed with dithiocarbamate transfer in our 
intermolecular C–H functionalization studies (Chapter 3), we reasoned that the enhanced kinetics 
provided by an ordered transition state may provide a fast-enough C–H abstraction for efficient 
chain propagation, as demonstrated by the successful C–H intramolecular dithiocarbamation 
(Chapter 4). Initial experiments using reagent 6.10 and hexanoic acid under blue light irradiation, 
however, revealed decarboxylated 6.11 as the major product. A similar observation was made 
using xanthylamide 6.12. Further studies into this unexpected pathway eventually led to the 
development of a highly efficient, decarboxylative xanthylation reaction.  
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Figure 6.5. Initial decarboxylation results observed with N-dithiocarbonyl amides. 
6.2 Background 
Carboxylic acids make up a ubiquitous class of organic starting materials, and in recent 
years have been featured heavily as radical precursors in the context of decarboxylative 
functionalization.92 Despite the breadth of transformations available via decarboxylation 
techniques, there is a considerable dearth of methods available for generating thiols.  
Sulfur features predominantly in a variety of biologically active natural products, most 
notably in the cores of the penicillin and cephalosporin family of antibiotics and from the 
cysteine residue of various peptides and coenzymes.93  The low-lying σ* orbitals of the C–S 
bond allow for interactions with electron donating atoms with implications in providing 
conformational control for enhanced binding affinity in drug design. Thiols especially play a 
prevalent role in biology, performing a wide range of regulatory and metabolic functions 
imparted by its nucleophilicity, high affinity metal binding, and ability to form disulfide bonds.94 
Thiols are also used in thiol-ene click chemistry, useful for bioconjugation with additional 
applications in polymer synthesis and materials science.95 Despite the unique chemical attributes 
granted by sulfur, its introduction into pharmaceutically relevant molecules remains difficult, 
especially in late-stage modifications. Thiols are most commonly prepared by alkylation, 
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traditionally using an organolithium with elemental sulfur or a thioacetate salt with subsequent 
deprotection.96 
To the best of our knowledge, the only method of generating thiols from aliphatic 
carboxylic acids comes from Nyfeler and Renaud using dithiocarbamoyloxycarbonyl (MDMOC) 
esters (6.14, Figure 6.6).97 Irradiation of 6.14 under a 300 W sunlamp generates sulfide 6.15, 
which can then be reduced to thiol 6.16 with LiAlH4. While Nyfeler and Renaud demonstrate the 
practical use of MDMOC esters for also accessing decarboxylative azidation and bromination 
products, the requirement for a pre-activation step and also the use of a strong reductant limits its 
potential utility in late-stage implementation.   
 
 
Figure 6.6. Dithiocarbamoyloxycarbonyl (MDMOC) ester decarboxylation.  
Recognizing the xanthate as a masked thiol, which can be easily cleaved under 
mild aminolysis or hydrolysis conditions, we believed that a decarboxylative xanthylation would 
enable a general approach for the syntheses of thiols.   
6.3 Reaction Optimization  
Early optimization efforts focused on cyclohexanecarboxylic acid as substrate with 
xanthylamide 6.12. A screen of different initiators revealed that dilauroyl peroxide (DLP) 
provided the highest yield of 71% yield while maintaining excellent mass balance (Entry 3, 
Table 6.1). Increasing the loading of xanthylamide 6.12 to 1.5 equivalents boosted the yield of 
6.17 to 90% yield (Entry 5).  
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Table 6.1. Decarboxylative Xanthylation of Cyclohexanecarboxylic Acid 
 
Entry Initiator 6.12 conversion (%) SM (%) Yield (%) 
1b Blue LED >95 28 58 
2 AIBN 21 81 16 
3 DLP >95 30 71 
4 BPO 83 34 57 
5c DLP 87 >95 90 
a 1H NMR yields based off of HMDS internal standard; b Reaction at ambient temperature; 
 c 1.5 equivalents of reagent 6.12 used. 
 
 
Further optimization of the decarboxylative xanthylation was performed on the primary 
acid hexanoic acid. Using 1 equivalent of xanthylamide 6.12 furnished moderate yields of 
xanthate 6.19 with either DLP initiation or blue LED irradiation (Entries 1–2, Table 6.2). Using a 
more powerful blue LED light source (45 W vs 23 W) had a positive effect on the yield 
(compare Entry 2 to Figure 6.5). Reaction efficiency improved with the pentafluorophenyl-
substituted N-xanthylamide (6.18), especially under photoinitiation, and an excellent yield could 
be obtained using only a slight excess of the reagent (Entry 4). Initiation by DLP was less 
efficient compared to blue light initiation, but a good reaction yield could be obtained with 2 
equivalents of xanthylamide 6.18 (Entry 6). Xanthylamide 6.18 is synthesized similarly to 
xanthylamide 6.12 by treating chloroamide 6.20 with potassium ethyl xanthate salt and can be 






Table 6.2. Decarboxylative Xanthylation of 1-Hexanoic Acid  
 
Entry Xanthylamide reagent  Initiation Yield (%)a 
1 6.12 (1 equiv) 10 mol % DLP 49 
2 6.12 (1 equiv) 440 nm LED 59 
3 6.18 (1 equiv) 440 nm LED 81 
4 6.18 (1.2 equiv) 440 nm LED 86 
5 6.18 (1 equiv) 10 mol % DLP 55 
6 6.18 (2 equiv) 10 mol % DLP 70 
7b 6.18 (1 equiv) 10 mol % DLP <2 
8 6.18 (1 equiv) - <2 
a Determined by 1H NMR spectroscopy of the crude reaction mixtures using hexamethyldisiloxane as an internal 




Figure 6.7. Synthesis of the pentafluorophenyl-substituted N-xanthylamide. 
 
6.4  Substrate Scope 
Simple primary acids were converted to xanthates 6.13, 6.20–6.25 in good yields (Figure 
6.8). Both aryl and alkyl halides were tolerated, the latter of which is notable considering that 
alkylation is a common method for the synthesis of both alkyl xanthates and thiols.96 Ester, 
ketone, and olefin functionalities were well-tolerated. N-heterocycle containing substrates also 
reacted well, for instance providing indole 6.25 in 62% yield. Simple secondary acids appended 
to either acyclic chains or rings reacted well, providing quantitative yields of hexylxanthates 6.17 
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and 6.26. The reaction of endo norbornane-2-carboxylic acid resulted exclusively in the exo-
xanthate diastereomer 6.27 in 92% yield. Reaction of the 1,4-substituted cyclohexane diacid 
resulted in decarboxylation of both carboxylic acid moieties to give dixanthate 6.28 as a mixture 
of diastereomers. Cyclobutane derivative 6.29 could be accessed in good yield, and 
decarboxylation on the tetrahydropyran and piperidine rings were likewise efficient, providing 
6.30 and 6.31 in 73 and 69% yield, respectively. 
 
Figure 6.8. Simple substrate scope. 
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Finally, a variety of tertiary acids reacted to provide xanthates 6.32–6.35 in good to 
excellent yields (80–99% yield). Ketopinic acid reacted to give xanthate 6.36 in 67% yield, 
which is notable considering that decarboxylation of the β-ketoacid without promoting ring 
cleavage is reportedly difficult due to the bridgehead ketone.98 Compared to primary carboxylic 
acids, secondary and tertiary carboxylic acids generally reacted more efficiently. We attribute the 
higher efficiency to both a faster rate of decarboxylation and also a faster rate of radical addition 
into the thiocarbonyl group of the xanthate in the group transfer sequence.   
 
 
Figure 6.9. Complex substrate scope. 
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To further demonstrate the broad scope and functional group tolerance of the 
decarboxylative xanthylation reaction, we turned to implementing late-stage modifications 
on various natural products and drug derivatives (Figure 6.9). The clotting agent tranexamic acid 
provided 6.37 in 84% yield as a mixture of diastereomers. Reactions of the nonsteroidal anti-
inflammatory drugs (NSAIDs) ibuprofen and indomethacin provided benzylic xanthates 6.38 and 
6.39. Benzylic carboxylic acids ibuprofen and indomethacin provided 6.38 and 6.39, 
respectively, in moderate yields, most likely due to the relative stability of benzylic radicals 
resulting in reversible reactivity.67 Ibuprofen was the only substrate for which xanthylamide 6.12 
provided a superior yield. Reaction of the hydrolyzed derivative of terpenoid sclareolide initially 
suffered from competing lactonization, but could be optimized to deliver 6.40 in good yield 
when using fan cooling with blue LED irradiation. 
Opportunities for synthesizing various steroid derivatives are possible, 
with xanthylations on the chain end of lithocholic acid (6.41) and on the D ring of 
progesterone (6.42). The bioactive natural product isosteviol provided xanthate 6.43 in excellent 
yield. Likewise, the triterpenoid glycyrrhetinic acid provided xanthate 6.44 in excellent 
yield. The plant hormone gibberellic acid, containing allylic alcohol and lactone functionalities, 
provided xanthate 6.45 in 72% yield as a single diastereomer. Various protected amino acids 
provided decarboxylative xanthates 6.46 and 6.47 in good yields. Notably, glutamic acid, with its 
acid-containing side chain, provides opportunities for both unnatural amino acid synthesis and 
incorporation in peptides. As an example, we took the tripeptide consisting of the sequence N-
Phth-Glu-Glu-Gly-OMe, which reacted modestly to give 6.48 under standard conditions but with 
good recovery of the starting material. Considering the importance of cysteine-containing 
peptides in maintaining regulatory and metabolic functions in plants, animals, fungi and 
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bacteria, we envision this method for peptide modification will be of significant value in future 
biological studies.   
 
 
Figure 6.10. Unsuccessful substrates. 
 Notable functionalities that were not tolerated in the reaction include pyridines, tertiary 
amines, and phenols (6.49–6.51, Figure 6.10). Although Boc-protected secondary amines made 
competent substrates (6.31, Figure 6.8), Boc-protected primary amines furnished little to no yield 
(6.52, Figure 6.10). The decarboxylative xanthylation of Boc-protected proline 6.53 proceeded in 
low yield under standard conditions (<10% yield), although higher temperatures of 130 °C using 
dicumyl peroxide (DCP) initiation could afford the product up to 34% yield. We hypothesize that 
the relative stability of alpha heteroatom radicals and the reversible reactivity of activated 
xanthates are responsible for the diminished yield.  
 
Figure 6.11. Reactions of other oxyacids.  
76 
We found that other oxyacids react similarly: unoptimized reactions of oxoacetic acid 
6.54 derived from cyclohexanol and xanthylamide 6.12 resulted in formal dehydroxylative 
xanthylation product 6.17 (Figure 6.11). Finally, α-keto acids such as 6.55 reacted to give acyl 
xanthate 6.56 in good yield.  
6.5 Post-Transformations of the Xanthate  
 
Figure 6.12. Post-transformation reactions. 
As stated before, we viewed the decarboxylative xanthylation as a facile method for 
accessing thiols, which we demonstrated with lithocholic xanthate 6.41 to provide the 
corresponding thiol with isopropylamine in excellent yield. A subsequent photochemical thiol-
ene reaction with glucose-derived allyl glycoside then provided the thiol-ene adduct 6.57 in 54% 
yield over two steps (Figure 6.12). Additionally, using conditions we developed for accessing 
hydroxy or ketone functional groups from xanthates, we were able to take gibberellic xanthate 
6.45 to the TEMPO-trapped adduct, which was further derivatized to the hydroxy product 6.58 in 
55% yield over two steps (Figure 6.12).  Collectively, these two post-transformation reactions 
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constitute examples that greatly broadening the scope of decarboxylative functionalizations of 
unactivated, aliphatic carboxylic acids.   
6.6  Mechanistic Insights 
We first considered a mechanism involving partial dissociation of the carboxylic acid 
(i.e., deprotonation by adventitious base), followed by single electron transfer from xanthylamide 
to form the acyloxyl radical. However, no reaction was observed in the presence of a non-
coordinating base (Entry 7, Table 6.2). Initiation, using either photo- or radical initiators is 
required, and no reaction was observed in the dark or without initiator, even with heating (Entry 
8). The complete racemization observed with enantioriched carboxylic acid 6.59 supports a 
radical pathway involving a carbon-centered radical.  
 
 
Figure 6.13. Racemization pathway. 
Overall, the chain chemistry is very efficient, with all efforts to trap the radical with 
exogenous alkene traps proving unsuccessful, although a tandem decarboxylative alkylation 
could be achieved with carboxylic acid substrates containing pendant olefins (e.g. 6.61, Figure 
6.14) in good yield.  
 
 




Figure 6.15. Initial rates KIE results. 
A primary kinetic isotope effect (KIE) of 5.4 was determined from initial rate 
experiments between the decarboxylative xanthylation of the O–H and O–D forms of 1-methyl-
1-cyclohexanecarboxylic acid (Figure 6.15), with full deuterium incorporation observed on the 
amide (6.64) in the reaction with deuterated 6.63. The high KIE value suggested that an 
irreversible O–H HAT process was taking place in the reaction, and we hypothesized that the 
amidyl radical was responsible for a direct O–H HAT, which was not outside the realm of 
possibility considering that the range of BDEs for carboxylic O–H bonds (BDE ≈ 112 kcal/mol) 
is similar that of the amide N–H bond (BDE ≈ 111 kcal/mol).   
 
 
Figure 6.15. Competition experiments. 
To test our hypothesis, we analyzed the reactivity of xanthyl sulfonamide 6.65, which has 
a calculated N–H bond strength (BDE = 104 kcal/mol)99 lower than the range for carboxylic acid 
O–H bonds. Indeed, in a reaction of 1-hexanoic acid and xanthyl sulfonamide 6.65, no 
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decarboxylation products were observed, instead resulting in a mixture of C–H functionalization 
products. As attempts to synthesize the pentafluorophenyl-substituted xanthyl sulfonamide were 
unsuccessful, comparisons were made with the 3,5-bis(trifluoromethyl)phenyl derivatives.  
A competition experiment with cyclohexane and 1-hexanoic acid with xanthyl 
sulfonamide 6.65 resulted in functionalization of cyclohexane only (Figure 6.15). In contrast, the 
same experiments using xanthylamides 6.18 and 6.12 were selective for decarboxylative 
xanthylation, with a selectivity (kO−H/kC−H) of 24 and 10 observed, respectively, correcting for the 
number of hydrogen atoms. This difference in reactivity between the amide and sulfonamide 
reagents provides opportunities for parallel xanthylations of carboxylic acid containing 
substrates. Adamantanecarboxylic acid was taken to both decarboxylative xanthylation product 
6.33 with xanthylamide 6.18 in 80% yield, and also to C–H xanthylated acid 6.66 with xanthyl 
sulfonamide 6.65 in 67% yield (Figure 6.16).   
 
Figure 6.16. Parallel xanthylations of adamantanecarboxylic acid. 
6.7 Calculations 
Computational analysis was undertaken in a collaboration with Prof. Davide Ravelli from 
the University of Pavia, specifically modeling the proposed O–H HAT of n-propanoic acid 
involving the relevant nitrogen-centered radicals. The O–H HAT of n-propanoic acid by the 
pentafluorophenyl-substituted amidyl radical 6.18’ (from reagent 6.18) and the 3,5-




Figure 6.17. O−H HAT processes as modeled by computations. 
The calculations suggested that the O–H HAT involving 6.18’ is slightly exergonic (ΔG 
= −1.68 kcal·mol–1), while endergonic for 6.65’ (ΔG = +5.90 kcal·mol-1). Furthermore, the 
reaction of 6.18′ proceeds with a lower energy barrier (ΔG⧧ = +20.04 kcal·mol-1) than that 
promoted by 6.65’ (ΔG⧧ = +25.39 kcal·mol-1), with a ΔΔG⧧ value of 5.35 kcal·mol-1. Overall, 
the computational data support a facile O–H HAT by amidyl radical 6.18′, with a somewhat 
larger barrier for the reaction of 6.65′.  
While the calculations rationalize the feasibility of a direct O–H HAT, they do not 
account for the selectivity observed for the carboxylic O–H bond over relatively weaker C–H 
bonds. For instance, no competing C–H xanthylation of weaker C–H bonds was observed, 
including activated benzylic, allylic, and α-heteroatom positions while investigating the substrate 
scope for the reaction. We hypothesize that the high selectivity for the carboxylic O–H bond is a 
result of hydrogen bonding between the amide and carboxylic acid directing the O–H bond to 
the amidyl radical for facile HAT, which would rationalize in part the low yields observed with 
substrates containing functionalities that can participate in competitive hydrogen bonding (see 
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Figure 6.10). Considering that reactivity is only observed with carboxylic acids and other 
oxyacids and not with alcohols, the enhanced dipole strength of the carboxylic O–H bond 
compared to the hydroxy O–H bond must play a key contributing factor. Additional 
computations targeting these mechanistic details are underway. 
6.8 Conclusion 
A method for direct decarboxylative xanthylation of aliphatic carboxylic acids was 
developed using N-xanthylamides. This transformation exhibits a broad substrate scope with 
excellent functional group tolerance and broadens the scope of decarboxylative functionalization 
available via the versatility of the xanthate. Mechanistic studies support a radical pathway 
involving a direct O–H HAT. Our studies further indicate the viability of sulfonamide reagents 
for the C–H functionalization of carboxylic acid substrates, opening possibilities in the future for 
reagent designs that use hydrogen bonding to guide selectivity.  
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APPENDIX A: SUPPORTING INFORMATION FOR CHAPTER 2 
General Methods and Materials 
Infrared (IR) spectra were obtained using a Jasco 260 Plus Fourier transform infrared 
spectrometer. GC spectra were obtained using a Shimadzu GC-2010 gas chromatograph with a 
Shimadzu AOC-20s Autosampler, and Shimadzu SHRXI-5MS GC column. The results of the 
kinetic isotope study were analyzed using an Agilent Gas Chromatograph-Mass Spectrometer 
with a 6850 series GC system and a 5973 Network Mass Selective Detector. Proton and carbon 
magnetic resonance spectra (1H NMR and 13C NMR) were recorded on a Bruker model DRX 
400, or a Bruker AVANCE III 600 CryoProbe (1H NMR at 400 or 600 MHz and 13C NMR at 
100 or 151 MHz) spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 
at 7.26 ppm; 13C NMR: CDCl3 at 77.16 ppm). 
1H NMR data are reported as follows: chemical 
shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, ddd = 
doublet of doublet of doublets, td = triplet of doublets, tdd = triplet of doublet of doublets, qd = 
quartet of doublets, m = multiplet, br. s. = broad singlet, app = apparent), coupling constants 
(Hz), and integration. Mass spectra were obtained using a Thermo LTqFT mass spectrometer 
with electrospray introduction and external calibration. Thin layer chromatography (TLC) was 
performed on SiliaPlate 250μm thick silica gel plates provided by Silicycle. Visualization was 
accomplished with short wave UV light (254 nm), iodine, aqueous basic potassium 
permanganate solution, or aqueous acidic ceric ammonium molybdate solution followed by 
heating. Flash chromatography was performed using SiliaFlash P60 silica gel (40-63 μm) 
purchased from Silicycle. Tetrahydrofuran, diethyl ether, and dichloromethane were dried by 
passage through a column of neutral alumina under nitrogen prior to use. Irradiation of 
xanthylation reactions was performed using either PAR38 Royal Blue 21W aquarium LED 
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lamps (Model #6851) fabricated with high-power Cree XR-E LEDs as purchased from Ecoxotic 
(www.ecoxotic.com) or Kessil KSH150B Blue 36W LED Grow Lights. UV light experiments 
were performed in a Luzchem LZC-ORG photoreactor containing UVA lamps. All other 
reagents were obtained from commercial sources and used without further purification unless 




N-(tert-butyl)-3,5-bis(trifluoromethyl)benzamide (A1): Prepared similarly to previous reports 
from our lab.1,2 To a solution of 3,5-bis(trifluoromethyl)benzoic acid (15 g, 58.11 mmol) in 
CH2Cl2/DMF (232 mL/1 mL) at 0 ˚C was added oxalyl chloride (9.85 mL, 116.23 mmol) 
dropwise, and the resulting solution was allowed to warm to rt overnight. The mixture was 
concentrated in vacuo and resuspended in THF (200 mL) and chilled to 0 ˚C. tert-Butylamine 
(12.21 mL, 116.23 mmol) was added, and the mixture was warmed to rt and stirred overnight. 
The ammonium salts were filtered and the mixture was concentrated in vacuo and the residue 
suspended in Et2O (250 mL) and washed with 3M NaOH (1 x 200 mL), 1M HCl (1 x 200 mL), 
brine (1 x 200 mL), dried with MgSO4 and concentrated to afford A1 as a pale yellow solid 




N-(tert-butyl)-N-chloro-3,5-bis(trifluoromethyl)benzamide (A2): Prepared similarly to a 
previous report from our lab.2 With the laboratory lights off, to a solution of amide A1 in EtOAc 
(296 mL) was added tBuOH (7.8 mL). To this solution was added a solution of AcOH (68 mL), 
NaOCl (172 mL), and H2O (103 mL) dropwise over 2 h via addition funnel. The mixture was 
stirred vigorously for 2 days, then diluted with CH2Cl2 (200 mL) and quenched with sat. aq. 
NaHCO3 (200 mL). The aqueous phase was extracted with CH2Cl2 (3 x 300 mL), and the 
combined organic phase was washed with brine (1 x 500 mL), dried with MgSO4, and 
concentrated in vacuo followed by 1 day under high vacuum to afford chloroamide A2 as a 
yellow oil (14.2 g, 97% yield), which was used without any additional purification. 
 
N-(tert-butyl)-N-((ethoxycarbonothioyl)thio)-3,5-bis(trifluoromethyl)benzamide (2.36): 
Adapted from an analogous literature procedure using N-chlorophthalimide.3 With the laboratory 
and hood lights off, in a 2-neck, 5L round-bottom flask, potassium ethyl xanthate (6.55 g, 40.84 
mmol) was suspended in MeCN (1.7 L). To this suspension was added a solution of chloroamide 
S4 (14.2 g, 40.84 mmol) in MeCN (350 mL) via cannula wire over 20 min. The round-bottom 
was foil wrapped and stirred for 16 h, at which point the suspension was concentrated in vacuo 
and left under high-vacuum for 20 h. The residue was taken up in CH2Cl2/H2O (1:1, 2L total 
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volume) and the layers were separated. The organic layer was washed with brine, dried with 
MgSO4, and concentrated in vacuo. The resultant orange solid was purified by careful flash 
column chromatography on a short, wide silica column (hexanes flush until the first yellow band 
had fully eluted, then 0–5% Et2O in hexanes) to afford xanthylamide 2.36 as a yellow solid (8.47 
g, 48% yield): 
1H NMR (600 MHz, CDCl3) δ 7.88 (s, 1H), 7.86 (s, 2H), 4.71 – 4.61 (m, 2H), 1.58 (s, 9H), 1.49 
(t, J = 7.1 Hz, 3H).  
13C NMR (151 MHz, CDCl3) δ 212.00, 172.59, 139.98, 131.60 (q, J = 33.8 Hz), 127.11 (d, J = 
3.9 Hz), 123.69 (q, J = 3.7 Hz), 123.05 (q, J = 272.8 Hz), 70.84, 64.15, 28.94, 13.77.  
IR (film) 2981.41, 2938.02, 2360.44, 1680.66, 1368.25, 1279.59, 1183.11, 1136.83 cm-1.  
HRMS (ES+) Exact mass calcd for C16H18F6NO2S2 [M+H]
+, 434.0677. Found 434.0686. 
 
The xanthylamide shows no degradation to the parent amide after being stored foil-wrapped at 0 
˚C for four months. At room temperature in CDCl3 solution in ambient laboratory light, less than 




General Procedure A: A 1 dram vial was charged with xanthylamide 2.36 (1–3 equiv) in the 
dark (overhead laboratory lights turned off), fitted with a PTFE lined screw cap, and taken into 
the glovebox. The xanthylamide was dissolved in PhCF3 (0.15 mL), and the resulting solution 
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was sealed with Teflon tape and removed from the glovebox. Liquid substrate (0.15 mmol, 1 
equiv) was added by syringe (note: solid substrate is added at the same time as xanthylamide 
outside the glovebox), and the vial was placed in a 3D-printed holder. The holder was suspended 
above an Ecoxotic PAR38 23 W blue LED such that the bottom of each vial was directly aligned 
with and 1 cm above one of the five LEDs, and the apparatus was covered with aluminum foil. 
The reaction was irradiated until completion and then either diluted with CH2Cl2 and added 
dodecane (1 equiv) for GC analysis or concentrated in vacuo and added hexamethyldisiloxane 
(0.17 equiv) for NMR analysis. When a standard could not be easily prepared or for complex 
substrates, the crude residue was purified by flash column chromatography to afford the alkyl 
xanthate products. 
  
Figure A1. Pictures of C–H xanthylation reactions with the blue LED turned off or on for 
General Procedures A. The reaction vials are suspended in a 3D-printed vial holder such that the 
bottom of the vials is about 1 cm from the LED below.  
 
General Procedure B: A 1 dram vial with a stir bar was charged with xanthylamide 2.36 (1–3 
equiv) and solid substrate (1 equiv) in the dark (overhead laboratory lights turned off), fitted with 
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a PTFE lined screw cap, and taken into the glovebox. The xanthylamide was dissolved in PhCF3 
or C6F6 (1 M), and the resulting solution was sealed with Teflon tape and removed from the 
glovebox. The vial was suspended on a stir plate and irradiated with a Kessil Blue KSH150B 
34W LED Grow Light from the side (2 cm away) with the apparatus covered by aluminum foil 
until completion. The reaction was then concentrated in vacuo or by passing a stream of nitrogen 
over the solution. The crude residue was purified by flash column chromatography to afford the 
alkyl xanthate products.  
  
Figure A2. Pictures of C–H xanthylation reactions with the blue LED turned off or on for 
General Procedure B. The reaction vial is suspended such that it is approximately 1–2 cm away 
from the Kessil blue LED. 
 
General Procedure C: A 1 dram vial with a stir bar was charged with xanthylamide 2.36 (3 
equiv) and solid substrate (1 equiv) in the dark (overhead laboratory lights turned off), fitted with 
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a PTFE lined screw cap, and taken into the glovebox. The xanthylamide was dissolved in MeCN 
or C6F6 (1 M), and the resulting solution was sealed with Teflon tape and removed from the 
glovebox. The vial was placed directly on a stir plate maintained at 80 ˚C and irradiated with a 
Kessil Blue KSH150B 34W LED Grow Light from the side (2 cm away) with the apparatus 
covered by aluminum foil until completion. The reaction was then concentrated in vacuo or by 
passing a stream of nitrogen over the solution. The crude residue was purified by flash column 
chromatography to afford the alkyl xanthate products. 
   
Figure A3. Pictures of C–H xanthylation reactions with the blue LED turned off or on for 
General Procedure E. The reaction vial is placed directly on the hot plate such that it is 
approximately 1–2 cm away from the Kessil blue LED. The temperature probe of the IKA is 







oxododecahydronaphtho[2,1-b]furan-8-yl) carbonodithioate: Prepared according to General 
Procedure A using sclareolide (1 mmol, 1 equiv) and xanthylamide 2.36 (1 mmol, 1 equiv) in 
PhCF3 (1 mL) giving 55% NMR yield. The crude residue was purified by flash column 
chromatography (10 – 20% EtOAc in hexanes) to afford pure 2.37 as an off-white solid (0.205 g, 
55% yield, 91% yield brsm): 
1H NMR (600 MHz, CDCl3) δ 4.63 (q, J = 7.1, 2H), 4.01 (tt, J = 12.9, 3.6 Hz, 1H), 2.43 (t, J = 
14.9 Hz, 1H), 2.24 (dd, J = 16.3, 6.6 Hz, 1H), 2.09 (dt, J = 12.0, 3.2 Hz, 1H), 1.99 (dd, J = 14.7, 
6.6 Hz, 1H), 1.90 (td, J = 13.0, 3.1 Hz, 3H), 1.69 (td, J = 12.6, 4.1 Hz, 1H), 1.41 (td, J = 7.2, 2.3 
Hz, 3H), 1.36 – 1.31 (m, 4H), 1.26 – 1.23 (m, 1H), 1.17 (t, J = 12.4 Hz, 1H), 1.11 (dd, J = 12.7, 
2.5 Hz, 1H), 1.05 (s, 3H), 0.96 (s, 3H), 0.94 (s, 3H).  
13C NMR (151 MHz, CDCl3) δ 214.06, 176.37, 86.12, 69.89, 58.75, 56.22, 47.24, 45.23, 42.37, 
38.57, 37.68, 35.16, 32.93, 28.74, 21.75, 21.27, 20.38, 15.59, 13.93.  
IR (film) 2950.55, 2360.44, 2342.12, 1777.08, 1385.60, 1220.72, 1113.69, 1049.09 cm-1.  
HRMS (ES+) Exact mass calcd for C19H31O3S2 [M+H]
+, 371.1709. Found 371.1704. 
 
A gram-scale reaction was run with sclareolide (4 mmol, 1 equiv) and xanthylamide 2.36 (4 
mmol, 1 equiv) using General Procedure B on 4 mmol scale (0.804 g, 54% yield). 
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O-ethyl S-((6S)-4,8,8-trimethyl-9-methylenedecahydro-1,4-methanoazulen-6-yl)  
carbonodithioate (2.38): Prepared according to General Procedure A using (+)-longifolene 
(0.50 mmol, 1 equiv) and xanthylamide 2.36 (0.50 mmol, 1 equiv) with the exception that no 
solvent was used. The crude residue was purified by flash column chromatography to afford pure 
2.38 as an off-white solid (87.6 mg, 54% yield): 
1H NMR (600 MHz, CDCl3) δ 4.81 (s, 1H), 4.64 (qdd, J = 10.3, 7.2, 3.5 Hz, 2H), 4.55 (d, J = 
2.1 Hz, 1H), 3.93 (td, J = 12.2, 6.2 Hz, 1H), 2.65 (d, J = 4.8 Hz, 1H), 2.19 (d, J = 3.7 Hz, 1H), 
2.17 – 2.11 (m, 2H), 1.78 – 1.67 (m, 4H), 1.42 (tdd, J = 12.3, 5.8, 1.6 Hz, 6H), 1.12 (s, 3H), 1.03 
(s, 3H), 0.93 (s, 3H).  
13C NMR (151 MHz, CDCl3) δ 214.43, 166.47, 100.29, 69.66, 61.70, 48.39, 47.69, 44.92, 
44.61, 43.96, 43.09, 34.06, 30.80, 30.36, 29.92, 29.60, 25.56, 14.04.  
IR (film) 3063.37, 2955.38, 2867.63, 1655.59, 1364.39, 1213.01, 1111.76, 1051.98 cm-1. 
HRMS (ES+) Exact mass calcd for C18H28OS2Na [M+Na]
+, 347.1474. Found 347.1474. 
 
 
S-((1s,3r,5R,7S)-3-(5-bromo-2-methoxyphenyl)adamantan-1-yl) O-ethyl  
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carbonodithioate (2.39). Prepared according to General Procedure A (0.15 mmol scale) using 2-
(1-adamantyl)-4-bromoanisole and xanthylamide 2.36 (1 equiv). The crude residue was purified 
by flash column chromatography to afford pure 2.39 as an off-white solid (33.8 mg, 51% yield): 
1H NMR (600 MHz, CDCl3) 7.29 (d, J = 8.7 Hz, 1H), 7.26 (br. s, 1H, underneath residual 
CHCl3), 6.75 (d, J = 8.6 Hz, 1H), 4.67 (q, J = 7.2 Hz, 2H), 3.82 (s, 3H), 2.45 (s, 1H), 2.27 – 2.23 
(m, 2H), 2.19 – 2.13 (m, 4H), 1.91 (d, J = 12.4 Hz, 2H), 1.74 – 1.69 (m, 2H), 1.47 (t, J = 7.2 Hz, 
3H), 1.43 (s, 1H), 1.25 (s, 2H). 
13C NMR (151 MHz, CDCl3) δ 214.16, 157.72, 138.79, 130.00, 129.68, 113.42, 113.37, 69.39, 
55.41, 55.10, 43.89, 41.26, 39.31, 39.24, 35.76, 30.43, 30.36, 29.85, 13.94.  
IR (film) IR 2915.84, 2853.17, 1744.30, 1483.46, 1455.03, 1234.22, 1133.94, 1112.73, 1046.19, 
1027.87 cm-1. 
HRMS (ES+) Exact mass calcd for C20H26BrO2S2 [M+H]




yl) carbonodithioate (22): The reaction was run according to General Procedure A for 4 hr on a 
0.3 mmol scale (note: product decomposition occurs under reaction conditions after 4 hr). The 
mixture was concentrated in vacuo and extensively dried via high-vacuum. 1H NMR of the crude 
reaction with an HMDS internal standard reveals an NMR yield of 80% with 1.2:1 dr. The solid 
residue was triturated with pentanes, and the solution was passed over a cotton plug and 
concentrated in vacuo to remove amide S1. The resultant residue was heated at 115 ˚C in a sand 
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bath under high vacuum overnight to remove unreacted ambroxide, which is 
chromatographically inseparable from the xanthate products. Finally, the resultant residue was 
purified through rapid flash column chromatography on silica (5% EtOAc in hexanes, less than 
five minutes spent on the column) to afford pure ambroxide xanthates 2.40 as an inseparable 
mixture of diastereomers (34 mg, 32% yield): 
1H NMR (600 MHz, CDCl3) δ 6.10 (t, J = 7.8 Hz, 0.32H), 5.96 (dd, J = 7.5 Hz, 1.1 Hz, 0.56H), 
4.72 – 4.59 (m, 2H), 2.41 (td, J = 13.4, 7.6 Hz, 0.61H), 2.33 (dd, J = 12.8, 6.5 Hz, 0.37H), 2.01 – 
1.94 (m, 1.53H), 1.88 (td, J = 13.1, 8.1 Hz, 0.48H), 1.81 – 1.74 (m, 1H), 1.69 – 1.56 (m, 3H), 
1.48 – 1.40 (m, 6H), 1.30 – 1.15 (m, 5H), 1.10 – 1.03 (m, 1 H), 1.02 – 0.94 (m, 1H), 0.88 – 0.81 
(m, 9H) 
13C NMR (151 MHz, CDCl3) δ 213.85, 213.43, 86.06, 84.24, 83.29, 69.88, 69.44, 60.35, 58.51, 
57.12, 57.07, 42.43, 40.02, 39.99, 39.96, 39.61, 36.40, 36.29, 33.65, 33.63, 33.21, 31.90, 29.90, 
22.63, 22.40, 21.20, 21.18, 20.88, 20.57, 18.43, 15.58, 15.32, 13.94, 13.91. 
IR (film) 2978.52, 2941.88, 1518.67, 1378.85, 1267.00, 1230.36, 1130.08, 992.20 cm-1. 
HRMS (ES+) Exact mass calcd for C19H32O2S2Na [M+Na]
+, 379.1736. Found 379.1784. 
 
 
Reaction with trans-androsterone acetate: Prepared according to General Procedure C (0.064 
mmol scale) using trans-androsterone acetate and xanthylamide 2.36 (3 equiv) in C6F6 for 24 h 
giving 63% NMR yield. The crude residue was purified by flash column chromatography to 
afford pure 2.41 as an off-white solid (16.1 mg, 56% yield): 
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(3R,5S,8R,9S,10S,13S,14S)-2-((ethoxycarbonothioyl)thio)-10,13-dimethyl-17-
oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate (2.41a): 
1H NMR (600 MHz CDCl3) δ 4.76 (td, J = 11.3, 5.1 Hz, 1H), 4.67 – 4.59 (m, 2H), 3.96 (td, J = 
12.2, 4.3 Hz, 1H), 2.43 (dd, J = 19.3, 8.8 Hz, 1H), 2.33 (dd, J = 13.1, 4.3 Hz, 1H), 2.11 – 2.00 
(m, 1H), 2.03 (s, 3H), 1.93 (ddd, J = 14.3, 8.5, 5.9 Hz, 1H), 1.84 – 1.77 (m, 3H), 1.66 – 1.61 (m, 
1H), 1.56 – 1.46 (m, 2H), 1.42 (t, J = 7.2 Hz, 3H), 1.39 – 1.19 (m, 7H), 1.02 – 0.94 (m, 1H), 0.99 
(s, 3H), 0.89 – 0.83 (m, 1H), 0.86 (s, 3H), 0.76 (td, J = 12.7, 4.0 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 221.27, 213.80, 170.61, 72.74, 70.01, 54.15, 51.32, 50.32, 47.88, 
44.61, 44.54, 37.54, 35.95, 34.83, 34.59, 31.49, 30.71, 27.73, 21.89, 21.28, 20.63, 13.95, 12.42. 
(3S,5S,8R,9S,10R,13S,14S)-6-((ethoxycarbonothioyl)thio)-10,13-dimethyl-17-
oxohexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate (2.41b): 
1H NMR (600 MHz, CDCl3) δ 4.67 – 4.60 (m, 3H), 3.81 (td, J = 12.3, 4.1 Hz, 1H), 2.47 (dd, J = 
19.4, 7.9 Hz, 1H), 2.31 (dt, J = 12.8, 4.0 Hz, 1H), 2.17 (ddt, J = 12.4, 4.6, 2.6 Hz, 1H), 2.13 – 
2.03 (m, 2H), 2.04 (s, 3H), 1.97 – 1.92 (m, 1H), 1.90 – 1.79 (m, 2H), 1.78 – 1.69 (m, 2H), 1.56 – 
1.50 (m, 2H), 1.45 (t, J = 7.0 Hz, 3H), 1.37 – 1.25 (m, 5H), 1.10 (td, J = 13.7, 4.0 Hz, 1H), 1.02 
(s, 3H), 0.90 (s, 3H), 0.89 – 0.87 (m, 1H), 0.82 (td, J = 11.3, 3.9 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 220.77, 214.68, 170.67, 73.16, 70.15, 53.78, 51.13, 50.75, 48.72, 
47.88, 38.58, 37.80, 36.75, 35.95, 35.64, 31.47, 30.44, 27.34, 21.76, 21.57, 20.58, 13.96, 12.95. 
IR (film) 2943.8, 1771.30, 1734.66, 1652.70, 1540.85, 1239.04, 1047.16 cm-1. 
HRMS (ES+) Exact mass calcd for C24H37O4S2 [M+H]
+, 453.2128. Found 453.2159. 
 
Steroid regiochemistry assignments were made by converting the xanthate to the TEMPO adduct 
and oxidation to the corresponding ketone via the following procedure:  
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The starting xanthate was dissolved in PhCl (0.1 M) and stirred at 100 °C. TEMPO (6 equiv) and 
tris(trimethylsilyl)silane (3 equiv) were added in three portions over 48 h. The reaction mixture 
was stirred for an additional 24 hr, then was concentrated. The crude mixture was redissolved in 
CH2Cl2 (0.1 M) and cooled to 0 °C, into which a solution of 3-chloroperbenzoic acid (2 equiv) 
dissolved in CH2Cl2 was added dropwise. After the addition, the reaction mixture was stirred for 
2 h, then quenched with saturated Na2S2O3 and saturated NaHCO3. After stirring for 5 min at rt, 
EtOAc and 10% NaOH was added to the mixture. The organic layer was extracted and washed 
with brine, dried over anhydrous Na2SO4, filtered, and concentrated. 
 




cyclopenta[a]phenanthren-6-yl) O-ethyl carbonodithioate (2.42): Prepared according to 
General Procedure C (0.10 mmol scale) using 5α-androstanedione and xanthylamide 2.36 (3 
equiv) in MeCN for 3 days giving 38% NMR yield. A mix of the starting material and product 
was recovered by flash chromatography and resubjected to the reaction conditions. The resulting 
crude residue was purified by flash column chromatography to afford pure 2.42 as an off-white 
solid (18.0 mg, 44% yield):  
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1H NMR (400 MHz, CDCl3) δ 4.63 (q, J = 7.1 Hz, 2H), 3.89 (td, J = 12.4, 4.2 Hz, 1H), 2.71 
(ddd, J = 15.5, 4.1, 2.0 Hz, 1H), 2.51 – 2.29 (m, 5H), 2.13 – 2.04 (m, 2H), 1.98 – 1.91 (m, 1H), 
1.89 – 1.80 (m, 2H), 1.78 – 1.68 (m, 2H), 1.42 (t, J = 7.1 Hz, 3H), 1.36 – 1.22 (m, 4H), 1.19 (s, 
3H), 1.10 – 1.03 (m, 2H), 0.91 (s, 3H), 0.90 – 0.84 (m, 1H). 
13C NMR (151 MHz, CDCl3) δ 220.49, 214.47, 210.66, 70.39, 53.40, 51.08, 50.83, 50.42, 
47.84, 41.23, 38.12, 37.86, 37.82, 35.90, 35.65, 31.44, 21.80, 20.78, 13.98, 12.30. 
IR (film) 2945.73, 2856.06, 1735.62, 1715.37, 1670.05, 1540.85, 1218.79, 1047.16 cm-1. 
HRMS (ES+) Exact mass calcd for C22H33O3S2 [M+H]
+, 409.1866. Found 409.1885. 
 
The site selectivity of xanthate functionalization was determined through a similar procedure as 




cyclopenta[a]phenanthren-3-yl acetate (2.44): To a solution of steroidal xanthate 2.41b (35 
mg, 0.077 mmol) in PhCl (0.77 mL) stirring at 100 °C, TEMPO (72 mg, 0.23 mmol) and 
tris(trimethylsilyl)silane (72 μL, 0.15 mmol) were added in three portions over 48 h. The reaction 
mixture was stirred for an additional 24 h, then concentrated. Zinc powder (0.203 g, 3.08 mmol), 
then a mixture of HOAc/THF/H2O (3:1:1, 1.9 mL) was added and heated at 70 °C overnight. The 
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reaction mixture was filtered through a cotton plug and washed with EtOAc. The resulting 
filtrate was washed with saturated NaHCO3, water, dried over anhydrous Na2SO4, filtered, and 
concentrated. The crude material was purified by column chromatography (20 – 50% EtOAc in 
hexanes) to yield 2.44 (14.9 mg, 56% yield) as a white solid in accordance with the literature 
data.4 
1H NMR (600 MHz, CDCl3) δ 4.67 (ddt, J = 16.4, 11.2, 4.9 Hz, 1H), 3.44 (td, J = 10.8, 4.5 Hz, 
1H), 2.45 (dd, J = 19.4, 8.8 Hz, 1H), 2.22 (app d, J = 12.1, 1H), 2.15 – 2.04 (m, 2H), 2.02 (s, 
3H), 1.95 (ddd, J = 14.1, 8.7, 5.8 Hz, 1H), 1.87 – 1.76 (m, 2H), 1.76 – 1.60 (m, 3H), 1.57 – 1.45 
(m, 2H), 1.38 – 1.20 (m, 4H), 1.14 – 1.04 (m, 2H), 0.99 – 0.91 (m, 1H), 0.89 – 0.83 (m, 1H), 
0.85 (s, 6H), 0.75 (td, J = 11.4, 4.0 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 221.00, 170.76, 73.48, 69.29, 53.85, 51.74, 51.18, 47.89, 40.54, 




((trifluoromethyl)thio)decahydronaphtho[2,1-b]furan-2(3aH)-one (2.46): Sclareolide 
xanthate 2.37 (10 mg, 0.027 mmol) and ((2-phenylpropan-2-yl)oxy)(trifluoromethyl)sulfane5 (19 
mg, 0.081 mmol) were dissolved in PhCl (1.35 mL) and heated to 100 °C. DLP (5 mg, 0.014 
mmol) was added every half-hour for a total of eight additions under an argon atmosphere. After 
the last addition, the reaction was stirred for another 30 minutes. The mixture was then 
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concentrated, and the product was isolated by flash chromatography (10% EtOAc in hexanes) to 
yield 32 as a white solid in accordance with the literature data (6.7 mg, 71% yield):6 
1H NMR (600 MHz, CDCl3) δ 3.52 (tt, J = 12.8, 3.8 Hz, 1H), 2.44 (dd, J = 16.2, 14.7 Hz, 1H), 
2.27 (dd, J = 16.2, 6.5 Hz, 1H), 2.10 (dt, J = 12.0, 3.3 Hz, 1H), 1.99 (dd, J = 14.7, 6.5 Hz, 1H), 
1.93 – 1.89 (m, 2H), 1.86 (ddd, J = 12.5, 3.7, 2.1 Hz, 1H), 1.70 (td, J = 12.6, 4.3 Hz, 1H), 1.42 – 
1.31 (m, 1H), 1.34 (s, 3H), 1.21 (app t, J = 12.6 Hz, 1H), 1.10 (dd, J = 12.6, 2.9 Hz, 1H), 0.98 (s, 
3H), 0.97 (s, 3H), 0.92 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 176.19, 131.08 (q, J = 306.5 Hz), 86.00, 55.85, 49.14, 46.75, 
38.53, 37.60, 37.23, 35.13, 32.98, 28.69, 21.76, 21.30, 20.38, 15.73. 




one (A3): Adapted from the literature procedure.7 In a 2 dram vial in a glovebox, sclareolide 
xanthate 2.37 (20 mg, 0.054 mmol), allyl ethyl sulfone (22 mg, 0.16 mmol), and dilauroyl 
peroxide (2.2 mg, 0.0054 mmol) were dissolved in chlorobenzene (0.22 mL). The vial was fitted 
with a rubber septum, wrapped with Teflon tape, and placed under a balloon of argon once 
removed from the glovebox. The vial was heated at 100 ˚C, and additional dilauroyl peroxide 
was added every 30 minutes until the sclareolide xanthate had been consumed as determined by 
TLC (19.8 mg additional DLP). The crude reaction mixture was concentrated by passing a 
stream of nitrogen over the heated vial. The residue was purified via flash column 
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chromatography on silica (10 – 20% EtOAc in hexanes) to afford allylated sclareolide A3 as a 
yellow oil (11.4 mg, 73% yield): 
1H NMR (major diastereomer, 600 MHz, CDCl3) δ 5.79 – 5.71 (m, 1H), 4.99 (dd, J = 13.9, 
1.8 Hz, 2H), 2.44 – 2.38 (m, 1H), 2.27 – 2.22 (m, 1H), 2.10 – 2.06 (m, 1H), 1.93 (t, J = 6.6 Hz, 
2H), 1.88 (dd, J = 14.1, 4.0 Hz, 1H), 1.78 – 1.72 (m, 1H), 1.71 – 1.66 (m, 1H), 1.63 – 1.56 (m, 
2H), 1.52 – 1.42 (m, 3H), 1.33 (s, 3H), 1.07 – 0.99 (m, 2H), 0.91 (s, 3H), 0.89 (s, 3H), 0.84 (s, 
3H). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 177.04, 137.12, 116.07, 86.57, 59.21, 
56.79, 49.12, 46.18, 41.68, 38.74, 36.68, 33.80, 33.35, 28.95, 28.87, 21.76, 21.63, 20.60, 16.01. 
IR (film) 3446.17, 2925.48, 1867.72, 1772.26, 1670.05, 1540.85, 1521.56, 1456.96 cm-1. 
HRMS (ES+) Exact mass calcd for C19H31O2 [M+H]




2(3aH)-one (A4): Adapted from the literature procedure.8 To a solution of sclareolide xanthate 
2.37 (32 mg, 0.086 mmol) and styryl ethyl sulfone (51 mg, 0.26 mmol) dissolved in PhCl (1.35 
mL) and stirring at 130 °C, tert-butyl peroxide (10 μL, 0.068 mmol) was added. Four more tert-
butyl peroxide (5 μL, 0.034 mmol) additions were added in the following 24 hours. After the last 
addition, the reaction was left stirring overnight. The resulting dark brown mixture was 
concentrated, and the product was isolated by flash column chromatography (10% EtOAc in 
hexanes) to yield styrene A4 as a yellow oil (22.2 mg, 73% yield): 
99 
1H NMR (600 MHz, CDCl3) δ 7.36 – 7.32 (m, 2H), 7.32 – 7.27 (t, J = 7.7 Hz, 2H), 7.22 – 7.17 
(m, 1H), 6.37 (d, J = 15.9 Hz, 1H), 6.09 (dd, J = 15.9, 7.0 Hz, 1H), 2.75 (dd, J = 17.9, 7.9 Hz, 
1H), 2.49 – 2.39 (m, 2H), 2.35 (ddd, J = 14.8, 5.0, 2.0 Hz, 1H), 1.80 (d, J = 7.9 Hz, 1H), 1.72 (dt, 
J = 12.6, 2.7 Hz, 1H), 1.67 – 1.55 (m, 2H), 1.50 (td, J = 13.6, 12.7, 4.8 Hz, 1H), 1.34 (s, 3H), 
1.11 (app t, J = 12.8 Hz, 1H), 0.99 (s, 3H), 0.96 (s, 3H), 0.95 (s, 3H), 0.93 – 0.79 (m, 3H). 
13C NMR (151 MHz, CDCl3) δ 177.78, 137.75, 135.70, 128.64, 128.09, 127.11, 126.04, 85.75, 
54.80, 51.26, 48.09, 47.18, 36.71, 35.25, 33.73, 33.63, 32.56, 32.54, 30.14, 22.93, 18.38, 15.39. 
IR (film) 2951.52, 1772.26, 1646.91, 1576.52, 1540.85, 1507.10, 1473.35, 1456.96 cm-1. 
HRMS (ES+) Exact mass calcd for C24H33O2 [M+H]




one (A5): Adapted from the literature procedure.9 In a 2 dram vial in a glovebox, sclareolide 
xanthate 2.37 (20 mg, 0.054 mmol), azide ethyl sulfone (22 mg, 0.16 mmol), and dilauroyl 
peroxide (2.2 mg, 0.0054 mmol) were dissolved in chlorobenzene (0.22 mL). The vial was fitted 
with a rubber septum, wrapped with Teflon tape, and placed under a balloon of argon once 
removed from the glovebox. The vial was heated at 100 ˚C, and additional dilauroyl peroxide 
was added every 30 minutes until the sclareolide xanthate had been consumed as determined by 
TLC (19.8 mg additional DLP). The crude reaction mixture was concentrated by passing a 
stream of nitrogen over the heated vial. The residue was purified via flash column 
chromatography on silica (10 – 20% EtOAc in hexanes) to afford the azide A5 as a yellow oil in 
a 4:1 diastereomeric mixture (8.0  mg, 51% yield) in accordance with the literature:10 
100 
1H NMR (600 MHz, CDCl3) δ 3.61 (tt, J = 12.1, 4.2 Hz, 0.8H), 3.47 (tt, J = 12.2, 3.7 Hz, 0.2H), 
2.47 – 2.38 (m, 1H), 2.28 (dd, J = 16.1, 6.4 Hz, 1H), 2.12 – 2.07 (m, 1H), 2.01 (dd, J = 14.7, 6.4 
Hz, 1H), 1.93 – 1.88 (m, 1H), 1.86 – 1.75 (m, 2H), 1.73 – 1.67 (m, 1H), 1.64 – 1.54 (m, 2H), 1.33 
(s, 3H), 1.10 – 1.04 (m, 2H), 0.98 (s, 3H), 0.96 (s, 3H), 0.90 (s, 3H). 
13C NMR (major diastereomer, 151 MHz, CDCl3) δ 176.26, 86.02, 58.81, 56.10, 54.05, 47.09, 




2(3aH)-one (A6): Adapted from the literature procedure.11 In a 1 dram vial in the glovebox, to a 
solution of sclareolide xanthate 2.37 (40 mg, 0.11 mmol) in DCE/MeOH-d4 (0.4 mL/0.2 mL) 
was added triethylborane (0.54 mL, 0.54 mmol, 1M in hexanes). The vial was fitted with a 
Teflon-lined screw cap and sealed with Teflon tape. The vial headspace was purged with a dry 
O2 balloon for 2 min and then stirred under an O2 atmosphere for 72 h. The reaction mixture was 
diluted with DCM (1 mL), passed over a short silica plug, and concentrated to afford A6 as a 
pale yellow amorphous solid (16 mg, 62% yield). GC-MS analysis according to the literature 
revealed 72% D incorporation: 
1H NMR (600 MHz, CDCl3) δ 2.44 – 2.37 (m, 1H), 2.23 (dd, J = 16.3, 6.5 Hz, 1H), 2.07 (dt, J = 
12.0, 3.3 Hz, 1H), 1.96 (dd, J = 14.9, 6.5 Hz, 1H), 1.89 – 1.85 (m, 1H), 1.73 – 1.60 (m, 2H), 1.44 
– 1.36 (m, 2H), 1.33 (s, 3H), 1.22 – 1.14 (m, 2H), 1.08 – 1.02 (m, 1H), 0.99 – 0.93 (m, 1H), 0.91 
(s, 3H), 0.88 (s, 3H), 0.83 (s, 3H). 
101 
13C NMR (151 MHz, CDCl3) δ 177.10, 86.58, 59.23, 56.75, 42.18, 39.51, 38.81, 36.15, 33.43, 
33.31, 28.86, 21.71, 21.06, 20.68, 17.83 (t, J = 19.6 Hz), 15.21. 
IR (film) 2926.45, 2869.56, 1844.58, 1773.23, 1716.34, 1540.85, 1497.45, 1456.96 cm-1. 
HRMS (ES+) Exact mass calcd for C16H26O2D [M+H]
+, 252.2067. Found 252.2083. 
 
(3aR,5aS,8S,9aS,9bR)-8-hydroxy-3a,6,6,9a-tetramethyldecahydronaphtho[2,1-b]furan-
2(3aH)-one (A7): To a solution of sclareolide xanthate 2.37 (37 mg, 0.1 mmol) in PhCl (1 mL) 
stirring at 100 °C, TEMPO (94 mg, 0.6 mmol) and tris(trimethylsilyl)silane (93 μL, 0.3 mmol) 
were added in three portions over 48 h. The reaction mixture was stirred for an additional 24 h, 
then concentrated. Zinc powder (262 mg, 4.0 mmol), then a mixture of HOAc/THF/H2O (3:1:1, 
2.5 mL) was added and heated at 70 °C overnight. The reaction mixture was filtered through a 
cotton plug and washed with EtOAc. The resulting filtrate was washed with saturated NaHCO3 
and water, dried over anhydrous Na2SO4, filtered, and concentrated. The crude material was 
purified by flash column chromatography (20 – 50% EtOAc in hexanes) to yield A7 as a white 
solid in accordance with the literature data (16.2 mg, 61% yield):12 
1H NMR (600 MHz, CDCl3) δ 3.98 (tt, J = 11.3, 4.3 Hz, 1H), 2.43 (dd, J = 16.2, 14.7 Hz, 1H), 
2.26 (dd, J = 16.2, 6.4 Hz, 1H), 2.08 (dt, J = 11.9, 3.3 Hz, 1H), 2.00 (dd, J = 14.7, 6.4 Hz, 1H), 
1.90 (dd, J = 14.2, 3.6 Hz, 1H), 1.86 – 1.79 (m, 2H), 1.69 (td, J = 12.6, 4.3 Hz, 1H), 1.52 (br. s, 
1H), 1.41 – 1.31 (m, 1H), 1.32 (s, 3H), 1.15 (t, J = 12.1 Hz, 1H), 1.07 (dd, J = 12.7, 2.9 Hz, 1H), 
0.99 – 0.94 (m, 7H), 0.88 (s, 3H). 
102 
13C NMR (151 MHz, CDCl3) δ 176.66, 86.27, 64.42, 58.98, 56.23, 51.47, 48.39, 38.56, 37.44, 




2(3aH)-one (A8): 4-Methyl piperidine (49 µL, 0.40 mmol) was added to a solution of 
sclareolide xanthate 2.37 (37 mg, 0.10 mmol) dissolved in EtOH (0.5 mL) and was left stirring 
overnight at room temperature. The reaction mixture was then concentrated, and A8 was isolated 
by flash column chromatography (30% EtOAc in hexanes) as a white solid (20.2 mg, 71% 
yield): 
1H NMR (600 MHz, CDCl3) δ 2.97 (td, J = 10.7, 8.8, 6.3 Hz, 1H), 2.44 (app t, J = 15.4 Hz, 1H), 
2.24 (dd, J = 16.2, 6.4 Hz, 1H), 2.09 (app d, J = 11.9 Hz, 1H), 2.00 (dd, J = 14.8, 6.5 Hz, 1H), 
1.90 (dd, J = 14.5, 3.7 Hz, 1H), 1.86 – 1.77 (m, 2H), 1.70 (td, J = 12.6, 4.1 Hz, 1H), 1.65 (br. s, 
1H), 1.40 – 1.31 (m, 1H), 1.33 (s, 3H), 1.25 (app t, J = 13.0 Hz, 1H), 1.10 (app t, J = 12.8 Hz, 
2H), 0.95 (s, 3H) ,0.94 (s, 3H), 0.87 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 176.38, 86.21, 58.83, 56.08, 48.66, 46.01, 43.41, 38.54, 37.59, 
35.04, 33.09, 28.77, 21.75, 21.55, 20.44, 16.04. 
IR (film) 3445.21, 2947.66, 1772.26, 1646.91, 1540.85, 1473.35, 1033.66, 916.99 cm-1. 
HRMS (ES+) Exact mass calcd for C32H53O4S2 [2M+H]
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APPENDIX B: SUPPORTING INFORMATION FOR CHAPTER 4 
General Methods and Materials 
Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were recorded on a 
Bruker model DRX 400, or a Bruker AVANCE III 600 CryoProbe (1H NMR at 400 or 600 MHz 
and 13C NMR at 100 or 151 MHz) spectrometer with solvent resonance as the internal standard 
(1H NMR: CDCl3 at 7.26 ppm; 
13C NMR: CDCl3 at 77.16 ppm). 
1H NMR data are reported as 
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet 
of doublets, ddd = doublet of doublet of doublets, td = triplet of doublets, tdd = triplet of doublet 
of doublets, qd = quartet of doublets, m = multiplet), coupling constants (Hz), and integration. 
Mass spectra were obtained using a Q Exactive HF-X mass spectrometer with electrospray 
introduction and external calibration. Thin layer chromatography (TLC) was performed on 
SiliaPlate 250μm thick silica gel plates provided by Silicycle. Visualization was accomplished 
with short wave UV light (254 nm), iodine, aqueous basic potassium permanganate solution, or 
aqueous acidic ceric ammonium molybdate solution followed by heating. Flash chromatography 
was performed using SiliaFlash P60 silica gel (40-63 μm) purchased from Silicycle. 
Tetrahydrofuran, diethyl ether, and dichloromethane were dried by passage through a column of 
neutral alumina under nitrogen prior to use. Blue light irradiation of reactions was performed 
using the PAR38 Royal Blue 21W aquarium LED lamps (Model #6851) fabricated with high-
power Cree XR-E LEDs as purchased from Ecoxotic (www.ecoxotic.com) or Kessil KSH150B 
Blue 36W LED Grow Lights. Reaction temperatures reached 50 °C using the Ecoxotic lamp and 
40–50 °C with the Kessil light. All other reagents were obtained from commercial sources and 





Potassium methyl(phenyl)carbamodithioate: KOH (1 equiv) was dissolved in a minimum 
vol- ume of water and cooled to 0 °C in an ice bath. Carbon disulfide (1 equiv), then N-
methylaniline (1 equiv) was added dropwise into the stirring solution. The resulting red-orange 
mixture was stirred for 4 h and used directly in the next step. 
Thiocarbamylsulfenamide Synthesis – General Procedure A 
 
Adapted from an analogous literature procedure by Smith et al.1 A fresh solution of potassium 
methyl(phenyl)carbamodithioate (2 M in H2O) was prepared and chilled in an ice bath. In a 
separate flask, the primary amine (1.2 equiv) was treated with sodium hypochlorite (~1.5 M in 
H2O from Sigma Aldrich, 1 equiv) at 0 °C. After 5 to 10 minutes of stirring, the solution of 
potassium methyl(phenyl)carbamodithioate salt (1 equiv) was added dropwise, and the reaction 
mixture was allowed to come to room temperature overnight. The mixture was diluted with 
water and Et2O, and the layers were separated. The aqueous phase was extracted twice with 
Et2O, and the combined organic phase was washed with brine, dried over anhydrous MgSO4, 
filtered, and concentrated in vauo. The crude mixture was purified by column chromatography 
(2.5 to 5% EtOAc/hex) to give the corresponding thiocarbamylsulfenamide.  
Warning: Rapid addition of the potassium methyl(phenyl)carbamodithioate solution, especially 
with low-boiling chloroamines, can cause an exotherm and gas evolution resulting from the de- 
composition of the reagents. 
121 
 
N-methyl-N-(((propylamino)thio)carbonothioyl)aniline (B1): Prepared from N-propylamine 
according to General Procedure A (100 mmol) as a yellow oil (13.4 g, 56% yield): 
1H NMR (600 MHz, CDCl3) δ 7.47 – 7.40 (m, 3H), 7.25 – 7.21 (m, 2H), 3.76 (s, 3H), 3.57 (t, J 
= 5.6 Hz, 1H), 2.82 (td, J = 7.2, 5.5 Hz, 2H), 1.50 (h, J = 7.3 Hz, 2H), 0.89 (t, J = 7.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 205.86, 143.05, 129.81, 129.31, 126.73, 54.02, 54.00, 45.96, 23.43, 
11.52. 
HRMS (ES+) Exact mass calcd for C11H17N2S2 [M+H]




N-(((isopropylamino)thio)carbonothioyl)-N-methylaniline (B2): Prepared from 
isopropylamine according to General Procedure A (100 mmol) as a light yellow solid (14.9 g, 
62% yield): 
1H NMR (600 MHz, CDCl3) δ 7.48 – 7.41 (m, 3H), 7.26 – 7.23 (m, 2H), 3.76 (s, 3H), 3.11 (heptd, 
J = 6.3, 1.2 Hz, 1H), 1.06 (d, J = 6.3 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 205.79, 143.04, 129.64, 129.11, 126.53, 50.69, 45.88, 22.37. 
HRMS (ES+) Exact mass calcd for C11H17N2S2 [M+H]




N-(((tert-butylamino)thio)carbonothioyl)-N-methylaniline (B3): Prepared from tert-
butylamine according to General Procedure A (100 mmol) as a light yellow solid (15.3 g, 60% 
yield): 
1H NMR (400 MHz, CDCl3) δ 7.49 – 7.42 (m, 3H), 7.29 – 7.21 (m, 2H), 3.95 (s, 1H), 3.77 (s, 
3H), 1.09 (s, 10H). 
13C NMR (151 MHz, CDCl3) δ 207.51, 143.54, 129.85, 129.26, 126.81, 55.76, 46.30, 29.12. 
HRMS (ES+) Exact mass calcd for C12H19N2S2 [M+H]
+ 255.0990. Found 255.0984. 
 
 
N-(((butylamino)thio)carbonothioyl)-N-methylaniline (B4): Prepared from n-butylamine 
according to General Procedure A (40 mmol) as an orange oil (4.58 g, 45% yield): 
1H NMR (600 MHz, CDCl3) δ 7.47 – 7.41 (m, 3H), 7.25 – 7.22 (m, 2H), 3.76 (s, 3H), 3.56 (t, J 
= 5.6 Hz, 1H), 2.85 (td, J = 7.2, 5.6 Hz, 2H), 1.50 – 1.43 (m, 2H), 1.37 – 1.27 (m, 2H), 0.88 (t, 
J = 7.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 205.90, 143.11, 129.85, 129.35, 126.76, 52.00, 46.01, 32.41, 20.17, 
14.01. 
HRMS (ES+) Exact mass calcd for C12H19N2S2 [M+H]




N-methyl-N-(((pentylamino)thio)carbonothioyl)aniline (B5): Prepared from amylamine (10 
mmol) according to General Procedure A (10 mmol) as a red-orange oil (1.15 g, 43% yield): 
1H NMR (600 MHz, CDCl3) δ 7.47 – 7.41 (m, 3H), 7.25 – 7.22 (m, 2H), 3.76 (s, 3H), 3.56 (t, J 
= 5.6 Hz, 1H), 2.84 (td, J = 7.2, 5.6 Hz, 2H), 1.53 – 1.45 (m, 2H), 1.32 – 1.26 (m, 4H), 0.87 (t, 
J = 7.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 205.89, 143.12, 129.85, 129.35, 126.76, 52.28, 46.01, 29.98, 29.17, 
22.57, 14.10. 
HRMS (ES+) Exact mass calcd for C13H21N2S2  [M+H]
+ 269.1146. Found 269.1142. 
 
 
N-(((hexylamino)thio)carbonothioyl)-N-methylaniline (B6): Prepared from n-hexylamine ac- 
cording to General Procedure A (80 mmol) as a pale yellow oil (11.1 g, 49% yield): 
1H NMR (600 MHz, CDCl3) δ 7.47 – 7.40 (m, 3H), 7.25 – 7.21 (m, 2H), 3.76 (s, 3H), 3.56 (t, J 
= 5.6 Hz, 1H), 2.84 (td, J = 7.2, 5.6 Hz, 2H), 1.48 (p, J = 7.2 Hz, 2H), 1.34 – 1.20 (m, 6H), 0.86 
(t, J = 6.9 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 205.85, 143.08, 129.81, 129.31, 126.73, 52.27, 45.97, 31.68, 30.23, 
26.64, 22.63, 14.11. 
HRMS (ES+) Exact mass calcd for C14H23N2S2 [M+H]





Rimantadine hydrochloride (4.32 g, 20 mmol, 1 equiv) was charged to a 100-mL round-
bottomed flask equipped with a stir bar and dissolved in methyl tert-butyl ether (20 mL) and 
tBuOH (0.95 mL, 10 mmol, 0.5 equiv). With the laboratory lights off, an aqueous solution of 
sodium hypochlorite (14 mL, ~1.5 M in H2O from Sigma-Aldrich) was added dropwise at 0 °C, 
and the mixture was stirred vigorously for 30 min. The contents of the flask were transferred to 
a separatory funnel, where the organic phase was dispensed directly into another 100 mL round-
bottomed flask equipped with a stir bar. At 0 °C, solid sodium methyl(phenyl)carbamodithioate2 
(4.11 g, 20 mmol) was added slowly to the flask, and the mixture was left stirring overnight. The 
mixture was diluted with Et2O (100 mL) and water (100 mL). The layers were separated, and the 
aqueous phase was extracted twice with Et2O (2 x 100 mL). The combined organic phase was 
washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. The crude 
mixture was purified by column chromatography (5% EtOAc/hex) to give B7 as a light yellow 
solid (3.75 g, 52% yield). 
1H NMR (400 MHz, CDCl3) δ 7.49 – 7.41 (m, 3H), 7.25 – 7.22 (m, 2H), 3.74 (s, 3H), 2.68 (qd, J 
= 6.6, 2.6 Hz, 1H), 2.01 – 1.92 (m, 3H), 1.74 – 1.50 (m, 13H), 0.97 (d, J = 6.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 206.98, 143.41, 129.79, 129.21, 126.73, 63.44, 45.89, 38.60, 37.35, 
36.65, 28.60, 13.36. 
HRMS (ES+) Exact mass calcd for C20H29N2S2 [M+H]
+ 361.1772. Found 361.1766. 
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Substrate Synthesis – General Procedure B 
The acid chloride was prepared as following: to a solution of the carboxylic acid (1 equiv) in 
CH2Cl2 (0.5 M) at 0 °C was added oxalyl chloride (1.2 equiv) dropwise followed by 1 to 2 
drops of DMF. The resulting solution was stirred for 2-4 h and then concentrated to remove 
excess oxalyl chloride to give the acid chloride, which was used without further purification. 
The thiocarbamylsulfenamide (1 equiv) was charged to a separate round-bottomed flask with a 
stir bar and was dissolved in CH2Cl2 (0.5 M). Pyridine was added dropwise at 0 °C, followed by 
a solution of the acid chloride (2 M in CH2Cl2). The reaction mixture was allowed to warm to 
room temperature and was stirred until completion as determined by TLC and/or GC-MS (1 h 
to 14 h). 
The reaction mixture was diluted with CH2Cl2 and washed with water. The aqueous layer was 
extracted with CH2Cl2 (x 2). The combined organic phase was then washed with 2 M NaOH 
solu- tion and brine, then dried over anhydrous MgSO4. The solid was filtered, and the filtrate 
was concentrated in vacuo. The resulting residue was purified by flash column chromatography 
on silica to afford the desired functionalized amides. 
 
 
N-((methyl(phenyl)carbamothioyl)thio)-N-propylhexanamide (B8): Prepared according to 
General Procedure B from hexanoyl chloride (1 mmol) and B1 as a colorless oil (0.305 g, 90% 
yield): 
126 
1H NMR (600 MHz, CDCl3) δ 7.53 – 7.48 (m, 3H), 7.30 – 7.27 (m, 2H), 4.33 – 4.27 (m, 1H), 
3.75 (s, 3H), 2.80 (ddd, J = 13.5, 7.9, 6.5 Hz, 1H), 2.48 (ddd, J = 16.0, 8.6, 6.4 Hz, 1H), 2.37 
(ddd, J = 15.7, 8.7, 6.4 Hz, 1H), 1.61 – 1.51 (m, 2H), 1.51 – 1.43 (m, 2H), 1.32 – 1.23 (m, 4H), 
0.87 (t, J = 7.0 Hz, 3H), 0.79 (t, J = 7.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 198.88, 178.57, 142.78, 130.18, 129.96, 126.90, 53.36, 46.52, 
33.58, 31.56, 25.09, 22.65, 21.61, 14.12, 11.34. 
HRMS (ES+) Exact mass calcd for C17H26N2OS2Na [M+Na]
+, 361.1384. Found 361.1376. 
 
 
N-isopropyl-N-((methyl(phenyl)carbamothioyl)thio)hexanamide (B9): Prepared according 
to General Procedure B from hexanoyl chloride (1 mmol) and B2 as a white solid (0.200 g, 59% 
yield): 
1H NMR (600 MHz, CDCl3) δ 7.54 – 7.48 (m, 3H), 7.34 – 7.28 (m, 2H), 4.91 (hept, J = 6.7 Hz, 
1H), 3.75 (s, 3H), 2.52 – 2.43 (m, 2H), 1.64 – 1.53 (m, 2H), 1.35 – 1.22 (m, 4H), 1.12 (d, J = 6.7 
Hz, 3H), 0.94 (d, J = 6.5 Hz, 3H), 0.87 (t, J = 6.9 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 200.80, 178.75, 143.02, 130.18, 129.93, 126.91, 49.54, 46.76, 
34.61, 31.56, 25.16, 22.68, 22.35, 19.45, 14.14. 
HRMS (ES+) Exact mass calcd for C17H26N2OS2Na [M+Na]





N-(tert-butyl)-N-((methyl(phenyl)carbamothioyl)thio)hexanamide (4.6): Prepared according 
to General Procedure B from hexanoyl chloride (2 mmol) and B3 as a white solid (0.312 g, 
44% yield): 
1H NMR (600 MHz, CDCl3) δ 7.52 – 7.48 (m, 3H), 7.29 – 7.27 (m, 2H), 3.75 (s, 3H), 2.52 (ddd, 
J = 16.2, 8.6, 6.2 Hz, 1H), 2.43 (ddd, J = 16.2, 8.7, 6.5 Hz, 1H), 1.59 – 1.49 (m, 2H), 1.44 (s, 9H), 
1.34 – 1.18 (m, 4H), 0.88 (t, J = 7.0 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 201.77, 179.01, 143.09, 130.14, 129.89, 126.81, 63.54, 46.67, 
36.57, 31.52, 29.93, 25.34, 22.77, 14.18. 
HRMS (ES+) Exact mass calcd for C18H28N2OS2Na [M+Na]
+, 375.1541. Found 375.1534. 
 
 
N-hexyl-N-((methyl(phenyl)carbamothioyl)thio)hexanamide (B10): Prepared according to 
General Procedure B from hexanoyl chloride (2.5 mmol) and B6 to give a yellow oil (0.607 g, 
64% yield): 
1H NMR (600 MHz, CDCl3) δ 7.55 – 7.49 (m, 3H), 7.33 – 7.27 (m, 2H), 4.34 (ddd, J = 12.9, 
8.6, 6.6 Hz, 1H), 3.75 (s, 3H), 2.80 (ddd, J = 14.0, 8.6, 5.8 Hz, 1H), 2.47 (ddd, J = 15.3, 8.5, 6.2 
Hz, 1H), 2.36 (ddd, J = 15.7, 8.6, 6.2 Hz, 1H), 1.63 – 1.51 (m, 2H), 1.49 – 1.39 (m, J = 6.7 Hz, 
2H), 1.36 – 1.14 (m, 10H), 0.87 (t, J = 6.8 Hz, 3H), 0.83 (t, J = 6.7 Hz, 3H). 
128 
13C NMR (151 MHz, CDCl3) δ 198.85, 178.56, 142.70, 130.18, 129.98, 126.89, 51.80, 46.56, 
33.58, 31.59, 31.54, 28.31, 26.51, 25.07, 22.67, 22.65, 14.16, 14.14. 
HRMS (ES+) Exact mass calcd for C20H32N2OS2Na [M+Na]
+, 403.1854. Found 403.1846. 
 
 
N-hexyl-N-((methyl(phenyl)carbamothioyl)thio)benzamide (B11): Prepared according to 
General Procedure B from benzoyl chloride (2 mmol) and B6 to give an amorphous yellow 
solid (0.619 g, 80% yield): 
1H NMR (600 MHz, CDCl3) δ 7.47 – 7.29 (m, 9H), 6.91 – 6.78 (m, 1H), 4.59 – 4.46 (m, 1H), 
3.61 (s, 3H), 3.16 – 3.06 (m, 1H), 1.61 – 1.48 (m, 2H), 1.32 – 1.18 (m, 8H), 0.84 (t, J = 7.2 Hz, 
3H). 
13C NMR (151 MHz, CDCl3) δ 198.76, 176.28, 142.57, 136.31, 129.92, 129.72, 129.52, 127.51, 
127.33, 126.75, 51.66, 46.14, 31.55, 28.11, 26.51, 22.62, 14.10. 
HRMS (ES+) Exact mass calcd for C21H26N2OS2Na [M+Na]




2,2,2-trifluoro-N-hexyl-N-((methyl(phenyl)carbamothioyl)thio)acetamide (B12): To a 
solution of B6 (2 mmol) dissolved in CH2Cl2 (0.5 M) was added DMAP (4 equiv) and 
trifluoroacetic anhydride (3 equiv) at 0 °C. The cooling bath was removed and the mixture was 
allowed to stir at room temperature until the reaction was complete as indicated by TLC. Upon 
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complete conversion of the starting material, the reaction mixture was diluted with CH2Cl2, then 
washed with sat. NaHCO3 and brine. The organic phase was dried over anhydrous MgSO4, 
filtered, and concentrated. The residue was purified by column chromatography to give an 
amorphous yellow solid (0.694 g, 92% yield). 
1H NMR (400 MHz, CDCl3) δ 7.54 – 7.47 (m, 3H), 7.31 – 7.27 (m, 2H), 4.38 (dt, J = 13.6, 7.7 
Hz, 1H), 3.74 (s, 3H), 3.03 (dt, J = 14.0, 7.3 Hz, 1H), 1.54 – 1.43 (m, 2H), 1.31 – 1.16 (m, 6H), 
0.84 (t, J = 6.9 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 196.67, 161.41 (q, J = 35.9 Hz), 142.17, 130.37, 130.32, 126.97, 
118.83, 115.96 (q, J = 288.6 Hz) 54.30, 46.46, 31.44, 27.19, 26.28, 22.55, 14.05. 
19F NMR (376 MHz, CDCl3) δ -68.39. 
HRMS (ES+) Exact mass calcd for C16H21F3N2OS2Na [M+Na]
+, 401.0945. Found 401.0938. 
 
 
N-(tert-butyl)-N-((methyl(phenyl)carbamothioyl)thio)butyramide (B13): Prepared 
according to General Procedure B from butyric acid (2.5 mmol) and B3 to give an egg-white 
solid (0.492 g, 61% yield): 
1H NMR (600 MHz, CDCl3) δ 7.49 (dd, J = 5.3, 2.0 Hz, 3H), 7.29 – 7.27 (m, 2H), 3.75 (s, 
3H), 2.50 (ddd, J = 16.1, 8.0, 6.4 Hz, 1H), 2.42 (ddd, J = 16.2, 8.2, 6.8 Hz, 1H), 1.61 – 1.52 (m, 
2H), 1.43 (s, 9H), 0.89 (t, J = 7.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 201.69, 178.74, 143.01, 130.12, 129.87, 126.76, 77.16, 63.50, 
46.65, 38.36, 29.88, 18.87, 13.81. 
HRMS (ES+) Exact mass calcd for C16H24N2OS2Na [M+Na]




To a solution of B4 (2 mmol) dissolved in CH2Cl2 (0.5 M) was added DMAP (4 equiv) and 
trifluoro- acetic anhydride (3 equiv) at 0 °C. The cooling bath was removed and the mixture 
was allowed to stir at room temperature until the reaction was complete as indicated by TLC. 
Upon complete conversion of the starting material, the reaction mixture was diluted with 
CH2Cl2, then washed with sat. NaHCO3 and brine. The organic phase was dried over anhydrous 
MgSO4, filtered, and concentrated. The residue was purified by column chromatography to give 
an amorphous yellow solid (0.700 g, 100% yield). 
1H NMR (600 MHz, CDCl3) δ 7.53 – 7.49 (m, 3H), 7.30 – 7.26 (m, 2H), 4.40 (dt, J = 13.6, 7.6 
Hz, 1H), 3.74 (s, 3H), 3.03 (dt, J = 14.0, 6.9 Hz, 1H), 1.54 – 1.45 (m, 2H), 1.28 – 1.18 (m, 2H), 
0.86 (t, J = 7.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 196.68, 161.43 (q, J = 35.9 Hz), 142.17, 130.38, 130.33, 126.97, 
115.96 (q, J = 288.6 Hz), 54.06, 46.46, 29.34, 19.90, 13.80. 
19F NMR (376 MHz, CDCl3) δ -68.39. 
HRMS (ES+) Exact mass calcd for C14H17F3N2OS2Na [M+Na]







Prepared according to General Procedure B from 2-cyclohexylacetic acid (1 mmol) and B2 to 
give an amorphous colorless solid (0.299 g, 79% yield): 
1H NMR (600 MHz, CDCl3) δ 7.56 – 7.46 (m, 3H), 7.32 – 7.28 (m, 2H), 4.90 (hept, J = 6.6 
Hz, 1H), 3.74 (s, 3H), 2.47 (dd, J = 15.5, 6.6 Hz, 1H), 2.27 (dd, J = 15.5, 6.9 Hz, 1H), 1.83 – 
1.71 (m, 2H), 1.67 – 1.56 (m, 4H), 1.29 – 1.18 (m, 2H), 1.14 – 1.06 (m, 4H), 0.97 – 0.83 (m, 
5H). 
13C NMR (151 MHz, CDCl3) δ 200.76, 177.90, 143.03, 130.14, 129.88, 126.85, 49.50, 46.70, 
41.88, 35.14, 33.34, 33.26, 26.43, 26.32, 26.24, 22.39, 19.42. 
HRMS (ES+) Exact mass calcd for C19H28N2OS2Na [M+Na]




Prepared according to General Procedure B from cyclohexanecarboxylic acid (1 mmol) and B2 
to give a white solid (0.281 g, 80% yield): 
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1H NMR (600 MHz, CDCl3) δ 7.56 – 7.48 (m, 3H), 7.34 – 7.29 (m, 2H), 4.90 (hept, J = 6.7 
Hz, 1H), 3.75 (s, 3H), 2.73 (tt, J = 11.5, 3.4 Hz, 1H), 1.83 – 1.74 (m, 2H), 1.71 – 1.57 (m, 4H), 
1.28 – 1.13 (m, 4H), 1.09 (d, J = 6.7 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 201.65, 181.87, 143.14, 130.18, 129.89, 126.84, 77.37, 77.16, 
76.95, 49.13, 46.82, 41.98, 30.11, 29.17, 26.31, 26.05, 25.48, 22.38, 19.31. 
HRMS (ES+) Exact mass calcd for C18H26N2OS2Na [M+Na]




((methyl(phenyl)carbamothioyl)thio)hexanamide (B17): Prepared according to General 
Procedure B from hexanoyl chloride (0.75 mmol) and B6 to give a pale yellow solid (0.335 g, 
97% yield): 
1H NMR (600 MHz, CDCl3) δ 7.51 – 7.46 (m, 3H), 7.29 – 7.26 (m, 2H), 4.79 (q, J = 7.0 Hz, 
1H), 3.71 (s, 3H), 2.58 (ddd, J = 15.3, 8.3, 6.7 Hz, 1H), 2.51 (ddd, J = 15.7, 8.4, 6.7 Hz, 1H), 
1.82  (q, J = 3.2 Hz, 3H), 1.61 – 1.53 (m, 5H), 1.50 – 1.45 (m, 3H), 1.36 – 1.32 (m, 3H), 1.32 – 
1.24 (m, 8H), 1.10 (d, J = 7.0 Hz, 3H), 0.87 – 0.84 (m, 2H). 
13C NMR (151 MHz, CDCl3) δ 201.58, 179.70, 142.98, 130.05, 129.84, 126.72, 59.58, 46.65, 
38.82, 37.68, 37.00, 36.96, 34.93, 31.55, 28.56, 28.41, 25.46, 22.58, 14.06, 10.18. 
HRMS (ES+) Exact mass calcd for C26H38N2OS2Na [M+Na]





((methyl(phenyl)carbamothioyl)thio)hexanamide (B18): Prepared according to General 
Procedure B from N-phthalimide protected norleucine3 (1.66 mmol) and B2 to give a yellow 
solid (0.370 g, 46% yield): 
1H NMR (600 MHz, CDCl3) δ 7.77 (dd, J = 5.4, 3.1 Hz, 2H), 7.68 (ddd, J = 11.7, 5.5, 3.1 Hz, 2H), 
7.34 (q, J = 8.6, 8.1 Hz, 5H), 4.96 (dd, J = 8.4, 6.3 Hz, 1H), 4.89 (p, J = 6.6 Hz, 1H), 3.73 (s, 3H), 
2.17 (dp, J = 16.2, 5.6 Hz, 1H), 1.90 – 1.80 (m, 1H), 1.39 – 1.23 (m, 2H), 1.23 – 1.13 (m, 2H), 
1.04 (d, J = 6.6 Hz, 3H), 0.86 – 0.80 (m, 6H). 
13C NMR (151 MHz, CDCl3) δ 199.83, 173.29, 167.08, 142.27, 134.07, 133.79, 131.65, 129.83, 
129.75, 123.19, 52.12, 50.53, 46.78, 30.24, 28.06, 22.54, 22.11, 18.95, 13.95. 
HRMS (ES+) Exact mass calcd for C25H29N3O3S2Na [M+Na]




oyl)thio)butanamide (B19): Prepared according to General Procedure B from N-phthalimide 
protected valine4 (2 mmol) and S2 to give a light yellow solid (0.514 g, 55% yield): 
1H NMR (400 MHz, CDCl3) δ 7.85 – 7.76 (m, 2H), 7.74 – 7.66 (m, 2H), 7.40 – 7.31 (m, 5H), 
4.93 (hept, J = 6.6 Hz, 1H), 4.68 (d, J = 9.4 Hz, 1H), 3.76 (s, 3H), 2.74 (dhept, J = 9.3, 6.7 Hz, 
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1H), 1.14 (d, J = 6.5 Hz, 3H), 1.06 (d, J = 6.7 Hz, 3H), 0.84 (d, J = 8.4 Hz, 3H), 0.80 (d, J = 9.0 
Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 199.89, 172.53, 167.39, 142.39, 134.15, 133.86, 131.60, 129.89, 
129.80, 123.31, 57.31, 50.37, 46.92, 28.96, 22.25, 21.04, 19.02, 18.89. 
HRMS (ES+) Exact mass calcd for C24H27N3O3S2Na [M+Na]




oyl)thio)cyclohexane-1-carboxamide (B20): Prepared according to General Procedure B from 
N-phthalimide protected tranexamic acid5 (1.5 mmol) and B2 to give a yellow solid (0.710 g, 
93% yield): 
1H NMR (600 MHz, CDCl3) δ 7.85 – 7.78 (m, 2H), 7.71 – 7.65 (m, 2H), 7.56 – 7.46 (m, 3H), 
7.35 – 7.31 (m, 2H), 4.86 (hept, J = 6.6 Hz, 1H), 3.75 (s, 3H), 3.52 (d, J = 7.2 Hz, 2H), 2.71 (tt, J 
= 11.9, 3.4 Hz, 1H), 1.87 (dt, J = 13.3, 3.0 Hz, 1H), 1.84 – 1.72 (m, 2H), 1.72 – 1.59 (m, 3H), 
1.15 
(qd, J = 12.9, 3.4 Hz, 1H), 1.10 – 0.96 (m, 5H), 0.88 (d, J = 6.5 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 201.27, 181.39, 168.70, 143.06, 134.00, 132.07, 130.18, 129.87, 
126.82, 123.28, 49.22, 46.81, 44.00, 41.68, 36.50, 30.39, 29.58, 29.18, 28.48, 22.31, 19.27. 
HRMS (ES+) Exact mass calcd for C27H31N3O3S2Na [M+Na]





((methyl(phenyl)carbamothioyl)thio)pentanamide (B21): Prepared according to General 
Procedure B from gemfibrozil (1.5 mmol) and B2 to give a pale yellow solid (0.481 g, 68% 
yield): 
1H NMR (600 MHz, CDCl3) δ 7.56 – 7.45 (m, 3H), 7.34 – 7.28 (m, 2H), 7.02 – 6.95 (m, 1H), 
6.67 – 6.62 (m, 1H), 6.61 – 6.58 (m, 1H), 4.65 (hept, J = 6.5 Hz, 1H), 3.90 (dt, J = 9.1, 5.7 Hz, 
1H), 3.85 (ddd, J = 9.1, 6.9, 5.4 Hz, 1H), 3.74 (s, 3H), 2.31 (s, 3H), 2.08 (s, 3H), 1.93 (td, J = 
12.9, 12.4, 3.7 Hz, 1H), 1.79 (ddtd, J = 17.2, 11.1, 5.5, 3.7 Hz, 1H), 1.74 – 1.59 (m, 2H), 1.37 (s, 
3H), 1.33 (s, 3H), 1.25 (d, J = 6.7 Hz, 3H), 1.08 (d, J = 6.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 201.61, 180.95, 157.03, 143.01, 136.44, 130.25, 130.10, 
129.85, 126.81, 123.57, 120.60, 111.97, 68.15, 54.16, 46.47, 44.55, 37.84, 27.11, 26.75, 25.22, 
22.54, 21.47, 19.66, 15.94. 
HRMS (ES+) Exact mass calcd for C26H36N2O2S2Na [M+Na]+, 495.2116. Found 495.2107. 
 
 
N-hexyl-N-((methyl(phenyl)carbamothioyl)thio)nicotinamide (B22): Prepared according to 
General Procedure B from nicotinic acid (2.5 mmol) and B6 to give a low-melting yellow-
orange solid (0.708 g, 73% yield): 
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1H NMR (600 MHz, CDCl3) δ 8.63 – 8.55 (m, 2H), 7.77 (d, J = 7.8 Hz, 1H), 7.38 (dd, J = 16.2, 
7.6 Hz, 3H), 7.29 – 7.23 (m, 2H), 6.89 (br s, 1H), 4.47 (dt, J = 14.9, 7.8 Hz, 1H), 3.58 (s, 3H), 
3.02(dt, J = 13.9, 7.1 Hz, 1H), 1.58 – 1.48 (m, 2H), 1.31 – 1.18 (m, 6H), 0.82 (t, J = 6.8 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 197.47, 173.90, 150.21, 148.05, 142.13, 135.18, 132.14, 129.98, 
129.91, 129.86, 126.49, 122.38, 51.70, 46.15, 31.37, 27.85, 26.36, 22.47, 13.96. 
HRMS (ES+) Exact mass calcd for C20H26N3OS2 [M+H]





boxamide (B23): To a solution of androstenone-176 (0.63 g, 2 mmol, 1 equiv) and pyridine (0.21 
mL, 2.6 mmol, 1.3 equiv) dissolved in toluene (10 mL, 0.2 M) was added dropwise a solution of 
(COCl)2 (0.19 mL, 2.26 mmol, 1.13 equiv) in toluene (4.5 mL) at 0 °C. The solution was stirred 
at rt for 1.5 h, then pyridine (0.18 mL, 2.2 mmol, 1.1 equiv) followed by a solution of B1 (0.48 
g, 2 mmol, 1 equiv) dissolved in 2 mL was added dropwise at 0 °C. The mixture was stirred at 
rt overnight. The reaction mixture was concentrated then resuspended in CH2Cl2 (50 mL) and 
washed with water (50 mL). The aqueous layer was extracted with CH2Cl2 (25 mL x 2). The 
combined organic phase was then washed with 2 M NaOH solution (100 mL) and brine (100 
mL), then dried over anhydrous MgSO4. The solid was filtered, and the filtrate was 
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concentrated in vacuo. The crude mixture was purified by flash column chromatography to give 
a light yellow solid (0.312 g, 29% yield): 
1H NMR (600 MHz, CDCl3) δ 7.48 – 7.44 (m, 3H), 7.27 – 7.23 (m, 2H), 5.68 (s, 1H), 4.35 (dt, J 
= 13.5, 7.6 Hz, 1H), 3.69 (s, 3H), 3.09 (t, J = 9.1 Hz, 1H), 2.69 (dt, J = 13.6, 6.7 Hz, 1H), 2.41 – 
2.19 (m, 6H), 1.95 (ddd, J = 13.3, 5.1, 3.1 Hz, 1H), 1.84 – 1.80 (m, 1H), 1.73 (dtd, J = 13.1, 
9.2, 6.1 Hz, 1H), 1.69 – 1.62 (m, 2H), 1.55 – 1.46 (m, 2H), 1.46 – 1.37 (m, 2H), 1.32 – 1.25 (m, 
2H), 1.17 – 1.08 (m, 2H), 1.11 (s, 3H), 1.06 – 0.99 (m, 1H), 0.88 (ddd, J = 12.4, 10.7, 4.3 Hz, 
1H), 0.74 (t, J = 7.4 Hz, 3H), 0.63 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 199.38, 199.31, 178.49, 171.21, 142.64, 129.97, 129.84, 126.67, 
123.75, 55.93, 53.82, 53.77, 50.59, 45.04, 38.59, 38.42, 35.70, 33.94, 32.81, 32.03, 26.58, 24.60, 
21.78, 20.89, 17.27, 13.85, 11.26. 
HRMS (ES+) Exact mass calcd for C31H43N2O2S2 [M+H]




thyl(phenyl)carbamothioyl)thio)acetamide (B24): Prepared according to General Procedure B 
from N-benzyl protected etodolac7 (1.5 mmol) and B2 to give a colorless amorphous solid (0.528 
g, 59% yield): 
1H NMR (600 MHz, CDCl3) δ 7.42 (tt, J = 7.5, 1.2 Hz, 0.5H), 7.35 (tt, J = 7.5, 1.2 Hz, 0.5H), 
7.30– 7.23 (m, 5H), 7.21 – 7.08 (m, 3H), 6.98 – 6.88 (m, 3H), 6.35 (dd, J = 7.4, 1.1 Hz, 1H), 6.23 
(dd, J = 7.4, 1.1 Hz, 0.5H), 4.99 (tq, J = 13.0, 6.5 Hz, 0.5H), 4.32 (ddd, J = 12.0, 9.7, 6.8 Hz, 
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0.5H), 4.23 (td, J = 11.6, 4.4 Hz, 0.5H), 3.89 (ddd, J = 12.1, 7.9, 2.7 Hz, 0.5H), 3.85 (ddd, J = 
12.1, 6.2, 2.2 Hz, 0.5H), 3.70 (s, 1.5H), 3.67 (s, 1.5H), 3.52 – 3.45 (m, 1H), 3.26 (d, J = 15.0 Hz, 
0.5H), 3.13 (d, J = 14.7 Hz, 0.5H), 2.96 (ddtd, J = 56.5, 29.3, 14.5, 7.4 Hz, 2H), 2.67 (d, J = 
13.5 Hz, 0.5H), 2.48 (dq, J = 14.0, 3.1 Hz, 2H), 2.26 (ddq, J = 28.5, 14.6, 7.3 Hz, 1H), 2.12 (dq, 
J = 14.4, 7.2 Hz, 0.5H), 2.01 (dt, J = 13.9, 6.9 Hz, 0.5H), 1.42 – 1.30 (m, 1H), 1.30 – 1.21 (m, 
4H), 1.13 (t, J = 7.2 Hz, 3H), 1.05 (td, J = 7.3, 2.2 Hz, 3H), 1.00 (t, J = 6.3 Hz, 3H). 
13C NMR (151 MHz, CDCl3)  δ 200.52, 200.44, 186.32, 184.43, 174.63, 174.22, 152.94, 152.46, 
142.73, 142.59, 137.05, 136.81, 136.79, 136.69, 131.23, 131.03, 130.09, 130.07, 129.85, 129.83, 
127.85, 127.77, 127.27, 127.25, 126.76, 126.70, 126.64, 124.31, 124.18, 121.34, 121.24, 80.32, 
80.19, 65.89, 58.04, 57.20, 56.74, 56.60, 49.50, 49.37, 46.71, 39.26, 38.95, 38.21, 37.78, 32.96, 
31.18, 30.84, 29.40, 24.43, 24.15, 22.38, 22.34, 19.48, 15.36, 15.30, 8.59, 7.94. 
HRMS (ES+) Exact mass calcd for C35H41N3O2S2Na [M+Na]
+, 622.2538. Found 622.2532. 




(B25): Prepared according to General Procedure B from linoleic acid (3.0 mmol) and B3 to 
give a golden oil (1.00 g, 65% yield): 
1H NMR (600 MHz, CDCl3) δ 7.52 – 7.49 (m, 3H), 7.29 – 7.27 (m, 2H), 5.41 – 5.30 (m, 4H), 
3.76 (s, 3H), 2.79 – 2.75 (m, 2H), 2.52 (ddd, J = 16.2, 8.5, 6.2 Hz, 1H), 2.44 (ddd, J = 16.1, 
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8.6, 6.4 Hz, 1H), 2.08 – 2.00 (m, 4H), 1.54 – 1.50 (m, 1H), 1.45 (s, 9H), 1.38 – 1.24 (m, 15H), 
0.89 (t, J = 6.9 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 201.83, 178.95, 130.35, 130.33, 130.15, 129.89, 128.09, 126.84, 
63.58, 46.68, 36.61, 31.67, 29.96, 29.85, 29.66, 29.50, 29.37, 29.33, 27.41, 27.36, 25.79, 25.67, 
22.73, 14.24. 
HRMS (ES+) Exact mass calcd for C30H48N2OS2Na [M+Na]
+, 539.3106. Found 539.3114. 
 
Functionalized Products 
General Procedure C – Product functionalization from light initiation 
A 1 dram vial was charged with substrate (1.0 equiv), fitted with a PTFE lined screw cap, and 
taken into the glovebox. The contents were dissolved in PhCF3 (0.5 M wrt substrate), and the 
resulting solution was sealed with Teflon tape and removed from the glovebox. Alternatively, 
reactions may be prepared using other air-sensitive techniques, such as with a Schlenk line. The 
vial was placed in a 3D-printed holder (see below picture). The holder was suspended above an 
Ecoxotic PAR38 23 W blue LED such that the bottom of each vial was directly aligned with and 
1 cm above one of the five LEDs, and the apparatus was covered with aluminum foil. The 
reaction was irradiated until completion. The temperature inside the reaction mixture reached 50 
°C. The reaction was concentrated in vacuo, and the crude residue was purified by flash column 
chromatography to afford the functionalized product. 
General Procedure D – Product functionalization using heat and initiator 
A 1 dram vial equipped with a stir bar was charged with substrate (1.0 equiv) and dicumyl 
peroxide (10 mol %), fitted with a PTFE lined screw cap, and taken into the glovebox. The 
contents were dissolved in PhCl (0.5 M wrt substrate), and the resulting solution was sealed with 
Teflon tape and removed from the glovebox. Alternatively, reactions may be prepared using 
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other air-sensitive techniques, such as with a Schlenk line. The vial was placed on a block plate 
at 120 °C to stir overnight. Upon completion, the reaction was concentrated in vacuo, and the 
crude residue was purified by flash column chromatography to afford the functionalized product. 
 
Figure B1. Pictures of the set up for General Procedure C with the blue LED turned off and on. 
The reaction vials are suspended in a 3D-printed vial holder such that the bottom of the vials is 
about 1 cm from the LED below. 
 
 
6-(tert-butylamino)-6-oxohexan-3-yl methyl(phenyl)carbamodithioate (4.6): Prepared 
according to General Procedures C and D from 4.4 (53 mg, 0.15 mmol). The crude residue was 
purified by flash column chromatography (15 – 30% EtOAc in hexanes) to afford 4.6 as a white 
solid (C: 32.2 mg, 61% yield; D: 29.6 mg, 56% yield). 
1H NMR (600 MHz, CDCl3) δ 7.47 – 7.38 (m, 3H), 7.24 – 7.20 (m, 2H), 5.44 (s, 1H), 3.97 – 
3.91 (m, 1H), 3.74 (s, 3H), 2.18 (qdd, J = 14.8, 8.9, 6.3 Hz, 2H), 2.02 – 1.95 (m, 1H), 1.82 (tq, J 
= 14.8, 8.6, 7.4 Hz, 1H), 1.71 – 1.57 (m, 2H), 1.33 (s, 9H), 0.92 (t, J = 7.3 Hz, 3H). 
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13C NMR (151 MHz, CDCl3) δ 199.61, 171.93, 129.81, 128.95, 126.96, 55.07, 51.25, 46.26, 
35.23, 30.14, 28.91, 28.02, 11.45. 
HRMS (ES+) Exact mass calcd for C18H29N2OS2 [M+H]
+, 353.1783. Found 353.1783. 
 
 
6-(isopropylamino)-6-oxohexan-3-yl methyl(phenyl)carbamodithioate (4.7): Prepared 
according to General Procedures C and D from B9 (51 mg, 0.15 mmol). The crude residue was 
purified by flash column chromatography (30 – 40% EtOAc in hexanes) to afford 4.7 as a white 
solid (C: 46.4 mg, 91% yield; D: 37.2 mg, 73% yield). 
1H NMR (600 MHz, CDCl3) δ 7.47 – 7.39 (m, 3H), 7.23 – 7.19 (m, 2H), 5.58 (d, J = 7.9 Hz, 
1H), 4.05 (ddq, J = 13.0, 7.8, 6.4 Hz, 1H), 3.95 (ddd, J = 13.6, 8.6, 5.5 Hz, 1H), 3.74 (s, 3H), 
2.22 (qdd, J = 14.8, 8.8, 6.4 Hz, 2H), 1.99 (ddt, J = 14.5, 9.0, 6.0 Hz, 1H), 1.85 (dq, J = 15.3, 8.2 
Hz, 1H), 1.71 – 1.55 (m, 2H), 1.14 (dd, J = 13.9, 6.6 Hz, 6H), 0.92 (t, J = 7.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 199.58, 171.62, 129.82, 128.97, 126.94, 55.01, 41.45, 34.43, 
30.23, 27.83, 22.89, 22.86, 11.45. 
HRMS (ES+) Exact mass calcd for C17H27N2OS2 [M+H]
+, 339.1564. Found 339.1625. 
 
 
Reaction of B8: Prepared according to General Procedures C and D from B8 (51 mg, 0.15 
mmol). The crude residue was purified by flash column chromatography to afford a mixture of 
4.8 and 4.9 as a white solid (C: 40.5 mg, 79% yield, 3:1 rr; D: 44.0 mg, 85% yield, 3:1 rr). 
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HRMS (ES+) Exact mass calcd for C17H27N2OS2 [M+H]
+, 339.1564. Found 339.1629. 
6-oxo-6-(propylamino)hexan-3-yl methyl(phenyl)carbamodithioate (4.8): 
1H NMR (600 MHz, CDCl3) δ 7.49 – 7.37 (m, 3H), 7.24 – 7.17 (m, 2H), 5.83 (t, J = 5.8 Hz, 
1H), 3.98 – 3.89 (m, 1H), 3.74 (s, 3H), 3.18 (tdd, J = 7.1, 5.8, 3.1 Hz, 2H), 2.25 (tdd, J = 14.7, 
11.6, 7.4 Hz, 2H), 2.03 – 1.96 (m, 1H), 1.87 (p, J = 7.4, 6.8 Hz, 1H), 1.67 (dp, J = 14.4, 7.3 Hz, 
1H), 1.59 (tt, J = 14.5, 7.4 Hz, 1H), 1.51 (h, J = 7.3 Hz, 2H), 0.91 (q, J = 7.1 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 199.57, 172.55, 129.82, 128.99, 126.91, 54.99, 41.36, 34.29, 
30.30, 27.77, 22.92, 11.56, 11.44. 
HRMS (ES+) Exact mass calcd for C17H27N2OS2 [M+H]
+, 339.1564. Found 339.1629. 
6-oxo-6-(propylamino)hexan-2-yl methyl(phenyl)carbamodithioate (4.9):  
1H NMR (600 MHz, CDCl3) δ 7.48 – 7.40 (m, 3H), 7.23 – 7.19 (m, 2H), 5.58 (s, 1H), 3.96 (p, J 
= 6.8 Hz, 1H), 3.74 (s, 3H), 3.19 (dt, J = 7.7, 6.3 Hz, 2H), 2.17 (ddt, J = 15.9, 14.4, 7.3 Hz, 2H), 
1.70 (tt, J = 8.9, 5.3 Hz, 4H), 1.50 (p, J = 7.3 Hz, 2H), 1.30 (d, J = 7.0 Hz, 3H), 0.91 (t, J = 7.4 
Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 199.33, 172.78, 129.84, 128.98, 127.01, 47.63, 41.32, 36.37, 
35.84, 23.30, 23.02, 20.66, 11.54. 
***The same ratio of products was obtained at lower concentrations (0.1 M), suggesting that the 





Reaction of B10: Prepared according to General Procedures C and D from B10 (57 mg, 0.15 
mmol). The crude residue was purified by flash column chromatography (20 – 50% EtOAc in 
hexanes) to afford a mixture of 4.10 and 4.11 as a colorless, amorphous solid (C: 49.6 mg, 87% 
yield, 2.5:1 rr; D: 49.6 mg, 87% yield, 1.6:1 rr). 
HRMS (ES+) Exact mass calcd for C20H33N2OS2 [M+H]
+, 381.2034. Found 381.2101. 
6-(hexylamino)-6-oxohexan-3-yl methyl(phenyl)carbamodithioate (4.10): 
1H NMR (600 MHz, CDCl3) δ 7.51 – 7.41 (m, 3H), 7.27 – 7.22 (m, 2H), 5.74 (s, 1H), 3.98 (tt, J 
= 8.3, 5.4 Hz, 1H), 3.78 (s, 3H), 3.30 – 3.19 (m, 3H), 2.35 – 2.22 (m, 2H), 2.21 – 2.13 (m, 1H), 
2.09 – 1.98 (m, 1H), 1.89 (dq, J = 15.1, 8.1 Hz, 1H), 1.75 – 1.57 (m, 2H), 1.55 – 1.47 (m, 2H), 
1.38 – 1.25 (m, 5H), 0.95 (t, J = 7.4 Hz, 3H), 0.93 – 0.87 (m, 3H). 
13C NMR (151 MHz, CDCl3) δ 199.67, 172.49, 129.86, 129.01, 126.97, 55.09, 39.74, 34.38, 
31.63, 31.61, 30.39, 29.70, 27.87, 26.78, 22.71, 14.17, 11.48. 
6-hexanamidohexan-3-yl methyl(phenyl)carbamodithioate (4.11): 
1H NMR (600 MHz, CDCl3) δ 7.50 – 7.40 (m, 3H), 7.27 – 7.21 (m, 2H), 5.80 (s, 1H), 4.00 – 
3.88 (m, 1H), 3.77 (s, 3H), 3.33 (dq, J = 12.9, 6.4 Hz, 1H), 3.23 (dq, J = 13.3, 6.5 Hz, 1H), 2.22 
– 2.13 (m, 2H), 1.76 – 1.53 (m, 7H), 1.38 – 1.25 (m, 5H), 0.99 – 0.87 (m, 6H). 
13C NMR (151 MHz, CDCl3) δ 199.64, 173.12, 129.73, 128.84, 126.88, 54.49, 38.88, 36.91, 




6-benzamidohexan-3-yl methyl(phenyl)carbamodithioate (4.12): Prepared according to 
General Procedures C and D from B11 (58 mg, 0.15 mmol). The crude residue was purified by 
flash column chromatography (20 – 50% EtOAc in hexanes) to afford 4.12 as a white solid (C: 
47.4 mg, 82% yield; D: 47.5 mg, 82% yield): 
1H NMR (600 MHz, CDCl3) δ 7.81 – 7.77 (m, 2H), 7.48 – 7.37 (m, 6H), 7.23 – 7.18 (m, 2H), 
6.56 (t, J = 5.8 Hz, 1H), 3.99 – 3.93 (m, 1H), 3.73 (s, 3H), 3.52 (dq, J = 12.6, 6.3 Hz, 1H), 3.39 
(dq, J = 12.7, 6.5 Hz, 1H), 1.76 – 1.65 (m, 5H), 1.57 (dt, J = 14.7, 7.5 Hz, 1H), 0.92 (t, J = 7.3 
Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 199.62, 167.50, 134.80, 131.32, 129.78, 129.75, 128.89, 128.55, 
128.53, 127.04, 126.97, 126.92, 54.51, 39.52, 31.54, 26.76, 26.73, 11.50. 
HRMS (ES+) Exact mass calcd for C21H27N2OS2 [M+H]
+, 387.1564. Found 387.1633. 
 
 
6-(2,2,2-trifluoroacetamido)hexan-3-yl methyl(phenyl)carbamodithioate (4.13): Prepared 
according to General Procedures C and D from B12 (57 mg, 0.15 mmol). The crude residue was 
purified by flash column chromatography (10 – 30% EtOAc in hexanes) to afford 4.13 as a white 
solid (C: 44.5 mg, 78% yield; D: 48.9 mg, 86% yield): 
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1H NMR (600 MHz, CDCl3) δ 7.48 – 7.39 (m, 3H), 7.24 – 7.20 (m, 2H), 6.81 – 6.75 (m, 1H), 
3.95 – 3.89 (m, 1H), 3.75 (s, 3H), 3.43 (dq, J = 12.6, 6.3 Hz, 1H), 3.33 (dq, J = 12.7, 6.3 Hz, 
1H), 1.73 – 1.62 (m, 5H), 1.60 – 1.53 (m, 1H), 0.92 (t, J = 7.3 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 199.45, 157.28 (q, J = 36.9 Hz), 129.83, 129.00, 126.92, 120.08 
– 112.19 (m), 54.17, 39.46, 31.36, 26.76, 26.02, 11.50. 
HRMS (ES+) Exact mass calcd for C16H22F3N2OS2 [M+H]
+, 379.1126. Found 379.1192. 
 
 
4-(tert-butylamino)-4-oxobutyl methyl(phenyl)carbamodithioate (4.14): Prepared according 
to General Procedures C and D from B13 (49 mg, 0.15 mmol). The crude residue was purified by 
flash column chromatography (20 – 30% EtOAc in hexanes) to afford 4.14 as a white solid (C: 
31.9 mg, 65% yield; D: 37.2 mg, 76% yield): 
1H NMR (600 MHz, CDCl3) δ 7.50 – 7.39 (m, 3H), 7.23 – 7.16 (m, 2H), 5.95 (s, 1H), 4.06 
(ddd, J = 9.6, 7.0, 4.0 Hz, 1H), 3.75 (s, 3H), 2.76 (dd, J = 13.5, 4.1 Hz, 2H), 2.13 (dd, J = 13.4, 
9.7 Hz, 2H), 1.34 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 198.77, 169.90, 129.83, 129.09, 126.81, 51.09, 45.76, 45.57, 
28.78, 18.95. 
HRMS (ES+) Exact mass calcd for C16H25N2OS2 [M+H]
+, 325.1408. Found 325.1466. 
 
 
4-(2,2,2-trifluoroacetamido)butyl methyl(phenyl)carbamodithioate (4.15): Prepared 
according to General Procedure D from B14 (52.5 mg, 0.15 mmol). The crude residue was 
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purified by flash column chromatography (5 – 10% EtOAc in hexanes) to afford 4.15 as a white 
solid (27.4 mg, 52% yield).  
1H NMR (600 MHz, CDCl3) δ 7.48 – 7.41 (m, 3H), 7.24 – 7.22 (m, 2H), 6.69 (s, 1H), 3.76 (s, 
3H), 3.39 (q, J = 6.5 Hz, 2H), 3.18 (t, J = 7.3 Hz, 2H), 1.73 – 1.60 (m, 4H). 
13C NMR (151 MHz, CDCl3) δ 199.22, 157.22 (q, J = 36.8 Hz), 144.70, 129.80, 129.07, 126.87, 
115.85 (q, J = 287.8 Hz), 46.17, 39.08, 36.46, 27.85, 26.00. 
HRMS (ES+) Exact mass calcd for C14H18F3N2OS2 [M+H]
+, 351.0813. Found 351.0876. 
 
 
2-(2-(isopropylamino)-2-oxoethyl)cyclohexyl methyl(phenyl)carbamodithioate (4.16): 
Prepared according to General Procedures C and D from B15 (57 mg, 0.15 mmol). The crude 
residue was purified by flash column chromatography (20 – 50% EtOAc in hexanes) to afford 
4.16 as a white solid (C: 50.6 mg, 89% yield, 2:1 dr; D: 44.8 mg, 79% yield, 2:1 dr). 
HRMS (ES+) Exact mass calcd for C19H29N2OS2 [M+H]
+, 365.1721. Found 365.1786. 
Major diastereomer (trans):  
1H NMR (600 MHz, CDCl3) δ 7.46 – 7.38 (m, 3H), 7.20 – 7.18 (m, 2H), 5.37 (d, J = 7.9 Hz, 
1H), 4.08 – 4.00 (m, 1H), 3.81 (td, J = 10.9, 4.2 Hz, 1H), 3.74 (s, 3H), 2.62 (dd, J = 12.4, 3.0 Hz, 
1H), 2.15 – 2.11 (m, 1H), 1.94 – 1.86 (m, 2H), 1.76 – 1.61 (m, 3H), 1.43 – 1.34 (m, 2H), 1.29 – 
1.19 (m, 2H), 1.16 – 1.08 (m, 6H). 
13C NMR (151 MHz, CDCl3) δ 199.33, 171.35, 129.87, 129.00, 126.94, 56.95, 41.88, 41.38, 
39.18, 34.39, 33.26, 32.65, 26.88, 25.41, 23.10, 22.84. 
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Minor diastereomer (cis): 
1H NMR (600 MHz, CDCl3) δ 7.52 – 7.43 (m, 3H), 7.27 – 7.20 (m, 2H), 5.37 (d, J = 7.7 Hz, 
1H), 4.50 – 4.44 (m, 1H), 4.11 – 4.04 (m, 1H), 3.78 (s, 3H), 2.38 – 2.30 (m, 1H), 2.27 (dd, J = 
14.2, 5.3 Hz, 1H), 2.01 – 1.89 (m, 2H), 1.81 – 1.53 (m, 5H), 1.43 – 1.22 (m, 2H), 1.15 (d, J = 7.6 
Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 198.96, 171.23, 129.88, 128.92, 127.02, 56.11, 41.50, 41.44, 
38.75, 32.31, 30.42, 23.02, 22.93. 
 
 
3-(isopropylcarbamoyl)cyclohexyl methyl(phenyl)carbamodithioate (4.17): Prepared 
according to General Procedures C and D from B16 (52.6 mg, 0.15 mmol). The crude residue 
was purified by flash column chromatography (30% EtOAc in hexanes) to afford 4.17 as a white 
solid (C: 42.5 mg, 81% yield, 2:1 dr; D: 45.7 mg, 87% yield, 2:1 dr). 
1H NMR (600 MHz, CDCl3) δ 7.46 – 7.36 (m, 3H), 7.21 – 7.17 (m, 2H), 6.36 (s, 0.33H), 5.43 
(s, 0.67H), 4.10 (hept, J = 6.9 Hz, 0.33H), 4.05 – 3.96 (m, 1H), 3.78 – 3.72 (m, 0.67H), 3.72 (s, 
1H), 3.71 (s, 2H), 2.32 (d, J = 8.4 Hz, 0.67H), 2.24 (d, J = 12.7 Hz, 0.67H), 2.16 (tt, J = 11.9, 3.5 
Hz, 0.67H), 2.02 (t, J = 7.3 Hz, 0.33H), 1.92 (t, J = 9.0 Hz, 0.33H), 1.85 – 1.73 (m, 2.67H), 1.61 
(m, 0.33H), 1.53 – 1.31 (m, 2.67H), 1.23 (m, .67H), 1.17 (dd, J = 17.0, 6.6 Hz, 3H), 1.09 (dd, J = 
6.6, 2.2 Hz, 3H). 
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13C NMR (151 MHz, CDCl3) δ 198.78, 198.47, 173.82, 173.19, 144.82, 129.85, 129.74, 128.94, 
126.89, 126.83, 49.94, 48.34, 45.69, 45.66, 41.49, 41.42, 41.12, 40.94, 35.75, 33.99, 31.59, 
30.74, 29.73, 28.60, 28.50, 25.85, 25.81, 22.99, 22.94, 22.89, 22.83, 22.81, 22.74. 
HRMS (ES+) Exact mass calcd for C18H27N2OS2 [M+H]




methyl(phenyl)carbamodithioate (4.38): Prepared according to General Procedures C and D 
from B17 (46 mg, 0.15 mmol). The crude residue was purified by flash column chromatography 
(15 – 30% EtOAc in hexanes) to afford 4.28 as a light yellow solid (C: 36.3 mg, 79% yield; D: 
22.1 mg, 48% yield and 17.5 mg B17 recovered) in a 1:1 diastereomeric mixture: 
1H NMR (600 MHz, CDCl3) δ 7.47 – 7.40 (m, 3H), 7.24 – 7.21 (m, 2H), 5.54 (t, J = 9.2 Hz, 
1H), 4.03 – 3.92 (m, 1H), 3.75 (s, 3H), 3.71 (dq, J = 9.8, 6.9 Hz, 1H), 2.35 – 2.20 (m, 2H), 2.06 – 
1.94 (m, 3H), 1.88 (dq, J = 14.5, 7.7 Hz, 1H), 1.72 – 1.66 (m, 4H), 1.65 – 1.57 (m, 4H), 1.57 – 
1.49 (m, 4H), 1.49 – 1.44 (m, 2H), 1.03 (d, J = 6.9 Hz, 2H), 1.00 (dd, J = 6.9, 2.1 Hz, 2H), 0.93 
(td, J = 7.4, 4.7 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 199.71, 199.60, 172.03, 171.94, 129.85, 128.99, 126.97, 55.46, 
55.15, 53.02, 38.54, 38.52, 37.19, 35.94, 35.90, 34.72, 34.65, 30.57, 30.49, 28.45, 28.44, 28.42, 
28.22, 27.96, 14.72, 14.69, 11.52, 11.48. 
HRMS (ES+) Exact mass calcd for C26H39N2OS2 [M+H]





methyl(phenyl)carbamodithioate (4.29): Prepared according to General Procedures C and D 
from B18 (72 mg, 0.15 mmol). The crude residue was purified by flash column chromatography 
(20 – 50% EtOAc in hexanes) to afford 4.29 as an off-white solid (C: 59.8 mg, 82% yield; D: 
53.5 mg, 74% yield) in a 1:1 diastereomeric mixture: 
HRMS (ES+) Exact mass calcd for C25H31N3O3S2 [M+H]
+, 485.1807. Found 485.1815. 
Diastereomer A: 
1H NMR (600 MHz, CDCl3) δ 7.89 – 7.81 (m, 2H), 7.78 – 7.70 (m, 2H), 7.48 – 7.27 (m, 5H), 
6.03 (d, J = 7.4 Hz, 1H), 4.94 (dd, J = 11.1, 4.8 Hz, 1H), 4.08 – 4.01 (m, 1H), 4.01 – 3.94 (m, 
1H), 3.64 (s, 3H), 2.84 (ddd, J = 15.5, 11.1, 4.8 Hz, 1H), 2.27 (ddd, J = 18.4, 12.3, 6.2 Hz, 1H), 
1.73 (dp, J = 13.5, 7.3, 6.8 Hz, 1H), 1.59 (dp, J = 14.6, 7.4 Hz, 1H), 1.13 (d, J = 6.5 Hz, 3H), 
1.12 (d, J = 6.5 Hz, 3H), 0.92 (t, J = 7.3 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 198.39, 168.35, 168.12, 134.15, 132.21, 129.84, 127.14, 123.57, 
52.77, 52.53, 42.10, 33.43, 28.50, 22.72, 22.70, 11.25. 
Diastereomer B: 
1H NMR (600 MHz, CDCl3) δ 7.94 – 7.84 (m, 2H), 7.79 – 7.69 (m, 2H), 7.46 – 7.37 (m, 3H), 
7.21 – 7.14 (m, 2H), 6.27 (d, J = 7.8 Hz, 1H), 4.84 (dd, J = 8.3, 5.4 Hz, 1H), 4.05 (hept, J = 6.8 
Hz, 1H), 3.89 (qd, J = 7.8, 4.4 Hz, 1H), 3.67 (s, 3H), 2.58 (dt, J = 14.0, 6.5 Hz, 1H), 2.39 (dt, J = 
14.8, 7.5 Hz, 1H), 1.88 – 1.80 (m, 1H), 1.58 (dq, J = 15.8, 8.0 Hz, 1H), 1.16 (d, J = 6.6 Hz, 3H), 
1.14 (d, J = 6.6 Hz, 3H), 0.93 (t, J = 7.3 Hz, 3H). 
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13C NMR (151 MHz, CDCl3) δ 198.74, 168.28, 167.73, 134.27, 132.08, 129.83, 127.01, 123.66, 




methyl(phenyl)carbamodithioate (4.30): Prepared according to General Procedures C and D 
from B19 (70 mg, 0.15 mmol). The crude residue was purified by flash column chromatography 
(30% EtOAc in hexanes) to afford 4.30 as a white solid (C: 59.5 mg, 85% yield; D: 38.4 mg, 
55% yield and 25.6 mg B19 recovered): 
1H NMR (600 MHz, CDCl3) δ 7.89 – 7.79 (m, 2H), 7.77 – 7.69 (m, 2H), 7.47 – 7.39 (m, 3H), 
7.25 – 7.21 (m, 2H), 7.03 (d, J = 7.6 Hz, 1H), 4.50 (d, J = 10.5 Hz, 1H), 4.10 – 4.02 (m, 1H), 
3.75 (s, 3H), 3.76 – 3.72 (m, 1H), 3.08 (tqd, J = 10.2, 6.7, 3.7 Hz, 1H), 2.91 (dd, J = 13.8, 9.8 
Hz, 1H), 1.23 (d, J = 6.6 Hz, 3H), 1.16 (d, J = 6.6 Hz, 3H), 0.86 (d, J = 6.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 198.79, 168.19, 166.66, 134.42, 131.52, 129.87, 129.11, 126.90, 
123.70, 60.54, 42.14, 41.67, 32.17, 22.69, 22.59, 16.37. 
HRMS (ES+) Exact mass calcd for C24H28N3O3S2 [M+H]






methyl(phenyl)carbamodithioate (4.31): Prepared according to General Procedures C and D 
from B20 (76 mg, 0.15 mmol). The crude residue was purified by flash column chromatography 
(40 – 50% EtOAc in hexanes) to afford 4.31 as an off-white solid (C: 65.3 mg, 85% yield; D: 
61.6 mg, 81% yield) in a 2:1 diastereomeric mixture. The reaction can be performed without any 
special treatment under air to provide the title compound in slightly lowered yield (C: 43.7 mg, 
58% yield): 
1H NMR (600 MHz, CDCl3) δ 7.85 – 7.76 (m, 2H), 7.74 – 7.66 (m, 2H), 7.52 – 7.30 (m, 4H), 
7.20 (d, J = 7.4 Hz, 1H), 5.33 (d, J = 7.9 Hz, 0.66H), 5.23 (d, J = 7.9 Hz, 0.33H), 4.65 (d, J = 3.8 
Hz, 0.33H), 4.06 – 3.91 (m, 2H), 3.73 (d, J = 13.4 Hz, 3H), 3.58 (dd, J = 13.8, 10.5 Hz, 0.66H), 
3.52 (d, J = 6.8 Hz, 0.33H), 3.46 (dd, J = 13.9, 8.0 Hz, 0.33H), 2.45 (qt, J = 8.7, 4.1 Hz, 0.33H), 
2.28 (d, J = 13.2 Hz, 0.66H), 2.16 (tt, J = 12.2, 3.3 Hz, 0.66H), 2.07 (d, J = 13.0 Hz, 0.66H), 1.99 
– 1.83 (m, 1.33H), 1.82 – 1.75 (m, 1.66H), 1.64 – 1.55 (m, 1H), 1.50 – 1.31 (m, 1H), 1.31 – 1.18 
(m, 1H), 1.14 – 1.05 (m, 6H). 
13C NMR (151 MHz, CDCl3) δ 198.29, 197.82, 173.95, 173.40, 168.53, 168.49, 134.04, 134.02, 
133.93, 132.19, 132.07, 129.87, 126.94, 123.33, 123.31, 123.23, 54.34, 52.70, 45.59, 41.99, 
41.67, 41.56, 41.25, 41.21, 39.70, 39.23, 37.22, 35.69, 30.11, 30.06, 28.98, 28.19, 22.88, 22.85. 
HRMS (ES+) Exact mass calcd for C27H32N3O3S2 [M+H]





methyl(phenyl)carbamodithioate (4.32): Prepared according to General Procedure C from B21 
(71 mg, 0.15 mmol). The crude residue was purified by flash column chromatography (10 – 50% 
EtOAc in hexanes) to afford 4.32 as a light yellow solid (40.5 mg, 57% yield). 
1H NMR (400 MHz, CDCl3) δ 7.50 – 7.34 (m, 3H), 7.23 – 7.15 (m, 2H), 6.97 (d, J = 7.7 Hz, 
1H), 6.70 – 6.62 (m, 2H), 5.60 (d, J = 7.6 Hz, 1H), 4.44 (ddt, J = 8.3, 6.4, 4.1 Hz, 1H), 4.17 – 
4.08 (m, 1H), 4.00 (dq, J = 7.4, 6.4 Hz, 1H), 3.87 (dd, J = 9.3, 6.5 Hz, 1H), 3.74 (s, 3H), 2.29 (s, 
3H), 2.19 (dd, J = 15.0, 4.0 Hz, 1H), 2.13 (s, 3H), 1.98 – 1.88 (m, 1H), 1.24 (s, 3H), 1.20 (s, 3H), 
1.12 (d, J = 6.4 Hz, 3H), 1.11 (d, J = 6.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 198.49, 176.14, 156.59, 144.65, 136.65, 130.32, 129.86, 129.09, 
126.96, 123.71, 121.14, 112.61, 70.84, 49.25, 42.09, 41.59, 40.42, 26.12, 22.80, 22.67, 21.44, 
16.02. 
HRMS (ES+) Exact mass calcd for C26H37N2O2S2 [M+H]
+, 473.2296. Found 473.2383. 
 
 
6-(nicotinamido)hexan-3-yl methyl(phenyl)carbamodithioate (4.33): Prepared according to 
General Procedures C and D from B22 (58 mg, 0.15 mmol). The crude residue was purified by 
flash column chromatography (75 – 100% EtOAc in hexanes) to afford 4.33 as a pale yellow 
amorphous solid (C: 47.1 mg, 81% yield; D: 47.4 mg, 82% yield): 
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1H NMR (600 MHz, CDCl3) δ 9.01 – 8.95 (m, 1H), 8.69 – 8.63 (m, 1H), 8.15 – 8.06 (m, 1H), 
7.45 – 7.36 (m, 3H), 7.34 (dd, J = 8.0, 4.7 Hz, 1H), 7.21 – 7.17 (m, 2H), 6.91 (t, J = 6.0 Hz, 1H), 
3.96 – 3.88 (m, 1H), 3.72 (s, 3H), 3.58 – 3.52 (m, 1H), 3.45 – 3.36 (m, 1H), 1.77 – 1.64 (m, 4H), 
1.61 – 1.51 (m, 1H), 1.30 – 1.25 (m, 1H), 0.90 (t, J = 7.3 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 199.73, 165.67, 152.26, 148.18, 147.81, 135.25, 130.52, 129.90, 
129.05, 126.98, 123.57, 54.35, 39.44, 31.77, 26.56, 11.65. 
HRMS (ES+) Exact mass calcd for C20H26N3OS2 [M+H]





methyl(phenyl)carbamodithioate (4.34): Prepared according to General Procedure C from B23 
(54 mg, 0.10 mmol). The crude residue was purified by flash column chromatography (10 – 30% 
EtOAc in hexanes) to afford 4.34 as a white solid (24.7 mg, 46% yield): 
1H NMR (600 MHz, CDCl3) δ 7.45 – 7.40 (m, 2H), 7.40 – 7.35 (m, 1H), 7.24 – 7.20 (m, 2H), 
5.72 (s, 1H), 5.15 (s, 1H), 3.99 (d, J = 13.9 Hz, 1H), 3.74 (s, 3H), 3.31 – 3.28 (m, 1H), 3.05 (d, J 
= 13.8 Hz, 1H), 2.52 – 2.38 (m, 2H), 2.33 – 2.20 (m, 4H), 2.06 – 1.87 (m, 4H), 1.79 – 1.70 (m, 
2H), 1.69 – 1.61 (m, 2H), 1.53 – 1.34 (m, 4H), 1.26 (s, 3H), 1.25 – 1.19 (m, 2H), 1.09 – 1.01 (m, 
2H), 0.95 – 0.86 (m, 2H), 0.78 (t, J = 7.4 Hz, 3H). 
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13C NMR (151 MHz, CDCl3) δ 200.67, 199.65, 171.63, 171.38, 129.74, 129.39, 127.22, 123.98, 
57.61, 56.36, 54.24, 48.21, 41.39, 38.81, 37.79, 35.84, 35.41, 35.34, 34.07, 32.82, 32.03, 24.09, 
23.69, 22.45, 21.07, 18.18, 13.80, 11.64. 
HRMS (ES+) Exact mass calcd for C31H43N2O2S2 [M+H]




b]indol-3-yl methyl(phenyl)carbamodithioate (4.35): Prepared according to General 
Procedure D from B24 (60 mg, 0.10 mmol). The crude residue was purified by flash column 
chromatography to afford 4.35 as a pale yellow amorphous solid (49.7 mg, 83% yield): 
1H NMR (600 MHz, CDCl3) δ 7.77 (s, 1H), 7.51 (d, J = 7.9 Hz, 1H), 7.44 – 7.23 (m, 7H), 7.17 
– 7.01 (m, 4H), 5.61 (s, 1H), 4.98 – 4.91 (m, 1H), 4.26 – 4.22 (m, 1H), 4.00 – 3.87 (m, 2H), 3.66 
(s, 3H), 3.25 (t, J = 7.6 Hz, 2H), 2.79 (q, J = 8.0 Hz, 2H), 2.70 (q, J = 7.4 Hz, 2H), 1.33 (t, J = 
8.0 Hz, 3H), 1.21 (d, J = 6.6 Hz, 3H), 1.16 (t, J = 7.5 Hz, 3H), 1.00 (d, J = 6.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 200.81, 174.34, 143.09, 138.73, 134.49, 134.05, 129.02, 128.83, 
128.74, 128.58, 128.26, 126.73, 126.26, 120.36, 116.18, 115.98, 109.20, 92.30, 67.93, 32.47, 
25.66, 24.29, 24.14, 24.00, 22.56, 19.98, 19.87, 14.02, 13.87, 12.20, 12.12. 
HRMS (ES+) Exact mass calcd for C35H42N3O2S2 [M+H]
+, 600.2718. Found 600.2807.  





methyl(phenyl)carbamodithioate (4.36): Prepared according to General Procedure C from B25 
(207 mg, 0.40 mmol). The crude residue was purified by flash column chromatography (10% 
EtOAc in hexanes) to afford 4.36 as a clear oil (110 mg, 53% yield): 
1H NMR (400 MHz, CDCl3) δ 7.51 – 7.38 (m, 3H), 7.24 – 7.20 (m, 2H), 5.47 – 5.26 (m, 5H), 
4.00 (dtd, J = 10.7, 5.8, 5.0, 2.9 Hz, 1H), 3.75 (s, 3H), 2.79 – 2.64 (m, 2H), 2.18 (dt, J = 8.7, 6.5 
Hz, 2H), 2.07 – 1.91 (m, 5H), 1.82 (dq, J = 15.0, 8.0 Hz, 1H), 1.63 – 1.55 (m, 2H), 1.41 – 1.21 
(m, 19H), 0.91 – 0.84 (m, 3H). 
13C NMR (151 MHz, CDCl3) δ 199.47, 171.91, 130.32, 129.92, 129.79, 128.92, 128.22, 127.98, 
126.96, 53.56, 51.22, 46.20, 35.18, 34.92, 31.59, 30.66, 29.55, 29.42, 28.89, 27.28, 27.14, 26.59, 
25.72, 22.66, 14.18. 
HRMS (ES+) Exact mass calcd for C30H49N2OS2 [M+H]
+, 517.3286. Found 517.3377. 
Reaction Scale-Up  
 
6-(nicotinamido)hexan-3-yl methyl(phenyl)carbamodithioate (4.33) was prepared from 
substrate B29 (0.775 g, 2.00 mmol) charged to a 2 dram vial equipped with a stir bar. The vial 
was fitted with a PTFE lined screw cap and taken into the glovebox. The contents were dissolved 
in PhCF3 (4.0 mL), and the resulting solution was sealed with Teflon tape and removed from the 
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glovebox. The vial was suspended on a stir plate and irradiated with a Kessil Blue KSH150B 
36W LED Grow Light from the side (2 cm away) until completion. Reaction temperatures 
ranged between 40 and 50 °C. The reaction was then concentrated in vacuo, and the crude 
residue was purified by flash column chromatography (75 – 100% EtOAc in hexanes) to afford 
4.33 as a pale yellow amorphous solid (0.604 g, 78% yield). 
 
Figure B2. Pictures of the set up used for scaled-up reactions with the Kessil blue LED. The 




N-(hexyl-4-d)nicotinamide (4.37): Adapted from a literature procedure.8 In a 1 dram vial, 
dithiocarbamate 4.33 (39 mg, 0.10 mmol), hypophosphorous acid (50% solution in water, 50 μL, 
0.50 mmol, 5.0 equiv), triethylamine (60 μL, 0.55 mmol, 5.5 equiv), and AIBN (2.3 mg, 0.010 
mmol) was dissolved in dioxane (1.24 mL, 0.08 M). The vial was heated to 100 °C under an 
argon atmosphere, and additional AIBN was added every 1 h until full consumption of 4.33 as 
indicated by TLC. The reaction mixture was then cooled and poured into water. Extraction with 
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EtOAc and subsequent flash chromatography (90 – 100% EtOAc in hexanes) afforded deuterated 
product 4.37 as a pale yellow amorphous solid (16.4 mg, 79% yield). 
1H NMR (600 MHz, CDCl3) δ 8.95 (d, J = 7.9 Hz, 1H), 8.69 (s, 1H), 8.10 (t, J = 7.0 Hz, 1H), 
7.37 (d, J = 8.9 Hz, 1H), 6.48 (s, 1H), 3.44 (q, J = 8.4, 7.5 Hz, 2H), 1.64 – 1.55 (m, 2H), 1.39 – 
1.21 (m, 5H), 0.87 (t, J = 7.6 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 165.60, 152.00, 147.72, 135.18, 130.58, 123.54, 40.26, 31.05 (t, 
J = 17.7 Hz), 29.52, 26.55, 22.45, 13.99. 
HRMS (ES+) Exact mass calcd for C12H18DN2O [M+H]
+, 208.1560. Found 208.1553. 
 
 
N-(4-azidohexyl)nicotinamide (4.38): Adapted from a literature procedure.9 In a 1 dram vial, 
dithiocarbamate 4.33 (51 mg, 0.13 mmol), benzenesulfonyl azide (73 mg, 0.39 mmol, 3.0 equiv), 
bis(tributyltin) (100 μL, 0.20 mmol, 1.5 equiv), and di-tert-butylhyponitrite (DTBHN; 2.3 mg, 
0.013 mmol) was dissolved in chlorobenzene (0.26 mL, 0.50 M). The vial was heated to 80 °C 
under an argon atmosphere, and additional DTBHN was added every 2 h. Another addition of 
benzenesulfonyl azide (73 mg, 0.39 mmol, 3.0 equiv) and bis(tributyltin) (100 μL, 0.20 mmol, 
1.5 equiv) was used after the first three additions of DTBHN for full conversion of 4.33. Upon 
completion, the crude mixture was then filtered through silica gel (hexane, then hexane/EtOAc), 
and the filtrate was concentrated in vacuo. The residue was purified by flash chromatography (85 
– 100% EtOAc in hexanes) to give 4.38 as a pale yellow amorphous solid (24.8 mg, 77% yield).  
1H NMR (600 MHz, CDCl3) δ 8.99 (d, J = 2.3 Hz, 1H), 8.74 (dd, J = 4.8, 1.7 Hz, 1H), 8.14 (dt, 
J = 7.9, 2.0 Hz, 1H), 7.41 (dd, J = 8.0, 4.6 Hz, 1H), 6.43 (s, 1H), 3.53 (td, J = 6.5, 5.7, 2.1 Hz, 2H), 
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3.31 – 3.25 (m, 1H), 1.81 (dddd, J = 16.2, 11.9, 7.4, 1.8 Hz, 1H), 1.74 (dtd, J = 13.2, 6.5, 3.4 Hz, 
1H), 1.69 – 1.53 (m, 4H), 1.01 (t, J = 7.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 165.81, 152.36, 147.87, 135.25, 130.41, 123.69, 64.22, 39.96, 
31.38, 27.57, 26.46, 10.63. 
HRMS (ES+) Exact mass calcd for C12H18N5O [M+H]
+, 248.1511. Found 248.1506. 
 
 
N-(4-ethylhept-6-en-1-yl)nicotinamide (4.39): In a 1 dram vial, dithiocarbamate 4.33 (42 mg, 
0.11 mmol. 1.0 equiv), allyl phenyl sulfone (50 μL, 0.33 mmol, 3.0 equiv), bis(tributyltin) (82 
μL, 0.17 mmol, 1.5 equiv), and di-tert-butylhyponitrite (DTBHN; 2.3 mg, 0.013 mmol) were 
dissolved in chlorobenzene (0.22 mL, 0.50 M). The vial was heated at 80 °C under an argon 
atmosphere, and additional DTBHN (2.3 mg, 0.013 mmol) was added every 2 h until full 
consumption of 4.33 as indicated by TLC (4.6 mg additional DTBHN). The crude mixture was 
then filtered through silica gel (hexane, then hexane/EtOAc), and the filtrate was concentrated in 
vacuo. The residue was purified by flash chromatography (85 – 100% EtOAc in hexanes) to give 
4.39 as a pale yellow amorphous solid (23.9 mg, 90% yield). 
1H NMR (600 MHz, CDCl3) δ 8.94 (d, J = 2.3 Hz, 1H), 8.71 (dd, J = 4.9, 1.7 Hz, 1H), 8.10 (dt, 
J = 7.9, 2.0 Hz, 1H), 7.38 (ddd, J = 8.0, 4.9, 1.0 Hz, 1H), 6.25 (s, 1H), 5.75 (ddt, J = 17.2, 10.1, 
7.1 Hz, 1H), 5.05 – 4.95 (m, 2H), 3.47 – 3.42 (m, 2H), 2.10 – 1.98 (m, 2H), 1.65 – 1.58 (m, 2H), 
1.41 – 1.28 (m, 5H), 0.86 (t, J = 7.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 165.69, 152.28, 147.83, 137.32, 135.22, 130.63, 123.65, 116.04, 
40.64, 38.68, 37.64, 30.14, 26.87, 25.86, 11.09. 
159 
HRMS (ES+) Exact mass calcd for C15H23N2O [M+H]
+, 247.1810. Found 247.1805. 
 
 
N-(4-mercaptohexyl)nicotinamide (4.40): Adapted from a literature procedure.10 Hydrazine 
hydrate (50 μL) was added to a solution of 4.33 (22 mg, 0.057 mmol) dissolved in 1,4-dioxane 
(50 μL) and was left stirring overnight at 100 °C. The reaction mixture was then concentrated, 
and 25 was isolated by flash column chromatography (90 – 100% EtOAc in hexanes) as a yellow 
amorphous solid (11.4 mg, 84% yield).  
1H NMR (600 MHz, CDCl3) δ 8.97 (d, J = 2.3 Hz, 1H), 8.71 – 8.70 (m, 1H), 8.12 (dt, J = 5.8, 
1.9 Hz, 1H), 7.40 – 7.37 (m, 1H), 6.48 (s, 1H), 3.50 – 3.43 (m, 2H), 2.77 – 2.70 (m, 1H), 1.84 
(ddt, J = 12.4, 9.7, 7.1 Hz, 1H), 1.79 – 1.65 (m, 2H), 1.62 (p, J = 7.4 Hz, 1H), 1.56 – 1.48 (m, 
2H), 1.35 (d, J = 7.0 Hz, 1H), 0.99 (t, J = 7.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 165.73, 152.22, 147.84, 135.33, 130.51, 123.69, 42.66, 40.04, 
35.82, 32.16, 27.38, 11.67. 
HRMS (ES+) Exact mass calcd for C12H19N2OS [M+H]
+, 239.1218. Found 239.1213. 
 
 
N-(hex-4-en-1-yl)nicotinamide, N-(hex-3-en-1-yl)nicotinamide (4.41): Adapted from a 
literature procedure.11 A solution of 4.33 (40 mg, 0.10 mmol) in diphenyl ether (1.0 mL) was 
heated under reflux for 1 h using alumina beads. Upon cooling, the reaction mixture was directly 
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subjected to flash column chromatography (50 – 100% EtOAc in hexanes) to give 4.41 (20.5 mg, 
99% yield) as a pale yellow oil in a 1:1 regioisomeric mixture: 
1H NMR (600 MHz, CDCl3) δ 9.00 – 8.89 (m, 1H), 8.71 (dd, J = 4.8, 1.7 Hz, 1H), 8.16 – 8.05 
(m, 1H), 7.38 (ddd, J = 8.0, 4.8, 0.9 Hz, 1H), 6.22 (d, J = 28.2 Hz, 1H), 5.66 – 5.33 (m, 2H), 3.55 
– 3.44 (m, 2H), 2.33 (qd, J = 6.8, 1.3 Hz, 1H), 2.13 – 2.08 (m, 1H), 2.08 – 2.00 (m, 1H), 1.74 – 
1.60 (m, 3H), 0.98 (t, J = 7.5 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 165.72, 165.67, 165.60, 152.20, 152.17, 152.15, 147.90, 147.88, 
147.82, 135.72, 135.21, 135.18, 130.27, 126.12, 125.31, 123.62, 123.59, 40.35, 39.96, 39.56, 
32.55, 31.57, 30.19, 29.65, 29.29, 26.76, 25.73, 22.65, 18.04, 14.12, 13.96. 
HRMS (ES+) Exact mass calcd for C12H17N2O [M+H]
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19F NMR (376 MHz, CDCl3) 
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APPENDIX C: SUPPORTING INFORMATION FOR CHAPTER 5 
General Methods and Materials 
All post-polymerization modifications were performed under inert atmosphere using 
standard glove box and Schlenk-line techniques. Xanthylamide1 and hyperbranched 
polyethylene2 were prepared using previously reported methods. Commercial polyolefins were 
obtained from their respective companies and purified prior to use by precipitation into 
methanol. The company and lot number are named in the individual procedures. Acetonitrile, 
diethyl ether, and dichloromethane were dried by passage through a column of neutral alumina 
under nitrogen prior to use. 1,2-Dichlorobenzene was degassed with argon through multiple 
freeze-pump-thaw cycles. Chlorobenzene and benzene were distilled over calcium hydride, 
degassed through three freeze-pump-thaw cycles, and stored in a glove box. Reagents, unless 
otherwise specified, were purchased and used without further purification. 
Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were recorded 
on a Bruker model DRX 400 MHz, Bruker 500 MHz, Varian Inova 600, or Bruker AVANCE III 
600 MHz CryoProbe spectrometer with solvent resonance as the internal standard (1H NMR: 
CDCl3 at 7.26 ppm; 
13C NMR: CDCl3 at 77.16 ppm). 
1H NMR data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = 
doublet of doublets, bs = broad singlet), coupling constants (Hz), and integration. Infrared (IR) 
spectra were obtained using PerkinElmer Frontier FT-IR spectrometer. Mass spectra were 
obtained using a Q Exactive HF-X mass spectrometer with electrospray introduction and external 
calibration. Thin layer chromatography (TLC) was performed on SiliaPlate 250μm thick silica 
gel plates provided by Silicycle. Visualization was accomplished with short wave UV light (254 
nm), iodine, aqueous basic potassium permanganate solution, or aqueous acidic ceric ammonium 
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molybdate solution followed by heating. Flash chromatography was performed using SiliaFlash 
P60 silica gel (40-63 μm) purchased from Silicycle. 
Gel permeation chromatography (GPC) spectra were obtained using Waters 2695 
separations module liquid chromatograph, Waters 2414 refractive index detector at room 
temperature, and Waters 2996 photodiode array detector with styragel HR columns. 
Tetrahydrofuran was the mobile phase and the flow rate was set to 1 mL/min. The instrument 
was calibrated using polystyrene standards in the range of 580 to 892,800 Da. Commercial 
polyolefin samples were analyzed at the Center for the Science and Technology Advancement of 
Materials and Interfaces (STAMI) using a Tosoh EcoSECHT (high temperature) GPC with 
refractive index detection against polystyrene standards in 1 mg/mL solutions of 
trichlorobenzene (TCB) at 120 °C. 
Differential scanning calorimetry (DSC) was used to determine the thermal 
characteristics of the polyolefins and graft copolymers using a TA Instruments DSC (Discovery 
Series). The DSC measurements were performed on 1 – 10 mg of polymer samples at a 
temperature ramp rate of 10 C/min. Data was taken from the second thermal scanning cycle. 
Thermal gravimetric analysis was obtained using a TA Instruments TGA (Discovery Series) in 
the temperature range of 40 – 600 C at a temperature ramp rate of 10 C/min. Irradiation of 






N-(tert-butyl)-N-((ethoxycarbonothioyl)thio)-3,5-bis(trifluoromethyl)benzamide (5.5) was 
prepared as described from a previous report.1  
 
N-(tert-butyl)-N-(((ethylthio)carbonothioyl)thio)-3,5-bis(trifluoromethyl)benzamide (5.7): 
With the laboratory and hood lights off, potassium ethyl carbonotrithioate3  (9.70 g, 55.0 mmol) 
was suspended in MeCN (2.5 L) in a 5 L round-bottomed flask. To this suspension was added a 
solution of N-chloroamide1 (19.1 g, 55.0 mmol) in MeCN (500 mL) via cannula wire over 20 
min. The flask was foil wrapped and stirred for 16 h, at which point the suspension was 
concentrated in vacuo. The residue was taken up in CH2Cl2/H2O (1:1, 1 L total volume), and the 
layers were separated. The organic layer was washed with brine, dried with MgSO4, and 
concentrated in vacuo. The resultant yellow mixture was purified by careful flash column 
chromatography (1 – 5% EtOAc in hexanes) to afford N-trithiocarbonylamide as a bright yellow 
solid (6.67 g, 27% yield): 
1H NMR (600 MHz, CDCl3) δ 7.92 – 7.90 (m, 2H), 7.85 (dt, J = 2.0, 1.0 Hz, 1H), 3.40 – 3.24 
(m, 2H), 1.66 (s, 9H), 1.31 (t, J = 7.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 226.46, 172.74, 140.06, 131.31 (q, J = 33.7 Hz), 126.66 (d, J = 
3.9 Hz), 125.75 (q, J = 273.4 Hz), 123.45 (p, J = 3.9 Hz), 65.40, 30.98, 29.42, 12.96. 
HRMS (ES+) Exact mass calcd for C16H18F6NOS3 [M+H]
+ 450.04547. Found 450.0440. 
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N-(((tert-butylamino)thio)carbonothioyl)-N-ethylethanamine: Adapted from an analogous 
literature procedure.4 Tert-Butylamine (37 mL, 0.35 mol) was treated with sodium hypochlorite 
(230 mL, ~1.5 M in H2O from Sigma Aldrich) at 0 °C. After 5 to 10 minutes of stirring, a 
solution of sodium diethylcarbamodithioate trihydrate (67.6 g, 0.30 mol, 2.0 M in H2O) was 
added dropwise, and the reaction mixture was allowed to come to room temperature overnight. 
The mixture was diluted with water and Et2O, and the layers were separated. The aqueous phase 
was extracted twice with Et2O, and the combined organic phase was washed with brine, dried 
over anhydrous MgSO4, filtered, and concentrated in vacuo. The crude mixture was purified by 
column chromatography (2.5 to 5% EtOAc/hex) to give the thiocarbamylsulfenamide (10.89 g, 
16% yield).  
Warning: Rapid addition of the salt solution can cause an exotherm and gas evolution resulting 
from the decomposition of the reagents.  
1H NMR (600 MHz, CDCl3) δ 4.11 (s, 1H), 3.99 (q, J = 7.1 Hz, 2H), 3.66 (q, J = 7.0 Hz, 2H), 
1.32 – 1.22 (m, 6H), 1.14 (s, 9H). 
13C NMR (151 MHz, CDCl3) δ 203.52, 50.14, 45.63, 29.08, 28.94, 12.93, 12.91, 11.81. 
HRMS (ES+) Exact mass calcd for C9H21N2S2 [M+H]
+, 221.1146. Found 221.1137. 
 
3,5-bis(trifluoromethyl)benzoyl chloride: To a solution of 3,5-bis(trifluoromethyl)benzoic acid 
(12.9 g, 50.0 mmol) in CH2Cl2 (125 mL) at 0 °C was added oxalyl chloride (4.8 mL, 55.0 mmol) 
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dropwise followed by 1 to 2 drops of DMF. The resulting solution was stirred for 2-4 h and then 
concentrated to remove excess oxalyl chloride to give the acid chloride in quantitative yield, 




(((tert-butylamino)thio)carbonothioyl)-N-ethylethanamine (6.61 g, 30.0 mmol) was charged to a 
round-bottomed flask with a stir bar and was dissolved in CH2Cl2 (100 mL). Pyridine (4.0 mL, 
50.0 mmol) was added dropwise at 0 °C, followed by a solution of the benzoyl chloride (2 M in 
CH2Cl2). The reaction mixture was allowed to warm to room temperature and was stirred until 
completion as determined by GC-MS (1–2 h). The reaction mixture was diluted with CH2Cl2 and 
washed with water. The aqueous layer was extracted with CH2Cl2 (x 2). The combined organic 
phase was then washed with 2 M NaOH solution and brine, then dried over anhydrous MgSO4. 
The solid was filtered, and the filtrate was concentrated in vacuo. The resulting residue was 
purified by flash column chromatography on silica (2.5–5% EtOAc in hexanes) to afford N-
diethyldithiocarbamyl amide 5.8 as a white solid (12.3 g, 89% yield). 
1H NMR (600 MHz, CDCl3) δ 8.00 – 7.97 (m, 2H), 7.79 – 7.77 (m, 1H), 3.88 (s, 1H), 3.77 (s, 
1H), 3.39 (s, 1H), 3.29 (s, 1H), 1.64 (s, 9H), 1.14 (s, 3H), 0.94 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 195.81, 173.79, 141.02, 130.64 (q, J = 33.6 Hz), 126.69 (d, J = 
3.9 Hz), 122.34 (p, J = 3.8 Hz), 64.72, 50.65, 45.85, 29.54, 12.62, 11.28. 
HRMS (ES+) Exact mass calcd for C18H23F6N2OS2 [M+H]
+, 461.1156. Found 461.1139. 
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Synthesis of Functionalized Cyclooctanes 
General Procedure I (product functionalization using light initiation):  
A 1 dram vial was charged with a functionalized amide (0.15 mmol, 1.0 equiv) and PhCF3 (0.15 
mL) in an argon-filled glovebox. The vial was fitted with a PTFE lined screw cap, sealed with 
Teflon tape, and removed from the glovebox. Cyclooctane (14 μL, 0.15 mmol, 1.0 equiv) was 
added by syringe. The vial was suspended above an Ecoxotic PAR38 23 W blue LED such that 
the bottom of each vial was directly aligned with and 1 cm above one of the five LEDs, and the 
apparatus was covered with aluminum foil. The reaction was irradiated for 15 h, and then was 
concentrated in vacuo and analyzed by 1H NMR. 
General Procedure II (product functionalization using heat and initiator):  
A 1 dram vial equipped with a stir bar was charged with a functionalized amide (0.15 mmol, 1.0 
equiv), dicumyl peroxide (4.1 mg, 0.015 mmol, 0.10 equiv), and PhCl (0.30 mL) in an argon-
filled glovebox. The vial was fitted with a PTFE lined screw cap, sealed with Teflon tape, and 
removed from the glovebox. Cyclooctane (14 μL, 0.15 mmol, 1.0 equiv) was added by syringe. 
The vial was placed on a block plate at 130 °C to stir overnight. Upon completion, the reaction 
was concentrated in vacuo for 15 h, and then was concentrated in vacuo and analyzed by 1H 
NMR. 
 
S-cyclooctyl O-ethyl carbonodithioate (5.6): Prepared according to General Procedures I and II 




Cyclooctyl ethyl carbonotrithioate (5.9): Prepared according to General Procedures I and II, 
giving 48% and 47% NMR yield, respectively. An analytical sample was obtained after 
purification by column chromatography (2.5% EtOAc in hexanes). 
1H NMR (600 MHz, CDCl3) δ 4.29 (tt, J = 9.5, 3.9 Hz, 1H), 3.34 (q, J = 7.4 Hz, 2H), 2.05 (ddt, 
J = 14.4, 8.9, 3.6 Hz, 2H), 1.79 (dddd, J = 14.5, 9.4, 8.4, 3.0 Hz, 2H), 1.75 – 1.66 (m, 2H), 1.66 – 
1.50 (m, 8H), 1.34 (t, J = 7.4 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 224.06, 51.03, 31.77, 31.04, 26.98, 26.06, 25.52, 13.24. 
HRMS (ES+) Exact mass calcd for C11H20S3Na [M+Na]
+, 271.0625. Found 271.0628. 
 
 
Cyclooctyl diethylcarbamodithioate (5.10): Prepared according to General Procedures I and II, 
giving 11% and 42% NMR yield, respectively. An analytical sample was obtained after 
purification by column chromatography (2.5% EtOAc in hexanes). 
1H NMR (600 MHz, CDCl3) δ 4.14 (tt, J = 9.5, 4.0 Hz, 1H), 4.00 (q, J = 7.1 Hz, 2H), 3.71 (q, J 
= 7.1 Hz, 2H), 2.09 (ddt, J = 14.4, 9.0, 3.6 Hz, 2H), 1.79 (dddd, J = 14.4, 9.5, 8.2, 3.0 Hz, 2H), 
1.74 – 1.67 (m, 2H), 1.67 – 1.55 (m, 6H), 1.55 – 1.48 (m, 2H), 1.25 (t, J = 7.1 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 195.76, 51.68, 49.13, 46.73, 32.38, 27.16, 26.08, 25.62, 12.50, 
11.76. 
HRMS (ES+) Exact mass calcd for C13H26NS2 [M+H]





Figure C1: Gel permeation chromatography with tandem photodiode array (PDA) detector 
monitored the eluent polymers upon functionalization. The UV-Vis spectra (inset) reinforces that 
the polymers are indeed functionalized with dithiocarbamate (absorptions of 254 and 282 nm),5 
trithiocarbonate (absorption of 310 nm),6 and xanthate (absorption of 284 nm).6 The size 
exclusion chromatograph depicts larger changes in molecular weight and dispersity in higher 
loadings of xanthylamide than in higher loadings of trithiocarbonylamide and diethyl 
dithiocarbamylamide. A small, high molecular weight species is observed during 
trithiocarbonylation, but it is diminished when more equivalents of trithiocarbonylamide are 
added. Hardly any change in molecular weight distribution is observed when changing the 
stoichiometry of diethyl dithiocarbamylamide and repeat unit; however, in all reactions, a small 
shoulder at shorter retention times was present. For quantitative values for the molecular weight 












Figure C2: Infrared spectroscopy of dithiocarbamylated HBPE reveals key absorptions at 1265 
and 1069 cm-1.7 The 1450 – 1550 cm-1 stretch associated with R2N–CS2 was not visible at low 
degrees of functionalization. The 1265 peak reflects the C=S bond character present. The C–N 














Figure C3: Infrared spectroscopy of trithiocarbonylated HBPE displays with key absorptions at 












Figure C4: Infrared spectroscopy of xanthylated HBPE contains key peaks at 1212 and 1054 cm-




Synthesis of Functionalized Polyolefins 
General Procedure A (amorphous reactions): The required amount of polyolefin, amidyl 
reagent, peroxide, and chlorobenzene were added to a 1-dram reaction vial equipped with a 
magnetic stir bar under inert atmosphere. The reaction vial was sealed and placed on a magnetic 
stir plate in a pie block to stir for 30 min, ensuring complete dissolution of the polymer prior to 
heating. The temperature was set to 130 C and the reaction mixture was heated for 6 to 19 
hours, depending on the reagent loading (see Table C1). After the reaction was complete, the 
solution was concentrated in vacuo and precipitated in cold methanol to yield the functionalized 
hyperbranched polyethylene as a viscous liquid.  
General Procedure B (semi-crystalline reactions): The required amount of polyolefin was pre-
dissolved in half the total volume of solvent by heating the solution for 30 min above the 
material’s melting temperature with magnetic stirring. The pre-dissolved polyolefin, amidyl 
reagent, and peroxide were then combined in a 1-dram reaction vial and diluted with the other 
half volume of solvent in the glovebox. The vial was equipped with a magnetic stir bar under 
inert atmosphere. The reaction vial was sealed and placed on a magnetic stir plate at the desired 
temperature. After completion of the reaction, the solution was concentrated in vacuo and 
precipitated in cold methanol to yield the functionalized commodity polyolefins as a fluffy, 
whitish yellow powder.  
General Procedure C (neat reactions): The required amount of polyolefin, amidyl reagent, and 
peroxide were added to a 1-dram reaction vial. The reagents were dissolved in dry 
dichloromethane to ensure sufficient mixing of the peroxide and amidyl reagent. 
Dichloromethane was removed in vacuo by rotary evaporation and then high vacuum on a 
double manifold Schlenk line. The reaction vial was backfilled with nitrogen after 20 min of 
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sufficient vacuum and sealed. The reaction vial was placed on a magnetic stir plate in a pie block 
set to the desired temperature (130 or 180 C). After completion of the reaction, the solution was 
concentrated in vacuo and precipitated in cold MeOH to yield the functionalized polyolefin. 
 
 
Xanthylated HBPE: HBPE, xanthylamide 5.5, and dicumyl peroxide were reacted according to 
General Procedure A and C. HBPE (𝑀𝑛 = 27 kg/mol, Ð = 1.04, 10% branched, 40 mg, 1.43 
mmol) reacted with xanthylamide (8 mg, 0.018 mmol) and dicumyl peroxide (0.5 mg, 0.002 
mmol) in chlorobenzene (0.1 mL) upon heating at 130 C for 1 h. The resultant material was 1 
mol% xanthylated HBPE. Similar characterization data was obtained using other stoichiometric 
ratios of xanthylamide to repeat unit. This material was previously characterized in another paper 
via blue light irradiation.8 
The following was gathered using 1 mol% xanthylated hyperbranched polyethylene: 
1H NMR (500 MHz, CDCl3) δ 4.67 (m), 3.73 (bs), 1.68 (bs), 1.61 (bs), 1.57 (bs), 1.28 (bs), 1.24 
(bs), 1.10 (bs), 0.91 (bs) 0.87 (bs), 0.85 (bs). IR (neat, ATR, cm-1) 2920, 2852, 1457, 1377, 
1212, 1063, 1054, 723. GPC (THF) 𝑀𝑛 = 28 kg/mol, Ð = 1.04; UV-Vis at 14 min = 228, 283 
nm. TGA (C) Td = 4 wt% lost at 252 C with terminal onset at 412 C. UV-Vis (nm): 225, 283. 
DSC (C): parent 𝑇𝑔 = –69, product 𝑇𝑔 = –67. 
Determination of percent functionalization of hyperbranched polyethylene: Upon 
purification, the percent xanthylation of HBPE can be determined through integration of the 1H 
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NMR. Considering the composition of the polymer, the peaks between 0.8 – 2.0 ppm were set to 
total to 4 protons. The methylene protons of the ethoxy group that appear at 4.7 ppm are used to 
determine mol% xanthylation per repeat unit. Regioselectivity was determined by integration of 
the two signals corresponding to primary and secondary xanthylation. For instance, protons 
alpha to primary xanthates appear between 3.0 – 3.5 ppm and protons alpha to secondary 
xanthates appear between 3.5 – 4.0 ppm. 
 
 
Trithiocarbonylated Hyperbranched Polyethylene: Hyperbranched polyethylene (𝑀𝑛= 32 
kg/mol, Ð = 1.07, mg, 1.07 mmol repeat unit, 10% branched), trithiocarbonylamide (96 mg, 
0.214 mmol), and dicumyl peroxide (6 mg, 0.0214 mmol) were reacted according to General 
Procedure A in chlorobenzene (1.0 mL). The mixture was stirred and heated at 130 C for 19h. 
The polymer was purified via precipitation in cold methanol to yield 32 mg of 
trithiocarbonylated polyolefin. Similar characterization data was obtained using other 
stoichiometric ratios of trithiocarbonylamide to repeat unit. See accompanying tables and figures 
for more information. 
The following was gathered for 3 mol% trithiocarbonylated hyperbranched polyethylene: 
1H NMR (400 MHz, CDCl3) δ 4.30 (bs), 4.21 (bs), 3.38 (q, J = 7.3 Hz), 1.69 (bs), 1.56 (bs), 
1.37 (bs), 1.28 (bs), 1.24 (bs), 1.11 (bs), 0.91 (bs), 0.87 (bs), 0.86 (bs). 13C NMR (125 MHz, 
CDCl3) δ 52.2, 46.8, 38.9, 37.2, 34.4, 33.7, 32.0, 31.0, 29.8, 26.8, 25.9, 22.7, 19.8, 19.3, 14.2, 
13.1, 10.9, 1.04. IR (neat, ATR, cm-1) 2921, 2853, 1458, 1378, 1262, 1076, 1028, 809, 721. 
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GPC (THF) 𝑀𝑛 = 39 kg/mol, Ð = 1.08. UV-Vis (nm): 225, 310. TGA (C) Td = 10 wt% lost at 
243 C and terminal onset at 436 C. DSC (C) parent 𝑇𝑔 = –69, product 𝑇𝑔 = –67. 
Determination of percent functionalization of HBPE: Upon purification, the percent 
trithiocarbonylation of HBPE can be determined through integration of the 1H NMR. 
Considering the composition of the polymer, the peaks between 0.8 – 2.0 ppm were set to total to 
4 protons. The methylene protons of the thioethoxy unit that appear at 3.4 ppm are used to 
determine mol% functionalization per repeat unit. Regioselectivity could not be determined as 
the functionalization peaks overlap in resonance with the primary trithiocarbonylation signal. 
Protons alpha to secondary trithiocarbonates appear between 4.2 – 4.3 ppm, and estimate to 
encompass 80% of functionalization. 
 
 
Diethyl Dithiocarbamylated HBPE: HBPE (𝑀𝑛 = 32 kg/mol, Ð = 1.07, 50 mg, 1.79 mmol 
repeat unit, 10% branched), dithiocarbamylamide (409 mg, 0.89 mmol), and dicumyl peroxide 
(24 mg, 0.089 mmol) were reacted according to General Procedure A in dry chlorobenzene (4.5 
mL). The mixture was stirred and heated at 130 C for 19h. The polymer was purified via 
precipitation in cold methanol to yield 43 mg of dithiocarbamylated polyolefin. Similar 
characterization data was obtained using other stoichiometric ratios of dithiocarbamylamide to 
repeat unit.  
The following was gathered for 1 mol% dithiocarbamylated HBPE: 
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1H NMR (400 MHz, CDCl3) δ 4.05 (q, J = 7.4 Hz), 3.77 (q, J = 6.2 Hz), 1.71 (bs), 1.58 (bs), 
1.28 (bs), 1.24 (bs), 1.11 (bs), 0.92 (bs), 0.91 (bs), 0.89 (bs), 0.87 (bs), 0.86 (bs), 0.84 (bs). 13C 
NMR (125 MHz, CDCl3) δ 77.3, 77.2, 77.0, 76.8, 49.2, 46.6, 39.2, 38.9, 37.7, 37.4, 37.2, 37.1, 
36.8, 36.7, 36.1, 34.9, 34.4, 34.1, 33.7, 33.4, 33.2, 32.8, 32.4, 32.0, 32.0, 30.9, 30.7, 30.5, 30.2, 
30.1, 30.1, 29.9, 29.8, 29.8, 29.7, 29.5, 29.4, 29.0, 27.6, 27.5, 27.2, 26.8, 26.4, 25.9, 25.5, 24.1, 
23.7, 23.2, 23.1, 22.8, 22.7, 19.8, 19.7, 19.3, 14.6, 14.2, 14.2, 12.5, 11.7, 11.5, 10.9, 10.9, 1.0. IR 
(neat, ATR, cm-1) 2921, 2852, 1462, 1378, 1265, 1211, 1139, 1069, 989, 921, 917, 832, 722. 
GPC (THF) 𝑀𝑛 = 36 kg/mol, Ð = 1.09. UV-Vis at 14 min = 228, 254, 282 nm. UV-Vis (nm) 
225, 254, 282. TGA (C) Td = 4 wt% lost at 229 C with terminal onset at 409 C. DSC (C) 
parent 𝑇𝑔 = –69, product 𝑇𝑔 = –66. 
Determination of percent functionalization of HBPE: Upon purification, the percent 
trithiocarbonylation of HBPE can be determined through integration of the 1H NMR. 
Considering the composition of the polymer, the peaks between 0.8 – 2.0 ppm were set to total to 
4 protons. The methylene protons of the diethyl amine unit appear as rotamers at 3.8 and 4.0 ppm 
and were used to determine mol% functionalization per repeat unit. Regioselectivity could not be 
determined as the functionalization peaks overlap in resonance with secondary carbon 






Xanthylated Low Density Polyethylene: DOWTM LDPE 4012 Low Density Polyethylene (𝑀𝑛 
= 41 kg/mol, Ð = 9.46, 40 mg, 1.43 mmol repeat unit), xanthylamide (30 mg, 0.070 mmol), and 
dicumyl peroxide (2 mg, 0.007 mmol) were reacted according to General Procedure B in 
dichlorobenzene (0.4 mL). The reaction was heated and stirred at 180 C for 1h. The crude 
mixture was precipitated from solution into methanol at room temperature. The reaction afforded 
3 mol% xanthylated low density polyethylene: 
1H NMR (500 MHz, C2D2Cl4, 110 C) δ 4.77 (bs), 1.78 (bs), 1.61 (bs), 1.51 (bs), 1.49 (bs), 1.40 
(bs), 1.00 (bs). IR (neat, ATR, cm-1) 2917, 2849, 1464, 1463, 1208, 1064, 1051, 720, 717. GPC 
(TCB, 150 C) 𝑀𝑛 = 26 kg/mol, Ð = 12.09. TGA (C) Td = 250 C with 10 wt% loss, terminal 
onset at 435 C. DSC (C) parent 𝑇𝑚 = 105, product 𝑇𝑚 = 84. 
Determination of percent functionalization of low density polyethylene: Upon purification, 
the percent xanthylation of low density polyethylene can be determined through integration of 
the 1H NMR. Considering the composition of the polymer, the peaks between 0.9 – 1.8 ppm 
were set to total to 4 protons. The methylene protons of the ethoxy unit that appear at 4.8 ppm 





Trithiocarbonylated Low Density Polyethylene: DOWTM Polyethylene 4012 Low Density 
Polyethylene (𝑀𝑛 = 41 kg/mol, Ð = 89.46, 20 mg, 0.714 mmol repeat unit), trithiocarbonylamide 
(32 mg, 0.070 mmol), and dicumyl peroxide (2 mg, 0.007 mmol) were reacted according to 
General Procedure B in dichlorobenzene (0.4 mL). The reaction was heated and stirred at 180 C 
for 1h. The crude mixture was precipitated from solution into methanol at room temperature. The 
reaction afforded 3 mol% trithiocarbonylated low density polyethylene: 
1H NMR (500 MHz, C2D2Cl4, 110 C) δ 4.30 (bs), 3.47 (m), 1.82 (bs), 1.78 (bs), 1.61 (bs), 1.51 
(bs), 1.47 (bs), 1.41 (bs), 1.02 (bs). IR (neat, ATR, cm-1) 2934, 2917, 2849, 1473, 1464, 1374, 
1279, 1264, 1149, 1085, 1075, 1067, 969, 809, 720. GPC (TCB, 150 C) 𝑀𝑛 = 43 kg/mol, Ð = 
17.95. TGA (C) Td = 233 C with 14 wt% loss, terminal onset at 422 C. DSC (C) parent 𝑇𝑚 = 
105, product 𝑇𝑚 = 85. 
Determination of percent functionalization of low density polyethylene: Upon purification, 
the percent trithiocarbonylation of low density polyethylene can be determined through 
integration of the 1H NMR. Considering the composition of the polymer, the peaks between 0.9 – 
1.8 ppm were set to total to 4 protons. The methylene protons of the thioethoxy unit that appear 




Xanthylated Linear Low Density Polyethylene: DOWTM DNDA-1081 NT 7 Linear Low 
Density Polyethylene Resin (𝑀𝑛 = 22 kg/mol, Ð = 3.37, 40 mg, 1.43 mmol repeat unit), 
xanthylamide (30 mg, 0.0070 mmol), and dicumyl peroxide (2 mg, 0.007 mmol) were reacted 
according to General Procedure B in dichlorobenzene (0.4 mL). The reaction was heated and 
stirred at 180 C for 1h. The crude mixture was precipitated from solution into methanol at room 
temperature. The reaction afforded 3 mol% xanthylated linear low density polyethylene. This 
material was previously characterized in another paper via blue light irradiation.8 
1H NMR (500 MHz, C2D2Cl4, 110 C) δ 4.76 (m), 3.75 (bs), 1.74 (bs), 1.49 (bs), 1.47 (bs), 1.44 
(bs), 1.36 (bs), 0.97 (bs). IR (neat, ATR, cm-1) 2917, 2849, 1469, 1465, 1207, 1117, 1110, 1050, 
720. GPC (TCB, 150 C) 𝑀𝑛 = 28 kg/mol, Ð = 7.66. TGA (C) Td = 240 C with 11 wt% loss, 
terminal onset at 411 C. DSC (C) parent 𝑇𝑚 = 125, product 𝑇𝑚 = 95. 
Determination of percent functionalization of linear low density polyethylene: Upon 
purification, the percent xanthylation of linear low density polyethylene can be determined 
through integration of the 1H NMR. Considering the composition of the polymer, the peaks 
between 0.9 – 1.8 ppm were set to total to 4 protons. The methylene protons of the ethoxy unit 




Trithiocarbonylated Linear Low Density Polyethylene: DOWTM DNDA-1081 NT 7 Linear 
Low Density Polyethylene Resin (𝑀𝑛 = 22 kg/mol, Ð = 3.37, 20 mg, 0.714 mmol repeat unit), 
trithiocarbonylamide (30 mg, 0.0.070 mmol), and dicumyl peroxide (2 mg, 0.007 mmol) were 
reacted according to General Procedure B in dichlorobenzene (0.4 mL). The reaction was heated 
and stirred at 180 C for 1h. The crude mixture was precipitated from solution into methanol at 
room temperature. The reaction afforded 3 mol% trithiocarbonylated linear low density 
polyethylene: 
1H NMR (500 MHz, C2D2Cl4, 110 C) δ 4.29 (bs), 3.47 (m), 1.82 (bs), 1.53 (bs), 1.47 (bs), 1.41 
(bs), 1.36 (bs), 1.02 (bs). IR (neat, ATR, cm-1) 2983, 2916, 2849, 1473, 1464, 1383, 1250, 1085, 
1074, 1028, 958, 812, 720. GPC (TCB, 150 C) 𝑀𝑛 = 23 kg/mol, Ð = 3.84. TGA (C) Td = 220 
C with 13 wt% loss, terminal onset at 433 C. DSC (C) parent 𝑇𝑚 = 122, product 𝑇𝑚 = 100. 
Determination of percent functionalization of linear low density polyethylene: Upon 
purification, the percent trithiocarbonylation of linear low density polyethylene can be 
determined through integration of the 1H NMR. Considering the composition of the polymer, the 
peaks between 0.9 – 1.8 ppm were set to total to 4 protons. The methylene protons of the 





Xanthylated Polypropylene: Basell™ Profax 6301 polypropylene (𝑀𝑛 = 64 kg/mol, Ð = 4.84, 
3.33 g, 0.079 mol repeat unit), xanthylamide (1.67 g, 0.004 mol), and dicumyl peroxide (90 mg, 
0.33 mmol) were reacted according to General Procedure C. The reaction was heated at 180 C 
for 1h. The reaction afforded 1 mol% xanthylated polypropylene: 
1H NMR (500 MHz, C2D2Cl4, 110 C) δ 4.78 (m), 3.30 (bs), 1.72 (d), 1.37 (s), 1.01 (t), 1.44 
(bs), 1.36 (bs), 0.97 (bs). IR (neat, ATR, cm-1) 2961, 2950, 2917, 2884, 2838, 1452, 1376, 1278, 
1255, 1217, 1177, 1153, 1146, 1053, 977, 972, 958, 844, 842, 841. GPC (TCB, 150 C) 𝑀𝑛 = 
67 kg/mol, Ð = 9.44. TGA (C) Td = 250 C with 3 wt% loss, terminal onset at 378 C. DSC 
(C) parent 𝑇𝑚 = 155, product 𝑇𝑚 = 137. 
Determination of percent functionalization of isotactic polypropylene: Upon purification, the 
percent xanthylation of polypropylene can be determined through integration of the 1H NMR. 
Considering the composition of the polymer, the peaks between 0.9 – 2.0 ppm were set to total to 
6 protons. The methylene protons of the ethoxy unit that appear at 4.8 ppm are used to determine 









Xanthylation of HBPE reverted by trithiocarbonylamide: Xanthylated HBPE (4.5 mol%, 𝑀𝑛 
= 40 kg/mol, Ð = 1.07, 10 mg, 0.35 mmol) was reacted with trithiocarbonylamide (16 mg, 0.04 
mmol) and dicumyl peroxide (1 mg, 0.004 mmol) according to General Procedure A in dry 
chlorobenzene (0.2 mL). The reaction was heated and stirred at 130 C for 6 h. The reaction 
afforded 3 mol% xanthylated and 2.5 mol% trithiocarbonylated HBPE: 
1H NMR (500 MHz, CDCl3) δ 4.64 (m), 4.27 (bs), 4.17 (bs), 3.78 (bs), 3.70 (bs), 1.65 (bs), 1.55 
(bs), 1.51 (bs), 1.42 (bs), 1.35 (bs), 1.25 (bs), 1.21 (bs), 1.06 (bs), 0.88 (bs), 0.83 (bs). GPC (THF) 
𝑀𝑛 = 38 kg/mol, Ð = 1.13; UV-Vis at 29 min = 285, 310 nm. 
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Figure C5: 1H NMR (top to bottom) of the 5.5 mol%, 4.5 mol%, and 2 mol% xanthylated HBPE, 
respectively. While these are not all the degrees of functionalization achievable, this collection 
demonstrates that degrees of functionalization clearly vary by 1H NMR, even at low mol% incorporation. 
Xanthylated HBPE was previously characterized by photochemical initiation in this same method.8 The 
percent functionalization was determined through the integration of peaks around δ 4.6 ppm 
corresponding to the methylene protons of the ethoxy Z group. Regioselectivity could be evaluated 
through the relative ratio of secondary xanthylation, with alpha polymeric protons appearing at δ 3.7 
ppm, and primary xanthylation, with alpha polymeric protons appearing at δ 3.2 ppm. In most cases, 




















Figure C6: 1H NMR (top) and 13C NMR (bottom) of the 2.5 mol% trithiocarbonylated HBPE. Protons 
alpha trithiocarbonates resonated at δ 4.2 ppm and the methylene protons of the ethanethiol group 
resonated at δ 3.3 ppm in the 1H NMR spectra. In the 13C NMR, a signature 13C–S bond can be surmised 
from the peak at δ 52 ppm. The modest degree of functionalization hampered resolution of the 



























Figure C7: 1H NMR (top) and 13C NMR (bottom) of the 1 mol% dithiocarbamylated HBPE. In the 1H 
NMR, percent functionalization was determined through the integration of rotameric methylene protons 
of the diethyl amine Z group at δ 3.7 and 4.0 ppm. The polymeric alpha protons were not resolved at such 
low degrees of functionalization. 13C NMR further supports functionalization with a peak at 49 ppm, 


















Figure C8: 1H NMR of 3.5 mol% xanthylated linear low density polyethylene at 110 C in CD2Cl4. 13C 
NMR of this material was previously reported via photochemical initiation. The degree of 
functionalization was confirmed by methylene protons of the ethoxy unit at δ 4.7 and protons alpha 
xanthate at δ 3.7 ppm. This reaction seems to be regioselective for the secondary sites over the primary 


















Figure C9: 1H NMR of trithiocarbonylated linear low density polyethylene at 110 C in CD2Cl4 revealed 
key peaks at δ 3.5 and δ 4.2 ppm. Thermal gravimetric analysis depicts a13 wt% loss at 220 C, consistent 


















Figure C10: 1H NMR of 3.5 mol% xanthylated low density polyethylene at 110 C in CD2Cl4. The 
methylene protons of the ethoxy moiety are present at δ 4.7 ppm. 13C NMR of this material was 

















Figure C11: 1H NMR of 3.5 mol% trithiocarbonylated low density polyethylene at 110 C in CD2Cl4. 
Percent functionalization was determined through integration of the ethanethiol peak at δ 3.5 ppm and 


















Figure C12: Xanthylation of polypropylene was proven by 1H NMR at 110 C in CD2Cl4. The methylene 
protons of the ethoxy unit was present at δ 4.8 ppm. The protons on the polymer that are alpha the 


















Figure C13: 1H NMR of xanthylated and then trithiocarbonylated hyperbranched polyethylene in CDCl3 
was taken. Initially, HBPE was functionalized at 4.5 mol% incorporation, indicated by the peak at δ 4.7 
ppm consistent with the methylene protons of the ethoxy. Upon reacting xanthylated HBPE in a thermal 
C–H trithiocarbonylation reaction, the xanthylation dropped to 3 mol% functionalization, obvious with 
peaks at δ 3.6 and 4.6 ppm. The reaction installed new trithiocarbonyl moieties (2.5 mol%) with 
resonances at δ 3.4 and 4.2 ppm. The removal of previously functionalized sites proves the reaction to be 




APPENDIX D: SUPPORTING INFORMATION FOR CHAPTER 6 
General Methods and Materials 
Proton and carbon magnetic resonance spectra (1H NMR and 13C NMR) were recorded on a 
Bruker AVANCE III 600 CryoProbe (1H NMR at 600 MHz and 13C NMR at 151 MHz) 
spectrometer with solvent resonance as the internal standard (1H NMR: CDCl3 at 7.26 ppm; 
13C 
NMR: CDCl3 at 77.16 ppm). Fluorine magnetic resonance spectra (
19F NMR) was recorded on a 
Bruker model DRX 400 (19F NMR at 376 MHz). 1H NMR data are reported as follows: chemical 
shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, ddd = 
doublet of doublet of doublets, td = triplet of doublets, tdd = triplet of doublet of doublets, qd = 
quartet of doublets, m = multiplet), coupling constants (Hz), and integration. Mass spectra were 
obtained using a Q Exactive HF-X mass spectrometer using either electrospray (ES) or 
atmospheric-pressure photoionization (APPI) and external calibration. Thin layer 
chromatography (TLC) was performed on SiliaPlate 250μm thick silica gel plates provided by 
Silicycle. Visualization was accomplished with short wave UV light (254 nm), iodine, aqueous 
basic potassium permanganate solution, or aqueous acidic ceric ammonium molybdate solution 
followed by heating. Flash chromatography was performed using SiliaFlash P60 silica gel (40-63 
μm) purchased from Silicycle. Tetrahydrofuran, diethyl ether, and dichloromethane were dried 
by passage through a column of neutral alumina under nitrogen prior to use. Reactions involving 
blue light irradiation were performed using the PAR38 Royal Blue 21W aquarium LED lamps 
(Model #6851) fabricated with high-power Cree XR-E LEDs as purchased from Ecoxotic 
(www.ecoxotic.com) or Kessil PR160 440 nm LED Photoredox Lights. Reaction temperatures 
reached approximately 50 °C using the Ecoxotic lamp and 40–50 °C with the Kessil light. UV 
light experiments were performed in a Luzchem LZC-ORG photoreactor containing UV-A 
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lamps. All substrates were obtained from commercial vendors (Sigma-Aldrich, Matrix Scientific, 
TCI Chemicals) and used without further purification unless otherwise noted.  
Reagent Synthesis 
 
N-(tert-butyl)-N-((ethoxycarbonothioyl)thio)-3,5-bis(trifluoromethyl)benzamide (6.12) was 
prepared as described in a previous report (see Appendix A).1  
 
 
N-(tert-butyl)-N-chloro-2,3,4,5,6-pentafluorobenzamide (D1). To a solution of 2,3,4,5,6-
pentafluorobenzoic acid (21.2 g, 100 mmol, 1.0 equiv) in CH2Cl2/DMF (200 mL/0.1 mL) was 
added oxalyl chloride (9.63 mL, 110 mmol, 1.1 equiv) dropwise. The resulting solution was 
stirred for 2 h, then concentrated in vacuo to remove excess oxalyl chloride. The resulting crude 
mixture was resuspended in CH2Cl2 and chilled to 0 ˚C. Tert-Butylamine (27.0 mL, 250 mmol, 
2.5 equiv) was added, and the mixture was warmed to rt and stirred for 1 h. The mixture was 
diluted with CH2Cl2 (300 mL), and the organic layer was washed with 10% NaOH (1 x 500 mL), 
1M HCl (1 x 500 mL), brine (1 x 500 mL), dried with MgSO4 and concentrated to afford the 
amide as a white solid, which was used directly in the next step.  
With the laboratory lights off, to a solution of amide in EtOAc (200 mL) was added 
tBuOH (9.5 mL, 100 mmol, 1 equiv). To this solution was added AcOH (34 mL) and NaOCl 
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(400 mL, 10-15% available chlorine). The mixture was stirred vigorously for 1 h, then quenched 
with sat. aq. NaHCO3 (200 mL). The aqueous phase was extracted with EtOAc (300 mL), and 
the combined organic phase was washed with brine (1 x 500 mL), dried with MgSO4, and 
concentrated in vacuo to yield a colorless solid (28.9 g, 96% yield), which was used without 
further purification.2  
Note: Given the sensitivity of chloroamide D1 to light, special care is taken by turning off the 
laboratory lights during workup and foil-wrapping flasks when appropriate. The compound is 
stored in foil-wrapped vials in the freezer when not in use. The reagent can be weighed out on 
the benchtop without risk of decomposition.  
 
 
N-(tert-butyl)-N-((ethoxycarbonothioyl)thio)-2,3,4,5,6-pentafluorobenzamide (6.18): In a 5L 
round-bottom flask, potassium ethyl xanthate (8.82 g, 55.0 mmol, 1.0 equiv) was suspended in 
MeCN (2.0 L). To this suspension was added a solution of chloroamide D1 (16.6 g, 55.0 mmol, 
1.0 equiv) in MeCN (500 mL) via cannula wire over 20 min. The flask was stirred for 1 h, at 
which point the suspension was concentrated in vacuo. The residue was taken up in CH2Cl2/H2O 
(1:1, 1 L total volume), and the layers were separated. The organic layer was washed with brine, 
dried over anhydrous MgSO4, and concentrated in vacuo. The resultant solid was purified by 
flash column chromatography (1–5% EtOAc in hexanes) to afford the title compound as a light 
yellow solid (15.0 g, 70% yield):  
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1H NMR (600 MHz, Chloroform-d) δ 4.75 (dq, J = 10.8, 7.2 Hz, 1H), 4.58 (dq, J = 10.6, 7.1 
Hz, 1H), 1.58 (s, 9H), 1.49 (t, J = 7.1 Hz, 3H). 
19F NMR (376 MHz, Chloroform-d) δ -140.43 (dt, J = 24.3, 6.8 Hz, 1F), -142.52 (dt, J = 23.0, 
6.7 Hz, 1F), -152.52 (td, J = 20.5, 7.3 Hz, 2F), -160.43 (td, J = 21.6, 8.5 Hz, 1F), -160.82 (td, J = 
21.6, 8.5 Hz, 1F). 
13C NMR (151 MHz, Chloroform-d) δ 211.41, 163.40, 144.25 – 135.78 (m), 113.53 (t, J = 21.4 
Hz), 71.02, 64.69, 29.17, 13.43 (d, J = 1.6 Hz). 
HRMS (ES+) Exact mass calcd for C14H14F5NNaO2S2 [M+Na]
+, 410.0284. Found 410.0283. 
Note: Xanthylamide 6.18 is not particularly sensitive to ambient laboratory lighting and may be 




(6.65): To a solution of 3,5-bis(trifluoromethyl)benzenesulfonyl chloride (6.10 g, 19.5 mmol, 1.3 
equiv) and N,N-diisopropylethylamine (2.9 mL, 16.5 mmol, 1.1 equiv) in CH2Cl2 (100 mL) at 0 
°C was added tert-butylamine (1.6 mL, 15.0 mmol, 1 equiv) dropwise. The mixture was warmed 
to rt and stirred for 2 h. The mixture was diluted with CH2Cl2 (100 mL), and the organic layer 
was washed with 1M HCl (200 mL), sat. aq. NaHCO3 (200 mL), and brine (200 mL), dried over 
anhydrous MgSO4, and concentrated to afford the sulfonamide as a white solid, which was used 
directly in the next step.  
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With the laboratory lights off, to a solution of the sulfonamide in EtOAc (30 mL) was 
added tBuOH (1.4 mL, 15.0 mmol, 1 equiv). To this solution was added AcOH (2.6 mL) and 
NaOCl (60 mL, 10-15% available chlorine). The mixture was stirred vigorously for 1 h, then 
quenched with sat. aq. NaHCO3 (30 mL). The aqueous phase was extracted with EtOAc (30 
mL), and the combined organic phase was washed with brine (1 x 50 mL), dried with MgSO4, 
and concentrated in vacuo to yield a colorless oil (5.28 g, 92% yield over two steps), which was 
used without further purification (the chlorosulfonamide intermediate is prone to decomposition 
on silica gel.)  
In a 1L round-bottom flask, potassium ethyl xanthate (2.21 g, 13.8 mmol, 1.0 equiv) was 
suspended in MeCN (250 mL). To this suspension was added a solution of chlorosulfonamide 
(5.28 g. 13.8 mmol, 1 equiv) in MeCN (250 mL) via cannula wire over 20 min. The flask was 
stirred overnight, at which point the suspension was concentrated in vacuo. The residue was 
taken up in CH2Cl2/H2O (1:1, 250 mL total volume) and the layers were separated. The organic 
layer was washed with brine, dried with MgSO4, and concentrated in vacuo. The resultant solid 
was purified by flash column chromatography (1–5% EtOAc in hexanes) to afford the title 
compound as a light yellow solid (1.76 g, 27% yield):  
1H NMR (600 MHz, Chloroform-d) δ 8.36 (t, J = 2.2 Hz, 2H), 8.05 (d, J = 3.2 Hz, 1H), 4.63 (dt, 
J = 6.8, 3.2 Hz, 1H), 4.27 (dt, J = 7.2, 3.7 Hz, 1H), 1.57 (s, 9H), 1.32 (td, J = 7.2, 3.0 Hz, 3H). 
13C NMR (151 MHz, Chloroform-d) δ 212.03, 143.56, 132.74 (q, J = 34.5 Hz), 128.35 (d, J = 
4.2 Hz), 126.44 – 126.25 (m), 122.52 (q, J = 273.3 Hz), 70.70, 68.60, 30.84, 13.59. 
19F NMR (376 MHz, Chloroform-d) δ -62.88. 
HRMS (ES+) Exact mass calcd for C15H18F6NO3S3 [M+H]
+, 492.0172. Found 492.0172. 
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Tripeptide Synthesis  
 
H-Glu(OBn)-Gly-OMe (D2): A 250 mL round-bottom flask was charged with a solution of N-
(tert-butyloxycarbonyl)-γ-benzyl-L-glutamic acid (5.16 g, 15.3 mmol), glycine methyl ester 
hydrochloride (2.11 g, 16.8 mmol) and hydroxybenzotriazole (HOBt: 2.07 g, 15.3 mmol) in 
CH2Cl2 (150 mL) and cooled to 0 °C. To this solution was added iPr2NEt (2.9 mL, 16.8 mmol) 
dropwise over 5 min, and the resulting mixture was stirred at 0 °C for 10 min. To this solution 
was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC: 3.22 g, 16.8 
mmol), and the resulting mixture was warmed to room temperature. After 16 h, the reaction 
mixture was cooled to 0 °C and quenched with 1 M HCl (50 mL). The precipitate was filtered 
off, and the phases were separated. The aqueous phase was further extracted with CH2Cl2 (30 
mL × 3). The combined organic layers were washed with brine (100 mL), dried over MgSO4, 
filtered and concentrated under reduced pressure. The crude residue was purified by column 
chromatography (SiO2, 40% EtOAc/ hexanes) to provide the amide (6.26 g, quantitative yield) as 
a white solid: 
1H NMR (600 MHz, CDCl3) δ 7.41 – 7.28 (m, 5H), 7.00 (t, J = 5.4 Hz, 1H), 5.44 (d, J = 8.1 Hz, 
1H), 5.11 (s, 2H), 4.27 (q, J = 7.6 Hz, 1H), 4.01 (qd, J = 18.2, 5.5 Hz, 2H), 3.71 (s, 3H), 2.64 – 
2.42 (m, 2H), 2.16 (ddd, J = 15.3, 7.8, 5.8 Hz, 1H), 1.96 (ddd, J = 14.4, 8.1, 6.8 Hz, 1H), 1.41 (s, 
9H). 
13C NMR (151 MHz, CDCl3) δ 173.28, 172.05, 170.15, 155.80, 135.77, 128.65, 128.37, 128.32, 
80.22, 77.16, 66.64, 53.53, 52.44, 41.20, 30.44, 28.37, 28.01. 
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HRMS (ES+) Exact mass calcd for C20H28N2NaO7 [M+Na]
+, 431.1794. Found 431.1796. 
 
N-Boc deprotection: To a solution of the dipeptide (6.26 g, 15.3 mmol, 1 equiv) in CH2Cl2 (5 
mL) at room temperature was added aqueous phosphoric acid (85 wt %, 2.6 mL). The mixture 
was stirred vigorously for 3 h. Then 15 mL of water was added and the mixture was cooled to 0 
°C. A 50 wt % NaOH solution was added slowly to adjust the pH to 8. The mixture was then 
extracted with CH2Cl2 (3 x 30 mL). The combined organic phase was dried over MgSO4 and 
concentrated in vacuo to give D2 (3.99 g, 84% yield) as a white solid, which was used directly in 
the next step without further purification.  
 
Phth-Glu(OMe)-Glu(OH)-Gly-OMe (D3): A 50 mL round-bottom flask was charged with a 
solution of H-Glu(OBn)-Gly-OMe (D2) (0.50 g, 1.6 mmol, 1 equiv), N,N-phthaloyl-L-glutamic 
acid-1-methyl ester (0.58 g, 2.0 mmol) and hydroxybenzotriazole (HOBt: 0.27 g, 2.0 mmol, 1.2 
equiv) in CH2Cl2 (10 mL) and cooled to 0 °C. To this solution was added 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC: 0.31 g, 1.6 mmol, 1 equiv) and 
the resulting mixture was warmed to room temperature. After 16 h, the reaction mixture was 
cooled to 0 °C and quenched with 1 M HCl (10 mL). The phases were separated, and the 
aqueous phase was extracted with CH2Cl2 (10 mL x 3). The combined organic layers were 
washed with brine (30 mL), dried over MgSO4, filtered and concentrated under reduced pressure 
to provide the amide (0.63 g, 67% yield) as a pale-yellow oil, which was used directly in the next 
step. 
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OBn deprotection: To a stirred solution of the tripeptide (0.63 g, 1.1 mmol, 1 equiv) and 10% 
palladium on carbon (0.12 g, 0.11 mmol, 0.1 equiv) in MeOH (2 mL) under an Ar-filled balloon 
was added triethylsilane (1.7 mL, 11 mmol, 10 equiv) dropwise over 10 min. When the reaction 
was complete (TLC), the mixture was filtered through celite and the solvent was removed in 
vacuo. The residue was basified with saturated bicarbonate solution (10 mL), and the aqueous 
layer was washed with pentane (10 mL x 2). The aqueous layer was then acidified to pH = 2 with 
6 M HCl and extracted with CH2Cl2 (20 mL x 3). The combined organic layer was washed with 
brine (30 mL), dried over MgSO4, concentrated to give a white solid (0.49 g, 92% yield).  
1H NMR (600 MHz, CDCl3) δ 7.87 – 7.80 (m, 2H), 7.74 (dd, J = 5.5, 3.0 Hz, 2H), 7.70 (t, J = 
5.7 Hz, 1H), 7.04 (d, J = 8.3 Hz, 1H), 4.87 (dd, J = 10.2, 4.8 Hz, 1H), 4.71 (td, J = 8.2, 6.0 Hz, 
1H), 4.07 (dd, J = 18.0, 6.0 Hz, 1H), 3.93 (dd, J = 18.0, 5.4 Hz, 1H), 3.71 (s, 3H), 3.69 (s, 3H), 
2.65 – 2.54 (m, 1H), 2.54 – 2.35 (m, 3H), 2.35 – 2.22 (m, 2H), 2.12 – 2.02 (m, 1H), 1.91 (dq, J = 
14.2, 7.1 Hz, 1H). 
13C NMR (151 MHz, CDCl3) δ 176.15, 172.34, 172.23, 170.23, 169.46, 167.78, 134.48, 131.74, 
123.79, 52.99, 52.43, 51.96, 51.28, 41.29, 32.48, 29.93, 28.09, 24.75. 
HRMS (ES+) Exact mass calcd for C22H25N3NaO10 [M+Na]
+, 514.1438. Found 514.1438. 
 
Standard syntheses for GC analysis   
 
O-ethyl S-pentyl carbonodithioate (6.13): To a suspension of potassium ethyl xanthate (0.48 g, 
3.0 mmol, 1.5 equiv) in acetone (4 mL) was added 1-bromopentane (0.25 mL, 2.0 mmol, 1 
equiv). The mixture was stirred overnight at rt and then concentrated. The residue was taken up 
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in CH2Cl2 (20 mL) and washed with H2O (20 mL), brine (20 mL), dried with MgSO4, and 
concentrated to afford alkyl xanthate 3 (0.36 g, 94% yield) as a pale-yellow oil.  
1H NMR (600 MHz, CDCl3) δ 4.66 (q, J = 7.1 Hz, 2H), 3.13 (t, J = 7.7 Hz, 2H), 1.76 – 1.64 (m, 
2H), 1.47 – 1.32 (m, 6H), 0.92 (t, J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 215.34, 69.85, 35.98, 31.14, 28.17, 22.32, 14.05, 13.92. 
HRMS (ES+) Exact mass calcd for C8H16NaOS2 [M+Na]
+, 215.0540. Found 215.0538. 
 
S-(but-3-en-1-yl) O-ethyl carbonodithioate (6.24): To a suspension of potassium ethyl 
xanthate (0.48 g, 3.0 mmol, 1.5 equiv) in acetone (4 mL) was added 4-bromo-1-butene (0.20 mL, 
2.0 mmol, 1 equiv). The mixture was stirred overnight at rt and then concentrated. The residue 
was taken up in CH2Cl2 (20 mL) and washed with H2O (20 mL), brine (20 mL), dried with 
MgSO4, and concentrated to afford alkyl xanthate 6.24 (0.31 g, 88% yield) as a pale-yellow oil. 
1H NMR (600 MHz, CDCl3) δ 5.82 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 5.14 – 5.05 (m, 2H), 4.64 
(q, J = 7.1 Hz, 2H), 3.18 (t, J = 7.4 Hz, 2H), 2.51 – 2.31 (m, 2H), 1.42 (t, J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 214.88, 135.95, 116.80, 69.97, 35.14, 32.62, 13.92. 
HRMS (ES+) Exact mass calcd for C7H13OS2 [M+H]
+, 177.0408. Found 177.0403. 
 
 
O-ethyl S-(1-methylcyclohexyl) carbonodithioate (6.32): To a solution of 1-
methylcyclohexane-1-carboxylic acid (1.42 g, 10.0 mmol, 1 equiv) in CH2Cl2 (20 mL) was 
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added dimethylformamide (DMF; 1 drop). The solution was cooled to 0 °C, and oxalyl chloride 
(0.96 mL, 11.0 mmol, 1.1 equiv) was added in dropwise. The solution was warmed to rt and 
stirred for 2 h. Afterward, the mixture was concentrated in vacuo, resuspended in THF (20 mL), 
and cooled to 0 °C. Potassium ethyl xanthate salt (1.52 g, 9.50 mmol, 0.95 equiv) was added in 
one portion, and the mixture was allowed to stir for 3 h. The mixture was then concentrated in 
vacuo and redissolved in CH2Cl2 (50 mL) and washed with H2O (50 mL). The aqueous layer was 
extracted once with CH2Cl2 (50 mL). The combined organic phase was washed with brine (75 
mL), then dried over anhydrous MgSO4. The solid was filtered, and the filtrate was concentrated 
in vacuo. The crude was resuspended in DCE (20 mL) with dilauroyl peroxide (0.20 g, 0.050 
mmol, 0.05 equiv) and stirred overnight under reflux. Upon concentrating, the residue was 
purified by flash column chromatography (0–5% Et2O/hexanes) to afford xanthate 6.32 as a 
yellow oil (1.64 g, 75% yield).  
1H NMR (600 MHz, CDCl3) δ 4.65 (q, J = 7.1 Hz, 2H), 2.07 – 1.96 (m, 2H), 1.65 – 1.58 (m, 
1H), 1.57 (s, 3H), 1.55 – 1.47 (m, 5H), 1.44 (t, J = 7.1 Hz, 3H), 1.30 (qd, J = 9.3, 5.7 Hz, 1H), 
1.24 (s, 1H). 
13C NMR (151 MHz, CDCl3) δ 214.49, 69.40, 56.79, 37.65, 29.79, 25.73, 22.48, 13.84. 
HRMS (APPI+) Exact mass calcd for C10H19OS2 [M+H]
+, 219.0877. Found 219.0877. 
 
Functionalized Products 
General Procedure A – Product functionalization using heat and initiator 
A 1 dram vial equipped with a stir bar was charged with substrate (1 equiv), xanthylamide 6.18 
(1–2 equiv), and dilauroyl peroxide (DLP; 10 mol % wrt to xanthylamide 2), fitted with a PTFE 
lined screw cap, and taken into the glovebox. The contents were dissolved in PhCF3 (0.1 M wrt 
substrate), and the resulting solution was sealed with Teflon tape and removed from the 
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glovebox. Alternatively, reactions may be prepared using other air-sensitive techniques, such as 
with a Schlenk line. The vial was placed on a block plate at 80 °C and stirred for 4 h. If 
necessary, additional DLP (10 mol %) was added for full conversion of xanthylamide 6.18 as 
monitored by TLC. Upon completion, the reaction was concentrated in vacuo, and the crude 




Figure D1. Pictures of the light setup used in General Procedure B. Up to three reactions may be 
run at a time by using copper wiring to hold the vials together. 
 
 
General Procedure B – Product functionalization using blue LEDs 
A 1 dram vial equipped with a stir bar was charged with substrate (1 equiv) and xanthylamide 
6.18 (1.2 equiv), fitted with a PTFE lined screw cap, and taken into the glovebox. The contents 
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were dissolved in PhCF3 (0.1 M wrt substrate), and the resulting solution was sealed with Teflon 
tape and removed from the glovebox. Alternatively, reactions may be prepared using other air-
sensitive techniques, such as with a Schlenk line. The vial was centered approximately 4 cm 
away from a 440 nm Kessil PR160 LED light at max (100%) intensity. After 4 h, the light was 
turned off. The reaction was concentrated in vacuo, and the crude residue was purified by flash 
column chromatography to afford the desired product. 
 
 
O-ethyl S-pentyl carbonodithioate (6.13): Prepared according to General Procedure A using 
hexanoic acid (12.5 μL, 0.100 mmol, 1 equiv), xanthylamide 6.18 (77.4 mg, 0.200 mmol, 2 
equiv), and dilauroyl peroxide (8.0 mg, 0.020 mmol, 0.2 equiv), giving 70% NMR yield. 
Alternatively prepared according to General Procedure B using hexanoic acid (12.5 μL, 0.100 
mmol, 1 equiv) and xanthylamide 6.18 (46.4 mg, 0.120 mmol, 1.2 equiv), giving 86% NMR 
yield using a glovebox and 71% NMR yield using a Schlenk line.  
 
 
S-(5-bromopentyl) O-ethyl carbonodithioate (6.20): Prepared according to General Procedure 
A using 6-bromohexanoic acid (19.5 mg, 0.100 mmol, 1 equiv), xanthylamide 6.18 (77.4 mg, 
0.200 mmol, 2 equiv), and dilauroyl peroxide (8.0 mg, 0.020 mmol, 0.2 equiv). Alternatively 
prepared according to General Procedure B using 6-bromohexanoic acid (19.5 mg, 0.100 mmol, 
1 equiv) and xanthylamide 6.18 (46.4 mg, 0.120 mmol, 1.2 equiv). The crude residue was 
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purified by flash column chromatography (0.1–1% EtOAc/hex) to afford 6.20 as a pale yellow 
oil (A: 20.4 mg, 75% yield; B: 27.1 mg, 100% yield):  
1H NMR (600 MHz, CDCl3) δ 4.64 (q, J = 7.1 Hz, 2H), 3.41 (t, J = 6.7 Hz, 2H), 3.13 (t, J = 7.4 
Hz, 2H), 1.89 (p, J = 6.9 Hz, 2H), 1.73 (p, J = 7.5 Hz, 2H), 1.57 (q, J = 7.9 Hz, 3H), 1.42 (t, J = 
7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 215.09, 70.05, 35.68, 33.60, 32.30, 27.77, 27.52, 13.96. 
HRMS (APPI+) Exact mass calcd for C8H16BrOS2 [M+H]
+, 270.9826. Found 270.9826. 
 
 
S-(4-chlorophenethyl) O-ethyl carbonodithioate (6.21): Prepared according to General 
Procedure A using 3-(4-chlorophenyl)propanoic acid (18.5 mg, 0.100 mmol, 1 equiv), 
xanthylamide 6.18 (77.4 mg, 0.20 mmol, 2 equiv), and dilauroyl peroxide (8.0 mg, 0.020 mmol, 
0.2 equiv). Alternatively prepared according to General Procedure B using 3-(4-
chlorophenyl)propanoic acid (18.5 mg, 0.100 mmol, 1 equiv) and xanthylamide 6.18 (46.4 mg, 
0.120 mmol, 1.2 equiv). The crude residue was purified by flash column chromatography (0.1–
1% EtOAc/hex) to afford 6.21 as a colorless oil (A: 18.2 mg, 70% yield; B: 26.0 mg, 99% yield): 
1H NMR (600 MHz, CDCl3) δ 7.30 – 7.27 (m, 2H), 7.21 – 7.16 (m, 2H), 4.65 (q, J = 7.1 Hz, 
2H), 3.37 – 3.29 (m, 2H), 3.01 – 2.91 (m, 2H), 1.43 (t, J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 214.66, 138.31, 132.54, 130.11, 128.82, 70.19, 37.05, 34.33, 
13.97. 
HRMS (APPI+) Exact mass calcd for C11H14ClOS2 [M+H]




Methyl 3-((ethoxycarbonothioyl)thio)propanoate (6.22): Prepared according to General 
Procedure A using monomethyl succinate (6.6 mg, 50 µmol, 1 equiv), xanthylamide 6.18 (38.7 
mg, 100 µmol, 2 equiv), and dilauroyl peroxide (4.0 mg, 10 µmol, 0.2 equiv). Alternatively 
prepared according to General Procedure B using monomethyl succinate (13.2 mg, 0.100 mmol, 
1 equiv) and xanthylamide 6.18 (46.4 mg, 0.120 mmol, 1.2 equiv). The crude residue was 
purified by flash column chromatography (2.5–5% EtOAc/hex) to afford 6.22 as a colorless oil 
(A: 10.1 mg, 97% yield; B: 15.5 mg, 74% yield): 
1H NMR (600 MHz, CDCl3) δ 4.64 (q, J = 7.1 Hz, 1H), 3.71 (s, 1H), 3.37 (t, J = 7.1 Hz, 1H), 
2.78 (t, J = 7.0 Hz, 1H), 1.42 (t, J = 7.1 Hz, 2H). 
13C NMR (151 MHz, CDCl3) δ 214.36, 172.18, 70.29, 52.13, 33.33, 30.67, 13.94. 
HRMS (ES+) Exact mass calcd for C7H12NaO3S2 [M+Na]
+, 231.0126. Found 231.0124. 
 
 
O-ethyl S-(3-oxobutyl) carbonodithioate (6.23): Prepared according to General Procedure A 
using levulinic acid (11.6 mg, 0.100 mmol, 1 equiv), xanthylamide 6.18 (77.4 mg, 0.200 mmol, 2 
equiv), and dilauroyl peroxide (8.0 mg, 0.020 mmol, 0.2 equiv), giving 80% NMR yield. 
Alternatively prepared according to General Procedure B using levulinic acid (11.6 mg, 0.100 
mmol, 1 equiv) and xanthylamide 6.18 (46.4 mg, 0.120 mmol, 1.2 equiv), giving 88% NMR 
yield. Due to difficulties in isolation from inseparable byproducts, an analytical sample of 7 was 
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obtained from reaction of levulinic acid with xanthylamide 6.12 and purification by flash column 
chromatography (2.5–5% EtOAc/hex): 
1H NMR (600 MHz, CDCl3) δ 4.64 (q, J = 7.4, 6.7, 6.1 Hz, 2H), 3.32 (t, J = 6.9 Hz, 2H), 2.90 
(t, J = 6.8 Hz, 2H), 2.17 (s, 3H), 1.41 (t, J = 7.2 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 214.99, 206.44, 70.21, 42.46, 30.10, 29.47, 13.95. 
HRMS (ES+) Exact mass calcd for C7H12NaO2S2 [M+Na]
+, 215.0176. Found 215.0173. 
 
 
S-(but-3-en-1-yl) O-ethyl carbonodithioate (6.24): Prepared according to General Procedure A 
using 4-pentenoic acid (10.2 µL, 0.100 mmol, 1 equiv), xanthylamide 6.18 (77.4 mg, 0.20 mmol, 
2 equiv), and dilauroyl peroxide (8.0 mg, 0.020 mmol, 0.2 equiv). After 4 h, additional DLP (8.0 
mg, 0.020 mmol, 0.2 equiv) was added to the reaction mixture under an inert atmosphere, and 
the reaction vial was stirred at 80 °C for another 4 h, giving 45% NMR yield. Alternatively 
prepared according to General Procedure B using 4-pentenoic acid (10.2 µL, 0.100 mmol, 1 
equiv) and xanthylamide 6.18 (38.7 mg, 0.100 mmol, 1 equiv), giving 47% NMR yield.  
 
 
Tert-butyl 3-(2-((ethoxycarbonothioyl)thio)ethyl)-1H-indole-1-carboxylate (6.25): Prepared 
according to General Procedure A using 3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoic 
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acid3 (43.5 mg, 0.150 mmol, 1 equiv), xanthylamide 6.18 (116 mg, 0.300 mmol, 2 equiv), and 
dilauroyl peroxide (30.0 mg, 0.075 mmol, 0.5 equiv). After 4 h, additional DLP (30.0 mg, 0.075 
mmol, 0.5 equiv) was added to the reaction mixture under an inert atmosphere, and the reaction 
vial was stirred at 80 °C for another 4 h. The crude residue was purified by flash column 
chromatography (1–2.5% EtOAc/hex) to afford 6.25 as a white solid (34.0 mg, 62% yield). 
Alternatively prepared according to General Procedure B using 3-(1-(tert-butoxycarbonyl)-1H-
indol-3-yl)propanoic acid (43.5 mg, 0.150 mmol, 1 equiv) and xanthylamide 6.18 (46.4 mg, 
0.120 mmol, 1.2 equiv), giving 36% NMR yield: 
1H NMR (600 MHz, CDCl3) δ 8.15 (br s, 1H), 7.67 – 7.61 (m, 1H), 7.47 (br s, 1H), 7.39 – 7.33 
(m, 1H), 7.31 – 7.27 (m, 1H), 4.69 (q, J = 7.1 Hz, 2H), 3.49 – 3.43 (m, 2H), 3.17 – 3.08 (m, 2H), 
1.70 (s, 9H), 1.45 (t, J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 214.84, 124.61, 123.29, 122.62, 119.07, 118.78, 115.45, 70.19, 
35.50, 29.30, 28.35, 24.61, 13.97. 
HRMS (ES+) Exact mass calcd for C18H23NNaO3S2 [M+Na]
+, 388.1017. Found 388.1017. 
 
 
S-cyclohexyl O-ethyl carbonodithioate (6.17): Prepared according to General Procedure A 
using cyclohexanecarboxylic acid (12.8 mg, 0.100 mmol, 1 equiv), xanthylamide 6.18 (58.1 mg, 
0.150 mmol, 1.5 equiv), and dilauroyl peroxide (6.0 mg, 0.015 mmol, 0.15 equiv), giving 99% 




O-ethyl S-(hexan-2-yl) carbonodithioate (6.26): Prepared according to General Procedure A 
using 2-methylhexanoic acid (14.1 μL, 0.100 mmol, 1 equiv), xanthylamide 6.18 (58.1 mg, 0.150 
mmol, 1.5 equiv), and dilauroyl peroxide (6.0 mg, 0.015 mmol, 0.15 equiv), giving 99% GC 
yield. Spectral data was in accordance with literature values.1  
 
 
S-((1S,2S,4R)-bicyclo[2.2.1]heptan-2-yl) O-ethyl carbonodithioate (6.27): Prepared according 
to General Procedure A using norbornane-2-carboxylic acid (predominantly endo isomer) (14.0 
mg, 0.100 mmol, 1 equiv), xanthylamide 6.18 (58.1 mg, 0.150 mmol, 1.5 equiv), and dilauroyl 
peroxide (6.0 mg, 0.015 mmol, 0.15 equiv). Alternatively prepared according to General 
Procedure B using norbornane-2-carboxylic acid (predominantly endo isomer) (14.0 mg, 0.100 
mmol, 1 equiv) and xanthylamide 6.18 (43.5 mg, 0.120 mmol, 1.2 equiv). The crude residue was 
purified by flash column chromatography (0.1–1% EtOAc/hex) to afford 6.27 as a pale yellow 
oil (A: 19.9 mg, 92% yield; B: 15.7 mg, 73% yield). Spectral data was in accordance with 






S,S'-(cyclohexane-1,4-diyl) O,O'-diethyl bis(carbonodithioate) (6.28): Prepared according to 
General Procedure A using cyclohexane-1,4-dicarboxylic acid (25.8 mg, 0.150 mmol, 1 equiv), 
xanthylamide 6.18 (174 mg, 0.450 mmol, 3 equiv), and dilauroyl peroxide (18.0 mg, 0.045 
mmol, 0.45 equiv). Alternatively prepared according to General Procedure B using cyclohexane-
1,4-dicarboxylic acid (17.2 mg, 0.100 mmol, 1 equiv) and xanthylamide 6.18 (93.0 mg, 0.240 
mmol, 2.4 equiv). The crude residue was purified by flash column chromatography (1–2.5% 
EtOAc/hex) to afford 6.28 as a pale-yellow oil (A: 38.5 mg, 79% yield; B: 30.4 mg, 94% yield): 
1H NMR (600 MHz, CDCl3) δ 4.63 (q, J = 7.1 Hz, 4H), 3.90 – 3.82 (m, 1H), 3.64 – 3.57 (m, 
1H), 2.33 – 2.14 (m, 1H), 2.07 – 1.97 (m, 2H), 1.93 – 1.80 (m, 2H), 1.62 – 1.55 (m, 2H), 1.44 – 
1.40 (m, 6H), 1.31 – 1.22 (m, 1H). 
13C NMR (151 MHz, CDCl3) δ 214.08, 213.95, 69.87, 69.85, 47.44, 47.31, 29.80, 29.31, 13.94, 
13.93. 
HRMS (ES+) Exact mass calcd for C12H21O2S4 [M+H]
+, 325.0424. Found 325.0424. 
 
 
O-ethyl S-(3-oxocyclobutyl) carbonodithioate (6.29): Prepared according to General Procedure 
A using 3-oxocyclobutane-1-carboxylic acid (11.4 mg, 0.100 mmol, 1 equiv), xanthylamide 6.18 
(58.1 mg, 0.150 mmol, 1.5 equiv), and dilauroyl peroxide (6.0 mg, 0.015 mmol, 0.15 equiv). 
Altenatively prepared according to General Procedure B using 3-oxocyclobutane-1-carboxylic 
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acid (11.4 mg, 0.100 mmol, 1 equiv) and xanthylamide 6.18 (46.4 mg, 0.120 mmol, 1.2 equiv). 
The crude residue was purified by flash column chromatography (1–2.5% EtOAc/hex) to afford 
6.29 as a colorless amorphous solid (A: 16.1 mg, 85% yield; B: 14.7 mg, 77% yield):  
1H NMR (600 MHz, CDCl3) δ 4.64 (q, J = 7.1 Hz, 2H), 4.18 – 4.12 (m, 1H), 3.71 – 3.56 (m, 
2H), 3.18 – 3.10 (m, 2H), 1.43 (t, J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 213.22, 203.96, 70.21, 54.36, 30.75, 13.92. 
HRMS (ES+) Exact mass calcd for C7H10NaOS2 [M+Na]
+, 197.0071. Found 197.0068. 
 
O-ethyl S-(tetrahydro-2H-pyran-4-yl) carbonodithioate (6.30): Prepared according to General 
Procedure A using tetrahydro-2H-pyran-4-carboxylic acid (13.0 mg, 0.100 mmol, 1 equiv), 
xanthylamide 6.18 (58.1 mg, 0.150 mmol, 1.5 equiv), and dilauroyl peroxide (6.0 mg, 0.015 
mmol, 0.15 equiv). Alternatively prepared according to General Procedure B using tetrahydro-
2H-pyran-4-carboxylic acid (13.0 mg, 0.100 mmol, 1 equiv) and xanthylamide 6.18 (46.4 mg, 
0.120 mmol, 1.2 equiv). The crude residue was purified by flash column chromatography (1–
2.5% EtOAc/hex) to afford 6.30 as a pale yellow oil (A: 15.0 mg, 73% yield; B: 14.4 mg, 70% 
yield): 
1H NMR (600 MHz, CDCl3) δ 4.63 (q, J = 7.1 Hz, 2H), 3.94 (dt, J = 11.9, 3.9 Hz, 2H), 3.85 (tt, 
J = 10.7, 4.1 Hz, 1H), 3.55 (ddd, J = 11.7, 10.4, 2.5 Hz, 2H), 2.10 – 2.03 (m, 2H), 1.80 – 1.70 
(m, 2H), 1.42 (t, J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 213.58, 69.88, 67.49, 45.45, 32.11, 13.93. 
HRMS (ES+) Exact mass calcd for C8H15O2S2 [M+H]
+, 207.0513. Found 207.0508. 
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Tert-butyl 4-((ethoxycarbonothioyl)thio)piperidine-1-carboxylate (6.31): Prepared according 
to General Procedure A using 1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid5 (34.4 mg, 
0.150 mmol, 1 equiv), xanthylamide 6.18 (87.2 mg, 0.225 mmol, 1.5 equiv), and dilauroyl 
peroxide (9.0 mg, 0.023 mmol, 0.15 equiv). After 4 h, additional DLP (9.0 mg, 0.023 mmol, 0.15 
equiv) was added to the reaction mixture under an inert atmosphere, and the reaction vial was 
stirred at 80 °C for another 4 h. Alternatively prepared according to General Procedure B using 
1-(tert-butoxycarbonyl)piperidine-4-carboxylic acid (22.9 mg, 0.100 mmol, 1 equiv) and 
xanthylamide 6.18 (46.5 mg, 0.120 mmol, 1.2 equiv). The crude residue was purified by flash 
column chromatography (1–2.5% EtOAc/hex) to afford 6.31 as a white solid (A: 31.8 mg, 69% 
yield; B: 19.0 mg, 62% yield): 
1H NMR (600 MHz, CDCl3) δ 4.64 (q, J = 7.1 Hz, 2H), 3.91 (br s, 2H), 3.78 (tt, J = 10.4, 4.0 
Hz, 1H), 3.05 (br s, 2H), 2.08 – 2.00 (m, 2H), 1.67 – 1.57 (m, 3H), 1.45 (s, 9H), 1.42 (t, J = 7.1 
Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 213.56, 154.74, 79.90, 69.96, 46.56, 28.54, 13.94. 
HRMS (ES+) Exact mass calcd for C13H23NNaO3S2 [M+Na]




O-ethyl S-(1-methylcyclohexyl) carbonodithioate (6.32): Prepared according to General 
Procedure A using 1-methylcyclohexanecarboxylic acid (14.2 mg, 0.100 mmol, 1 equiv), 
xanthylamide 6.18 (58.1 mg, 0.150 mmol, 1.5 equiv), and dilauroyl peroxide (6.0 mg, 0.015 
mmol, 0.15 equiv), giving 95% GC yield.  
 
 
S-((3s,5s,7s)-adamantan-1-yl) O-ethyl carbonodithioate (6.33): Prepared according to General 
Procedure A using 1-adamantanecarboxylic acid (18.0 mg, 0.100 mmol, 1 equiv), xanthylamide 
6.18 (58.1 mg, 0.150 mmol, 1.5 equiv) and dilauroyl peroxide (6.0 mg, 0.015 mmol, 0.15 equiv).  
Alternatively prepared according to General Procedure B using 1-adamantanecarboxylic acid 
(18.0 mg, 0.100 mmol, 1 equiv) and xanthylamide 6.18 (46.5 mg, 0.120 mmol, 1.2 equiv). The 
crude residue was purified by flash column chromatography (0.1–1% EtOAc/hex) to afford 6.33 
as a white solid (A: 20.6 mg, 80% yield; B: 25.4 mg, 99% yield). Spectral data was in 




Methyl 4-((ethoxycarbonothioyl)thio)bicyclo[2.2.2]octane-1-carboxylate (6.34): Prepared 
according to General Procedure A using 4-(methoxycarbonyl)bicyclo[2.2.2]octane-1-carboxylic 
acid (21.2 mg, 0.100 mmol, 1 equiv), xanthylamide 6.18 (58.1 mg, 0.150 mmol, 1.5 equiv) and 
dilauroyl peroxide (6.0 mg, 0.015 mmol, 0.15 equiv). Alternatively prepared according to 
General Procedure B using 4-(methoxycarbonyl)bicyclo[2.2.2]octane-1-carboxylic acid (21.2 
mg, 0.100 mmol, 1 equiv) and xanthylamide 6.18 (48.5 mg, 0.120 mmol, 1.2 equiv). The crude 
residue was purified by flash column chromatography (1–2.5% EtOAc/hex) to afford 6.34 as an 
off-white solid (A: 26.9 mg, 93% yield; B: 29.0 mg, quantitative yield): 
1H NMR (600 MHz, CDCl3) δ 4.65 (q, J = 7.1 Hz, 2H), 3.63 (s, 3H), 2.10 – 1.93 (m, 6H), 1.93 
– 1.84 (m, 6H), 1.45 (t, J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 213.52, 177.41, 69.47, 51.97, 51.21, 37.95, 30.29, 29.06, 13.88. 
HRMS (ES+) Exact mass calcd for C13H21O3S2 [M+H]
+, 289.0932. Found 289.0931. 
 
 
O-ethyl S-(1-phenylcyclopropyl) carbonodithioate (6.35): Prepared according to General 
Procedure A using 1-phenylcyclopropane-1-carboxylic acid (16.2 mg, 0.100 mmol, 1 equiv), 
xanthylamide 6.18 (58.1 mg, 0.150 mmol, 1.5 equiv) and dilauroyl peroxide (6.0 mg, 0.015 
275 
mmol, 0.15 equiv).  The crude residue was purified by flash column chromatography (0.1–1% 
EtOAc/hex) to afford 6.35 as a pale yellow oil (23.8 mg, quantitative yield): 
1H NMR (600 MHz, CDCl3) δ 7.47 – 7.44 (m, 2H), 7.29 (dd, J = 8.4, 7.0 Hz, 2H), 7.23 – 7.19 
(m, 1H), 4.59 (q, J = 7.1 Hz, 2H), 1.48 – 1.45 (m, 2H), 1.45 – 1.41 (m, 2H), 1.39 (t, J = 7.1 Hz, 
3H). 
13C NMR (151 MHz, CDCl3) δ 213.82, 142.44, 128.46, 128.12, 126.86, 69.75, 30.60, 17.49, 
13.84. 
HRMS (APPI+) Exact mass calcd for C12H15OS2 [M+H]
+, 239.0564. Found 239.0560. 
 
 
S-((1S,2S,4R)-bicyclo[2.2.1]heptan-2-yl) O-ethyl carbonodithioate (6.36): Prepared according 
to General Procedure A using ketopinic acid (27.3 mg, 0.150 mmol, 1 equiv), xanthylamide 6.18 
(87.2 mg, 0.225 mmol, 1.5 equiv) and dilauroyl peroxide (9.0 mg, 0.023 mmol, 0.15 equiv).  
After 4 h, additional DLP (9.0 mg, 0.023 mmol, 0.15 equiv) was added to the reaction mixture 
under an inert atmosphere. Alternatively prepared according to General Procedure B using 
ketopinic acid (18.2 mg, 0.100 mmol, 1 equiv) and xanthylamide 6.18 (46.5 mg, 0.120 mmol, 1.2 
equiv). The crude residue was purified by flash column chromatography (5–10% EtOAc/hex) to 
afford 6.36 as a white solid (A: 25.8 mg, 67% yield; B: 15.4 mg, 60% yield): 
1H NMR (600 MHz, CDCl3) δ 4.62 (qd, J = 7.1, 1.5 Hz, 2H), 2.50 (ddd, J = 18.3, 4.9, 3.1 Hz, 
1H), 2.33 (ddd, J = 14.1, 9.3, 5.0 Hz, 1H), 2.24 – 2.16 (m, 2H), 2.10 (ttd, J = 12.2, 4.8, 3.2 Hz, 
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1H), 2.03 (d, J = 18.3 Hz, 1H), 1.54 (ddd, J = 12.8, 9.3, 3.7 Hz, 1H), 1.37 (t, J = 7.1 Hz, 3H), 
1.07 (s, 3H), 0.98 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 211.92, 209.00, 71.45, 70.17, 49.98, 43.18, 42.75, 29.80, 27.68, 
20.61, 20.07, 13.82. 
HRMS (ES+) Exact mass calcd for C12H19O2S2 [M+H]
+, 259.0826. Found 259.0824. 
 
 
S-(4-((1,3-dioxoisoindolin-2-yl)methyl)cyclohexyl) O-ethyl carbonodithioate (6.37): Prepared 
according to General Procedure A using 4-((1,3-dioxoisoindolin-2-yl)methyl)cyclohexane-1-
carboxylic acid6 (36.3 mg, 0.126 mmol, 1 equiv), xanthylamide 6.18 (73.4 mg, 0.190 mmol, 1.5 
equiv) and dilauroyl peroxide (7.6 mg, 0.019 mmol, 0.15 equiv). Alternatively prepared 
according to General Procedure B using 4-((1,3-dioxoisoindolin-2-yl)methyl)cyclohexane-1-
carboxylic acid (28.7 mg, 0.100 mmol, 1 equiv) and xanthylamide 6.18 (48.5 mg, 0.120 mmol, 
1.2 equiv). The crude residue was purified by flash column chromatography (5–10% EtOAc/hex) 
to afford 6.37 as a white solid (A: 41.1 mg, 90% yield; B: 32.1 mg, 88% yield): 
1H NMR (600 MHz, CDCl3) δ 7.88 – 7.80 (m, 2H), 7.76 – 7.67 (m, 2H), 4.65 – 4.57 (m, 2H), 
4.01 (p, J = 3.9 Hz, 0.6H), 3.59 – 3.45 (m, 2.4H), 2.19 – 2.10 (m, 0.8H), 1.99 (dq, J = 13.2, 4.0 
Hz, 1.2H), 1.88 (dqt, J = 10.5, 6.9, 3.6 Hz, 0.6H), 1.84 – 1.74 (m, 2.6H), 1.62 (dq, J = 12.7, 3.9 
Hz, 1.2H), 1.43 – 1.36 (m, 3H), 1.36 – 1.28 (m, 2.6H), 1.25 – 1.17 (m, 1.2H). 
13C NMR (151 MHz, CDCl3) δ 214.38, 214.04, 168.63, 134.04, 134.01, 131.93, 131.91, 123.29, 
123.27, 69.65, 69.61, 48.13, 47.53, 43.49, 43.02, 36.15, 35.83, 31.44, 30.62, 29.64, 28.68, 13.85, 
13.82. 
HRMS (ES+) Exact mass calcd for C18H21NNaO3S2 [M+Na]
+, 386.0861. Found 386.0860. 
277 
 
O-ethyl S-(1-(4-isobutylphenyl)ethyl) carbonodithioate (6.38): Prepared according to General 
Procedure A using ibuprofen (20.6 mg, 0.100 mmol, 1 equiv), xanthylamide 6.12 (43.5 mg, 
0.100 mmol, 1 equiv) and dilauroyl peroxide (4.0 mg, 0.010 mmol, 0.10 equiv). The crude 
residue was purified by flash column chromatography (0.1–1% EtOAc/hex) to afford 6.38 as a 
pale yellow oil (13.5 mg, 48% yield): 
1H NMR (600 MHz, CDCl3) δ 7.31 – 7.27 (m, 2H), 7.14 – 7.09 (m, 2H), 4.90 (q, J = 7.1 Hz, 
1H), 4.64 (q, J = 7.1 Hz, 2H), 2.47 (d, J = 7.2 Hz, 2H), 1.86 (dh, J = 13.6, 6.9 Hz, 1H), 1.74 (d, J 
= 7.1 Hz, 3H), 1.41 (t, J = 7.1 Hz, 3H), 0.92 (dd, J = 6.6, 1.4 Hz, 6H). 
13C NMR (151 MHz, CDCl3) δ 213.76, 141.19, 138.87, 129.41, 127.31, 69.81, 49.18, 45.18, 
30.33, 22.53, 22.51, 21.83, 13.87. 
HRMS (APPI+) Exact mass calcd for C15H23OS2 [M+H]




carbonodithioate (6.39): Prepared according to General Procedure A using indomethacin (53.7 
mg, 0.150 mmol, 1 equiv), xanthylamide 6.12 (116 mg, 0.300 mmol, 2 equiv), and dilauroyl 
peroxide (30 mg, 0.075 mmol, 0.5 equiv). After 4 h, additional DLP (30.0 mg, 0.075 mmol, 0.5 
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equiv) was added to the reaction mixture under an inert atmosphere, and the reaction vial was 
stirred at 80 °C for another 4 h. Alternatively prepared according to General Procedure B using 
indomethacin (35.8 mg, 0.100 mmol, 1 equiv) and xanthylamide 6.18 (48.5 mg, 0.120 mmol, 1.2 
equiv). The crude residue was purified by flash column chromatography (2.5–10% EtOAc/hex) 
to afford 6.39 as a yellow amorphous solid (A: 25.0 mg, 38% yield; B: 21.1 mg, 49% yield): 
1H NMR (600 MHz, CDCl3) δ 7.70 – 7.58 (m, 2H), 7.53 – 7.41 (m, 2H), 6.98 (d, J = 2.5 Hz, 
1H), 6.85 (d, J = 9.0 Hz, 1H), 6.68 (dd, J = 9.0, 2.5 Hz, 1H), 4.71 (q, J = 7.1 Hz, 2H), 4.51 (s, 
2H), 3.83 (s, 3H), 2.42 (s, 3H), 1.46 (t, J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 214.73, 168.31, 156.13, 139.56, 136.80, 133.72, 131.33, 130.90, 
130.03, 129.27, 115.13, 112.64, 112.10, 101.33, 70.26, 55.86, 31.07, 14.00, 13.59. 
HRMS (ES+) Exact mass calcd for C21H20ClNaNO3S2 [M+Na]




yl)methyl) carbonodithioate (6.40): Prepared according to General Procedure B using 2-
((1S,2R,4aS,8aS)-2-hydroxy-2,5,5,8a-tetramethyldecahydronaphthalen-1-yl)acetic acid7 (53.6 
mg, 0.200 mmol, 1 equiv) and xanthylamide 6.18 (77.4 mg, 0.200 mmol, 1 equiv) using fan 
cooling. The crude residue was purified by flash column chromatography (2.5–10% EtOAc/hex) 
to afford 6.40 as an off-white solid (73.5 mg, 71% yield): 
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1H NMR (600 MHz, CDCl3) δ 4.63 (qd, J = 7.1, 2.5 Hz, 2H), 3.34 (dd, J = 13.7, 4.9 Hz, 1H), 
3.19 (dd, J = 13.6, 5.0 Hz, 1H), 1.90 (dt, J = 12.6, 3.2 Hz, 1H), 1.75 – 1.63 (m, 4H), 1.57 (tt, J = 
13.5, 3.6 Hz, 1H), 1.48 (t, J = 5.0 Hz, 2H), 1.40 (t, J = 7.1 Hz, 3H), 1.33 – 1.22 (m, 2H), 1.22 – 
1.18 (m, 3H), 1.13 (td, J = 13.5, 4.2 Hz, 1H), 1.04 – 0.98 (m, 1H), 0.96 – 0.89 (m, 1H), 0.86 (s, 
6H), 0.79 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 216.12, 73.45, 69.89, 61.05, 55.92, 44.13, 41.77, 40.16, 39.16, 
33.47, 33.37, 32.00, 23.99, 21.59, 20.43, 18.51, 15.52, 13.96. 
HRMS (ES+) Exact mass calcd for C18H33O2S2 [M+H]
+, 345.1922. Found 345.1920. 




1H-cyclopenta[a]phenanthren-17-yl)butyl) carbonodithioate (6.41): Prepared according to 
General Procedure A using lithocholic acid (18.8 mg, 0.050 mmol, 1 equiv), xanthylamide 6.18 
(38.7 mg, 0.100 mmol, 2 equiv) and dilauroyl peroxide (4.0 mg, 0.010 mmol, 0.2 equiv). After 4 
h, additional DLP (4.0 mg, 0.010 mmol, 0.2 equiv) was added to the reaction mixture under an 
inert atmosphere. The crude residue was purified by flash column chromatography (20% 
EtOAc/hex) to afford 6.41 as a white solid (18.1 mg, 80% yield): 
1H NMR (600 MHz, CDCl3) δ 4.63 (q, J = 7.1 Hz, 2H), 3.61 (tt, J = 10.8, 4.8 Hz, 1H), 3.18 
(ddd, J = 12.6, 10.4, 4.7 Hz, 1H), 2.97 (ddd, J = 13.0, 10.0, 6.5 Hz, 1H), 1.95 (dt, J = 12.6, 3.2 
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Hz, 1H), 1.87 – 1.70 (m, 5H), 1.68 – 1.62 (m, 1H), 1.55 (tt, J = 9.6, 4.0 Hz, 1H), 1.52 – 1.46 (m, 
2H), 1.43 – 1.01 (m, 20H), 0.97 (d, zfJ = 6.5 Hz, 3H), 0.90 (s, 3H), 0.63 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 215.35, 71.99, 69.91, 56.55, 56.06, 42.88, 42.15, 40.48, 40.21, 
36.50, 35.91, 35.86, 35.42, 34.69, 34.67, 33.48, 30.61, 30.28, 27.28, 26.51, 24.33, 23.50, 20.91, 
18.52, 13.98, 12.15. 
HRMS (ES+) Exact mass calcd for C26H45O2S2 [M+H]




1H-cyclopenta[a]phenanthren-17-yl)butyl) carbonodithioate (6.42): Prepared according to 
General Procedure A using androst-4-en-3-one-17β-carboxylic acid8 (47.5 mg, 0.150 mmol, 1 
equiv), xanthylamide 6.18 (87.2 mg, 0.225 mmol, 1.5 equiv), and dilauroyl peroxide (9.0 mg, 
0.015 mmol, 0.15 equiv). After 4 h, additional DLP (9.0 mg, 0.023 mmol, 0.15 equiv) was added 
to the reaction mixture under an inert atmosphere. Alternatively prepared according to General 
Procedure B using androst-4-en-3-one-17β-carboxylic acid (31.6 mg, 0.100 mmol, 1 equiv), 
xanthylamide 6.18 (48.5 mg, 0.120 mmol, 1.2 equiv), The crude residue was purified by flash 
column chromatography (10–20% EtOAc/hex) to afford 6.42 as an off-white solid (A: 50.0 mg, 
85% yield; B: 25.7 mg, 65% yield): 
1H NMR (600 MHz, CDCl3) δ 5.71 – 5.69 (m, 1H), 4.59 (q, J = 7.1 Hz, 2H), 3.91 (dd, J = 8.7, 
2.3 Hz, 1H), 2.52 – 2.20 (m, 5H), 2.00 (ddd, J = 13.4, 5.1, 3.2 Hz, 1H), 1.89 – 1.81 (m, 1H), 1.76 
(dddd, J = 11.8, 9.4, 6.9, 2.5 Hz, 1H), 1.72 – 1.62 (m, 3H), 1.61 – 1.46 (m, 3H), 1.40 (t, J = 7.1 
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Hz, 3H), 1.25 (tdd, J = 11.9, 10.5, 7.0 Hz, 1H), 1.20 – 1.10 (m, 5H), 1.10 – 0.99 (m, 1H), 0.95 (s, 
3H), 0.93 – 0.89 (m, 1H). 
13C NMR (151 MHz, CDCl3) δ 214.75, 199.56, 171.04, 124.01, 123.97, 69.68, 58.55, 53.24, 
51.03, 45.30, 38.60, 36.10, 35.71, 34.00, 33.80, 32.83, 32.14, 29.70, 24.98, 20.92, 19.32, 17.51, 
13.88. 
HRMS (ES+) Exact mass calcd for C22H33O2S2 [M+H]




yl)cyclohexyl) carbonodithioate (6.43): Prepared according to General Procedure A using 
isosteviol9 (15.9 mg, 0.050 mmol, 1 equiv), xanthylamide 6.18 (32.5 mg, 0.075 mmol, 1.5 equiv) 
and dilauroyl peroxide (3.0 mg, 7.5 μmol, 0.15 equiv). Alternatively prepared according to 
General Procedure B using isosteviol (15.9 mg, 0.100 mmol, 1 equiv) and xanthylamide 6.18 
(46.5 mg, 0.120 mmol, 1.2 equiv). The crude residue was purified by flash column 
chromatography (2.5–5% EtOAc/hex) to afford 6.43 as a white solid (A: 16.3 mg, 82% yield; B: 
23.5 mg, 60% yield): 
1H NMR (600 MHz, CDCl3) δ 4.71 (dq, J = 10.8, 7.1 Hz, 1H), 4.65 (dq, J = 10.8, 7.1 Hz, 1H), 
2.65 (dd, J = 18.6, 3.8 Hz, 1H), 2.29 – 2.23 (m, 1H), 2.19 (td, J = 13.1, 4.8 Hz, 1H), 1.94 – 1.90 
(m, 1H), 1.87 (dd, J = 12.0, 1.8 Hz, 1H), 1.79 (d, J = 18.6 Hz, 1H), 1.68 – 1.59 (m, 7H), 1.59 – 
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1.52 (m, 3H), 1.48 (t, J = 7.1 Hz, 3H), 1.45 – 1.39 (m, 2H), 1.38 (s, 3H), 1.28 – 1.17 (m, 2H), 
0.97 (s, 3H), 0.90 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 214.41, 69.46, 63.26, 55.76, 54.44, 52.19, 48.86, 48.82, 40.87, 
39.69, 39.58, 39.10, 38.42, 37.22, 29.84, 21.60, 20.87, 20.09, 19.95, 18.93, 15.44, 14.03. 
HRMS (ES+) Exact mass calcd for C22H34NaO2S2 [M+Na]





carbonodithioate (6.44): Prepared according to General Procedure A using 18β-glycyrrhetinic 
acid (70.6 mg, 0.150 mmol, 1 equiv), xanthylamide 6.18 (87.2 mg, 0.225 mmol, 1.5 equiv) and 
dilauroyl peroxide (9.0 mg, 0.023 mmol, 0.15 equiv) in DCE. The crude residue was purified by 
flash column chromatography (10–30% EtOAc/hex) to afford 6.44 as a white solid (76.5 mg, 
93% yield): 
1H NMR (600 MHz, CDCl3) δ 5.58 – 5.50 (m, 1H), 4.64 (dq, J = 7.8, 4.5 Hz, 2H), 3.19 (dtd, J = 
12.4, 7.6, 6.5, 3.6 Hz, 1H), 2.73 (ddt, J = 14.0, 9.9, 3.9 Hz, 1H), 2.46 – 2.23 (m, 2H), 2.15 – 2.00 
(m, 1H), 2.00 – 1.89 (m, 2H), 1.86 – 1.73 (m, 2H), 1.73 – 1.53 (m, 7H), 1.53 – 1.46 (m, 2H), 
1.46 – 1.35 (m, 6H), 1.35 – 1.28 (m, 4H), 1.25 – 1.12 (m, 1H), 1.09 (d, J = 3.4 Hz, 6H), 1.02 – 
0.92 (m, 5H), 0.85 (dd, J = 10.0, 3.0 Hz, 3H), 0.80 – 0.74 (m, 3H), 0.66 (d, J = 11.3 Hz, 1H). 
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13C NMR (151 MHz, CDCl3) δ 213.50, 213.22, 200.18, 200.05, 168.74, 168.37, 128.71, 128.59, 
78.73, 78.69, 69.46, 69.40, 61.83, 61.82, 56.79, 55.32, 54.92, 54.87, 47.40, 47.15, 45.44, 45.38, 
43.32, 43.30, 42.70, 41.62, 39.14, 39.13, 39.10, 37.10, 37.06, 36.28, 36.00, 33.20, 32.73, 32.71, 
32.26, 32.11, 31.55, 30.18, 28.26, 28.16, 28.10, 27.27, 27.24, 26.58, 26.45, 26.32, 26.27, 23.52, 
23.47, 22.21, 18.68, 17.47, 16.40, 15.61, 13.90, 13.88. 
HRMS (ES+) Exact mass calcd for C32H51O3S2 [M+H]
+, 547.3280. Found 547.3282. 
A gram-scale reaction was run using the following procedure: A 100-mL single-necked, round-
bottomed flask was equipped with a 2-cm, Teflon-coated magnetic stir bar. The flask was 
charged sequentially with 18β-glycyrrhetinic acid (1.00 g, 2.12 mmol, 1 equiv), xanthylamide 
6.18 (0.988 g, 2.54 mmol, 1.2 equiv), and dilauroyl peroxide (102 mg, 0.254 mmol, 0.12 equiv). 
A rubber septum was attached to the flask, and DCE (25 mL) was added by syringe. The 
heterogenous solution was degassed with nitrogen for 1 h. The septum was then removed and 
replaced with a reflux condenser, and was heated under reflux. The reaction was monitored by 
TLC, adding additional dilauroyl peroxide (102 mg, 0.254 mmol, 0.12 equiv) every 3 h until full 
xanthylamide 6.18 conversion was observed (3 additional additions were made).The resulting 
yellow solution was concentrated, and the crude material was dry loaded onto silica and purified 






methanobenzo[a]azulen-2-yl acetate (6.45): Prepared according to General Procedure A using 
gibberellin A3-3-acetate
10 (58.3 mg, 0.150 mmol, 1 equiv), xanthylamide 6.18 (87.2 mg, 0.225 
mmol, 1.5 equiv) and dilauroyl peroxide (9.0 mg, 0.023 mmol, 0.15 equiv). After 4 h, additional 
DLP (9.0 mg, 0.023 mmol, 0.15 equiv) was added to the reaction mixture under an inert 
atmosphere. The crude residue was purified by flash column chromatography (15–35% 
EtOAc/hex) to afford 6.45 as an amorphous pale-yellow solid (50.3 mg, 72% yield): 
1H NMR (600 MHz, CDCl3) δ 6.37 (d, J = 9.3 Hz, 1H), 5.84 (dd, J = 9.3, 3.8 Hz, 1H), 5.33 (d, J 
= 3.7 Hz, 1H), 5.24 (t, J = 2.3 Hz, 1H), 4.97 (d, J = 2.6 Hz, 1H), 4.64 (q, J = 7.1 Hz, 2H), 4.23 
(d, J = 11.1 Hz, 1H), 2.86 – 2.65 (m, 2H), 2.15 – 2.10 (m, 1H), 2.09 (s, 3H), 2.08 – 1.87 (m, 4H), 
1.82 – 1.69 (m, 4H), 1.41 (t, J = 7.1 Hz, 3H), 1.27 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 212.13, 176.97, 169.99, 156.74, 134.36, 129.25, 107.35, 89.04, 
78.46, 70.98, 70.88, 55.03, 53.35, 52.48, 51.92, 50.21, 45.12, 44.09, 38.14, 20.93, 17.33, 14.36, 
13.92. 
HRMS (ES+) Exact mass calcd for C23H29O6S2 [M+H]




S-(1-(1,3-dioxoisoindolin-2-yl)pentyl) O-ethyl carbonodithioate (6.46): Prepared according to 
General Procedure A using 2-(1,3-dioxoisoindolin-2-yl)hexanoic acid11 (13.1 mg, 50.0 μmol, 1 
equiv), xanthylamide 6.18 (21.7 mg, 50.0 μmol, 1 equiv) and dilauroyl peroxide (2.0 mg, 5.0 
μmol, 0.1 equiv). The crude residue was purified by flash column chromatography (2.5–10% 
EtOAc/hex) to afford 6.46 as a white solid (12.9 mg, 77% yield): 
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1H NMR (600 MHz, CDCl3) δ 7.86 (dd, J = 5.4, 3.0 Hz, 2H), 7.74 (dd, J = 5.5, 3.0 Hz, 2H), 
6.23 (dd, J = 9.5, 6.7 Hz, 1H), 4.62 (q, J = 7.1 Hz, 2H), 2.30 – 2.22 (m, 1H), 2.11 (dddd, J = 
13.9, 9.7, 6.7, 5.3 Hz, 1H), 1.39 (t, J = 7.1 Hz, 3H), 1.37 – 1.26 (m, 4H), 0.87 (t, J = 7.0 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 211.50, 167.02, 134.45, 131.70, 123.70, 70.47, 57.79, 32.91, 
28.77, 22.05, 13.99, 13.88. 
HRMS (ES+) Exact mass calcd for C16H19NaNO3S2 [M+Na]
+, 360.0704. Found 360.0703. 
 
 
Methyl 4-(1,3-dioxoisoindolin-2-yl)-4-((ethoxycarbonothioyl)thio)butanoate (6.47): Prepared 
according to General Procedure A using (S)-2-(1,3-dioxoisoindolin-2-yl)-5-methoxy-5-
oxopentanoic acid12 (14.6 mg, 50.0 μmol, 1 equiv), xanthylamide 6.18 (38.7 mg, 100 μmol, 2 
equiv) and dilauroyl peroxide (4.0 mg, 10 μmol, 0.2 equiv). The crude residue was purified by 
flash column chromatography (5–10% EtOAc/hex) to afford 6.47 as a white solid (13.2 mg, 72% 
yield): 
1H NMR (600 MHz, CDCl3) δ 7.86 (dd, J = 5.4, 3.0 Hz, 2H), 7.75 (dd, J = 5.5, 3.0 Hz, 2H), 
6.32 (dd, J = 8.8, 7.1 Hz, 1H), 4.62 (q, J = 7.1 Hz, 2H), 3.63 (s, 3H), 2.60 – 2.39 (m, 4H), 1.40 (t, 
J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 210.87, 172.34, 166.86, 134.58, 131.59, 123.80, 70.73, 57.02, 
52.04, 31.13, 28.69, 13.85. 
HRMS (ES+) Exact mass calcd for C16H17NNaO5S2 [M+Na]





(1,3-dioxoisoindolin-2-yl)-5-oxopentanoate (6.48): Prepared according to General Procedure A 
using tripeptide D3 (49.2 mg, 0.100 mmol, 1 equiv), xanthylamide 6.18 (77.4 mg, 0.200 mmol, 2 
equiv) and dilauroyl peroxide (8.0 mg, 20 μmol, 0.2 equiv) in DCE. After 4 h, additional DLP 
(8.0 mg, 20 μmol, 0.2 equiv) was added to the reaction mixture under an inert atmosphere, and 
the reaction vial was stirred again at 80 °C. After 4 h, the vial was cooled to room temperature. 
The mixture was diluted with CH2Cl2 (20 mL), and the organic layer was washed with sat. 
NaHCO3 (20 mL). The aqueous layer was further extracted with CH2Cl2 (2 x 10 mL). The 
combined organic layer was concentrated to give a crude residue that was purified by flash 
column chromatography (30–60% EtOAc/hex) to afford 6.48 as a white solid (23.4 mg, 41% 
yield).  
1H NMR (600 MHz, CDCl3) δ 7.85 (dd, J = 5.5, 3.1 Hz, 2H), 7.74 (dd, J = 5.5, 3.0 Hz, 2H), 
7.01 (t, J = 5.6 Hz, 1H), 6.44 (d, J = 7.8 Hz, 1H), 4.91 (dd, J = 10.1, 4.9 Hz, 1H), 4.59 (tt, J = 
12.6, 6.8 Hz, 3H), 4.01 (d, J = 5.5 Hz, 2H), 3.73 (s, 3H), 3.72 (s, 3H), 3.24 – 3.07 (m, 2H), 2.66 
(dtd, J = 14.7, 7.7, 4.9 Hz, 1H), 2.44 (ddt, J = 14.0, 10.1, 6.6 Hz, 1H), 2.37 (dt, J = 15.5, 6.6 Hz, 
1H), 2.33 – 2.20 (m, 2H), 2.04 (dtd, J = 14.2, 8.6, 5.7 Hz, 1H), 1.40 (t, J = 7.1 Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 214.94, 171.87, 171.18, 170.04, 169.41, 167.74, 134.44, 131.80, 
123.79, 70.32, 53.00, 52.52, 52.26, 51.20, 41.31, 32.58, 31.76, 31.42, 24.78, 13.92. 
HRMS (ES+) Exact mass calcd for C24H30N3O9S2 [M+H]
+, 568.1427. Found 568.1424. 
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The basic aqueous layer was acidified using 3M HCl until pH = 2 and extracted with CH2Cl2 (20 
mL x 3). The combined organic layer was washed with brine (30 mL), dried over anhydrous 
MgSO4, filtered, and concentrated to recover the starting tripeptide S3 (23.2 mg, 47% recovery).  
 
Comparison to a One-Pot Barton Approach 
General Procedure C: One-Pot Barton Decarboxylative Xanthylation 
 
The acid chloride was prepared as following: to a solution of the carboxylic acid (1.0 equiv) in 
CH2Cl2 (0.2 M) at 0 °C was added oxalyl chloride (1.2 equiv) dropwise followed by 1 to 2 drops 
of DMF. The resulting solution was stirred for 2-4 h and then concentrated to remove excess 
oxalyl chloride to give the acid chloride, which was used without further purification. 
 
A solution of the acid chloride (0.10 mmol, 1 equiv) in benzene (0.1 M) was added dropwise to a 
suspension of N-hydroxypridin-2-thione sodium salt (17.9 mg, 1.2 mmol, 1.2 equiv) and 
xanthate dimer (97.0 mg, 0.200 mmol, 4 equiv). The solution was allowed to stir 2 h in the dark, 
then stirred an additional 2 h under blue light irradiation. The resulting mixture was filtered 
through a pad of celite and analyzed using 1H & 13C NMR.  
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Figure D2: Results for a handful of substrates using the Barton method to achieve a 






1H-cyclopenta[a]phenanthren-3-ol (D4): To a solution of xanthate 6.41 (29.7 mg, 65.0 μmol, 1 
equiv) in EtOH (1 mL) was added isopropylamine (10.6 uL, 0.130 mmol, 2 equiv) and was then 
stirred for 4 h. The reaction mixture was concentrated in vacuo. Thiol D4 was isolated by flash 
column chromatography as a yellow amorphous solid (21.5 mg, 90% yield) and used directly in 





yl)butyl)thio)ethoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate (6.57): In a vial in the 
glovebox, thiol D4 (21.5 mg, 59.0 μmol, 1 equiv), allylglycoside (34.3 mg, 88.4 μmol, 1.5 
equiv), 2,2-dimethoxy-2- phenylacetophenone (1.5 mg, 5.9 μmol, 0.1 equiv), and 4’-
methoxyacetophenone (0.9 mg, 5.9 μmol) were dissolved in DMF (0.10 mL). The vial was 
sealed with a teflon-lined screw cap, sealed with Teflon tape, and placed in a UV-A box and 
irradiated for 14 h. The crude reaction mixture was diluted with EtOAc (2 mL), washed with 
H2O (5 x 2 mL), brine (2 x 2 mL), dried over MgSO4, and concentrated in vacuo. The yellow 
residue was purified by flash column chromatography on silica (30% EtOAc in hexanes) to 
afford thiol-ene adduct 6.58 as a white solid (26.6 mg, 60% yield): 
1H NMR (600 MHz, CDCl3) δ 5.46 (dd, J = 10.2, 9.4 Hz, 1H), 5.09 – 5.00 (m, 2H), 4.86 (dd, J 
= 10.2, 3.7 Hz, 1H), 4.26 (dd, J = 12.4, 4.4 Hz, 1H), 4.09 (dd, J = 12.4, 2.4 Hz, 1H), 4.02 (ddd, J 
= 10.3, 4.4, 2.3 Hz, 1H), 3.81 (dt, J = 9.9, 6.1 Hz, 1H), 3.62 (tt, J = 11.1, 4.6 Hz, 1H), 3.51 (dt, J 
= 9.9, 6.1 Hz, 1H), 2.60 (t, J = 7.0 Hz, 2H), 2.57 – 2.51 (m, 1H), 2.40 (ddd, J = 12.3, 10.0, 6.6 
Hz, 1H), 2.10 (s, 3H), 2.06 (s, 3H), 2.03 (s, 3H), 2.01 (s, 3H), 1.96 (dd, J = 9.2, 6.1 Hz, 1H), 1.91 
– 1.71 (m, 6H), 1.66 (ddt, J = 16.9, 10.3, 3.0 Hz, 3H), 1.56 (ddt, J = 7.9, 4.9, 3.0 Hz, 1H), 1.53 – 
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1.45 (m, 2H), 1.39 (tt, J = 10.0, 4.1 Hz, 5H), 1.34 – 1.27 (m, 2H), 1.24 (tdd, J = 11.5, 6.4, 4.5 Hz, 
3H), 1.16 – 1.00 (m, 5H), 0.97 (dd, J = 14.2, 3.4 Hz, 1H), 0.92 (d, J = 6.6 Hz, 3H), 0.91 (s, 3H), 
0.64 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 170.85, 170.31, 170.30, 169.77, 95.88, 71.98, 70.93, 70.31, 
68.62, 67.34, 66.93, 61.98, 56.60, 56.14, 42.89, 42.18, 40.52, 40.27, 36.54, 35.94, 35.90, 35.59, 
35.44, 34.69, 30.64, 29.30, 29.08, 28.59, 28.46, 27.30, 26.54, 24.34, 23.50, 20.93, 20.92, 20.87, 
20.79, 18.57, 12.17. 
HRMS (ES+) Exact mass calcd for C40H64NaO11S [M+Na]






7,9a-methanobenzo[a]azulen-2-yl acetate (D5): To a solution of xanthate 6.45 (44.1 mg, 94.9 
μmol, 1 equiv) in PhCl (0.95 mL) stirring at 100 °C, TEMPO (89.1 mg, 0.569 mmol, 6 equiv) 
and tris(trimethylsilyl)silane (87.9 μL, 0.285 mmol, 3 equiv) were added in three portions over 
48 h. The reaction mixture was stirred for an additional 24 h, then concentrated. The crude 
residue was resuspended in EtOAc (10 mL) and washed with saturated Na2S2O3 (10 mL). The 
aqueous layer was further extracted with EtOAc (10 mL x 2). The combined organic layer was 
washed with brine, dried over anhydrous MgSO4, filtered, and concentrated. TEMPO-trapped 
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product D5 was obtained after purification by column chromatography (40% EtOAc/hex) to give 
an amorphous yellow solid (29.9 mg, 63% yield): 
1H NMR (600 MHz, CDCl3) δ 6.41 (d, J = 9.2 Hz, 1H), 5.86 (dd, J = 9.2, 3.8 Hz, 1H), 5.36 (d, J 
= 3.8 Hz, 1H), 5.25 (dd, J = 3.3, 1.7 Hz, 1H), 5.06 (d, J = 2.1 Hz, 1H), 4.27 (d, J = 6.5 Hz, 1H), 
3.27 (d, J = 6.5 Hz, 1H), 3.08 (dt, J = 16.6, 3.0 Hz, 1H), 2.27 (ddt, J = 16.5, 3.2, 1.7 Hz, 1H), 
2.10 (s, 3H), 2.07 – 1.92 (m, 4H), 1.81 – 1.65 (m, 4H), 1.62 (dt, J = 13.2, 3.8 Hz, 1H), 1.58 (s, 
3H), 1.52 – 1.34 (m, 5H), 1.27 (s, 2H), 1.23 (s, 3H), 1.20 (d, J = 1.7 Hz, 6H), 1.10 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 178.09, 169.97, 156.44, 134.88, 129.03, 106.59, 90.51, 85.05, 
78.24, 72.17, 61.87, 59.28, 58.07, 52.66, 52.03, 47.87, 46.32, 41.26, 40.30, 40.23, 38.44, 34.87, 
34.17, 21.65, 21.28, 20.88, 17.50, 17.42, 17.38. 
HRMS (ES+) Exact mass calcd for C29H43NNaO6 [M+Na]





acetate (35): An oven-dried 1 dram vial equipped with a stir bar was charged with zinc 
nanopowder (31.4 mg, 480 μmol, 20 equiv) and a solution of alkoxyamine D5 (12 mg, 24 μmol, 
1 equiv) dissolved in a mixture of AcOH/THF/H2O (3:1:1, 2 mL total). The reaction mixture was 
stirred at 60 °C under an Ar balloon. Additional zinc (20 equiv) was added every 3 h until full 
starting material conversion was observed by TLC (5 additions made). At 0 °C, a solution of 
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NaOH (5 mL, 2.5 M) was added slowly to the reaction mixture and subsequently extracted with 
CH2Cl2 (10 mL x 3). The combined organic layers were dried over anhydrous Na2SO4, filtered, 
and concentrated in vacuo. The crude residue was purified by column chromatography (50% 
EtOAc/hex) to give 6.58 (6.8 mg, 79% yield) as a white solid: 
1H NMR (600 MHz, CDCl3) δ 6.36 (d, J = 9.2 Hz, 1H), 5.86 (dd, J = 9.3, 3.8 Hz, 1H), 5.35 (d, J 
= 3.9 Hz, 1H), 5.29 (dd, J = 3.2, 1.8 Hz, 1H), 5.00 (d, J = 2.1 Hz, 1H), 4.02 (d, J = 8.8 Hz, 1H), 
2.75 – 2.66 (m, 2H), 2.15 – 2.05 (m, 4H), 2.04 –1.53 (m, 9H), 1.37 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 177.56, 170.12, 157.36, 134.59, 129.20, 107.34, 88.33, 78.57, 
76.43, 70.64, 57.84, 52.01, 51.05, 49.93, 43.58, 40.51, 38.41, 21.01, 17.13, 14.51. 
HRMS (ES+) Exact mass calcd for C20H25O6 [M+H]
+, 361.1651. Found 361.1650. 
 
Selectivity Studies  
 
A 1  dram  vial  was  charged  with  hexanoic acid (1 equiv), cyclohexane (1 equiv), and reagent 
6.12, 6.18, or 6.65 (1 equiv),  fitted  with  a  PTFE  lined  screw  cap,  and  taken  into  the  
glovebox.  The contents were dissolved in PhCF3 (0.5 M), and the resulting solution was sealed 
with Teflon tape and removed from the glovebox. The vial was placed in a 3D-printed holder 
(see picture below). The holder was suspended above an Ecoxotic PAR38 23 W blue LED such 
that the bottom of each vial was directly aligned with and 2 cm above one of the five LEDs, and 
the apparatus was covered with aluminum foil. The reaction was irradiated until completion and 
then concentrated in vacuo. Product distribution was analyzed by 1H NMR, with selectivity 
calculated by correcting for the number of reactive H’s available (i.e. 1 H for hexanoic acid and 
12 H’s for cyclohexane). 
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Table D1. Selectivity Data 
Reagent Product distribution (6.13:6.17) Selectivity (6.13:6.17) 
6.12 1:1.2 10:1 
6.18 2.0:1 24:1 
6.65 <1:25 <1:50 
 
  
Figure D3. Light setup for small volume reactions.  
 
 
(1r,3s,5R,7S)-3-((ethoxycarbonothioyl)thio)adamantane-1-carboxylic acid (6.66): A  1  dram  
vial  was  charged  with  1-adamantanecarboxylic acid (18.0 mg, 0.100 mmol, 1  equiv) and 
xanthylsulfonamide 6.65 (46.9 mg, 0.100 mmol, 1 equiv),  fitted  with  a  PTFE  lined  screw  
cap,  and  taken  into  the  glovebox.  The contents were dissolved in PhCF3 (0.10 mL), and the 
resulting solution was sealed with Teflon tape and removed from the glovebox. The vial was 
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placed in a 3D-printed holder (see Figure D3). The holder was suspended above an Ecoxotic 
PAR38 23 W blue LED such that the bottom of each vial was directly aligned with and 1 cm 
above one of the five LEDs, and the apparatus was covered with aluminum foil. The reaction 
was irradiated until completion, and then concentrated in vacuo. The crude residue was purified 
by flash column chromatography (30/70/0.1 ethyl acetate/hexanes/acetic acid) to afford the 
functionalized product (20.0 mg, 67% yield) as a white solid: 
1H NMR (600 MHz, CDCl3) δ 4.66 (q, J = 7.1 Hz, 2H), 2.35 (s, 2H), 2.24 – 2.19 (m, 2H), 2.14 
– 2.08 (m, 2H), 2.07 – 2.01 (m, 2H), 1.93 – 1.87 (m, 4H), 1.75 – 1.65 (m, 2H), 1.48 (t, J = 7.1 
Hz, 3H). 
13C NMR (151 MHz, CDCl3) δ 213.39, 182.63, 69.61, 53.52, 42.57, 42.47, 40.87, 38.66, 37.54, 
36.50, 35.22, 29.32, 27.90, 13.86. 
HRMS (ES+) Exact mass calcd for C14H20NaO3S2 [M+Na]




Control: A 1 dram vial equipped with a stir bar was charged with xanthylamide 6.18 (38.7 mg, 
0.100 mmol, 1 equiv), fitted with a PTFE lined screw cap, and taken into the glovebox. The 
content was dissolved in PhCF3 (1.0 mL), and the resulting solution was sealed with Teflon tape 
and removed from the glovebox. Hexanoic acid (12.5 μL, 0.100 mmol, 1 equiv) was added 
through the septum using a Hamilton syringe. The vial was placed on a block plate at 80 °C, 
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loosely covered in foil, and stirred for 15 h. The reaction was concentrated in vacuo, and the 
crude residue was dissolved in chloroform-d for NMR analysis. 
 
Figure D4: A stacked 13C NMR (151 Hz, CDCl3) plot of xanthylamide 6.18 (top) 
and the control experiment (bottom) indicating no reaction has taken place 
 
 
O-ethyl S-(4-phenylbutan-2-yl) carbonodithioate (6.60): Prepared according to General 
Procedure A using (R)-2-methyl-4-phenylbutanoic acid13 (6.59) (17.8 mg, 0.100 mmol, 1 equiv), 
xanthylamide 6.18 (38.7 mg, 0.100 mmol, 1 equiv) and dilauroyl peroxide (4.0 mg, 10 μmol, 0.1 
equiv). The crude residue was purified by flash column chromatography (1–2.5% EtOAc/hex) to 
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afford 6.60 as a pale yellow oil (18.5 mg, 72% yield). Spectral data were in accordance with 
literature values.1  
 
 
Peak # Area (%) 
1 97.6 
2 2.4 




Peak # Area (%) 
1 49.3 
2 50.7 




























1-Methylcyclohexane-1-carboxylic acid-d (6.63). Adapted from an analogous literature 
procedure.14 An oven-dried 50 mL round-bottom flask was charged with 1-methylcyclohexane-
1-carboxylic acid (D6) (0.43 g, 3.0 mmol, 1 equiv) and then sealed with septum and Teflon tape. 
Under positive nitrogen pressure, 20 mL D2O and 3.0 g of a 30 wt. % in D2O was added through 
the septum. After 30 minutes of stirring, concentrated DCl was added through the septum until 
the solution reached a pH of 1. The white solid that precipitated was filtered, washed with D2O, 
dried under vacuum, and stored in a desiccator until use. Deuterium incorporation was confirmed 
by IR via the lack of an –OH stretch and by 1H NMR via the reduction of the intensity of the 
carboxylic acid proton. A deuterium incorporation of 80% can be estimated comparing the 1H 
NMR of the proteo and deutero acid. NMR samples were prepared using dry CDCl3 in the 
glovebox and sealed with a Teflon coated cap.  
 
 
Determination of kinetic isotope effect (KIE) by initial rates: Stock solutions were prepared 
in oven-dried 1 dram vials charged with either D6 (35.6 mg, 0.25 mmol, 1 equiv) or 6.63 (35.8 
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mg, 0.25 mmol, 1 equiv), xanthylamide 6.18 (96.8 mg, 0.25 mmol, 1 equiv), and dilauroyl 
peroxide (5.0 mg, 12.5 μmol, 0.05 equiv). The contents were fully dissolved in benzene-d6 (2.5 
mL) and distributed evenly in four additional oven-dried 1 dram vials equipped with stir bars 
(0.5 mL each). The vials were fitted with a PTFE lined screw cap, sealed with Teflon tape, 
removed from the glovebox, and placed on a block plate at 80 °C. Reactions were stopped by 
immediately cooling the vials in an ice bath with simultaneous sparging with an O2 balloon for 1 
min. Initial rates were determined by calculating the instantaneous rate of the first five minutes 
of each reaction based from the conversion of 6.18 by 19F NMR. 
 
Table D2. KIE determination from initial rates 
 Initial rate (M s-1) 
kH 9.36 x 10
-6 







Methods. All calculations were carried out using the Gaussian16 program package (revision 
A.03) through the Longleaf cluster at the University of North Carolina at Chapel Hill.15 In our 
investigation, all the stationary points have been initially optimized having recourse to density 
functional theory (DFT) by adopting the wB97XD functional with an unrestricted (U) formalism 
when systems containing an unpaired number of electrons were considered, and the def2TZVP 
basis set in the gas phase. 
To confirm the nature of stationary points, vibrational frequencies have been calculated for the 
optimized structures at the same level of theory as geometry optimizations, and it was verified 
that local minima had only real frequencies, while transition states (TS) were identified by the 
presence of a single imaginary frequency corresponding to the expected motion along the 
reaction coordinate. 
The simulation has been focused on analyzing the feasibility of Hydrogen Atom Transfer from 
the COO–H bond in propanoic acid promoted by pentafluorophenyl-substituted amidyl radical 
6.18’ (from reagent 6.18) and the 3,5-bis(trifluoromethyl)phenyl-substituted sulfonamidyl radical 
6.65’ (from reagent 6.65) to give the carboxyl radical of propanoic acid and the corresponding 
amide/sulfonamide. For propanoic acid, the two reagents, the corresponding intermediates 
(carboxyl, amidyl and sulfonamidyl radicals) and the considered reacting situations, a systematic 
investigation on all of the possible conformations has been carried out. However, only the most 
stable conformation (in terms of Gibbs free energy value) has been reported and considered for 
further work, except where otherwise noted. 
The solvent effect was included by single-point calculations on the optimized geometries 
obtained in the gas phase at the (U)wB97XD/def2TZVP level of theory in dichloromethane bulk, 
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by maintaining the default solvent options. The SMD model has been used, since this is the 
recommended choice for determining solvation energies. The choice of dichloromethane is 
justified as a convenient alternative from a computational standpoint to trifluorotoluene, the 
solvent used throughout this work.16 
Spin density plots have been determined via the “cubegen” command and are shown in Figure D9. 
For the two reacting situations reported in Figure 6.17 in Chapter 6, the most stable TS 
describing the hydrogen transfer event has been located and fully analyzed. The detailed 
characterization of the TSs has been performed via the IRC method at the same level of theory as 
the optimizations (UwB97XD/def2TZVP) by describing 70 points in each direction (70 points in 
the forward and 70 points in the reverse direction). 
The thermodynamic parameters reported in the text (see Figure 4A), viz. DG and DG‡ values, 
have thus been determined according to the following equations: 
DG = S G (products) - S G (reactants) 
DG‡ = G (TS) - S G (reactants) - 1.90 kcal·mol-1 
Where the required Gibbs free energy (G) values were calculated via: 
G = Electronic Energy at the SMD(CH2Cl2)-UwB97XD/def2TZVP level of theory + thermal 
correction to Gibbs Free Energy at the UwB97XD/def2TZVP level of theory 
For the particular case of propanoic acid, two different conformations have been reported, 
namely the absolute minimum and one of the located relative minima, which is believed to be the 
reactive conformation. This conformation lies +4.90 kcal·mol-1 above the absolute minimum in 
the gas phase (+2.07 kcal·mol-1 in the solvent phase). In any case, the data reported in the main 
text do refer to the absolute minimum. 
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Thermochemical data have been calculated adopting the default options, viz. temperature: 
298.150 K and pressure: 1.00000 atm. The conversion factor between Hartree and kcal·mol-1 has 
been: 1 Hartree = 627.509 kcal·mol-1. When summing the data for calculating the G values 
reported in the main text, all the digits available from the calculations were used; nevertheless, 
the energy values reported below in Hartree and kcal·mol-1 units have been rounded considering, 
respectively, 6 and 2 significant digits after the unit. 
The 1.90 kcal·mol-1 correction value introduced into the expression for DG‡ is related to the 
conversion of the computed Gibbs free energy values from the 1 atm standard state into the 
standard state of molar concentration (ideal mixture at 1 mol·L-1 and 1 atm) in order to allow a 
direct comparison with the experimental results in solution. Thus, the contribution RT ln R′T, 
where R′ is the value of R in L·atm·K-1·mol-1 was added to the Gibbs free energy term. This 
contribution always cancels out unless a process where a molecularity change (Δn) between 
reagents and products occurs (as in the expression of DG‡). Accordingly, this contribution should 
be written as ΔnRT ln R′T. As an example, in the reaction A + B → C, Δn = −1 and the 
contribution will be −RT ln R′T (−1.90 kcal·mol-1 at 298.150 K, as indicated in the expression of 
DG‡).17  
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Table D3. Calculated parameters for the TSs describing the processes reported in Figure 6.17. 
 
Gibbs Free Energy (G) at the SMD(CH2Cl2)-
UwB97XD/def2TZVP//UwB97XD/def2TZVP 



















-1935.273307 -1935.229825 -1935.263908 + 25.39 a + 5.90 
a These values already include the conversion factor from 1 atm standard state to 1 mol·L-1 standard 
state. 
 
Table D4. Terms adopted to calculate the Gibbs Free Energy (G) values reported in Table D3. 
 Electronic Energy, 
gas phase 
Thermal correction 









                                           
-268.428720 
-268.420698 
                                       
0.062037 
0.061823 









-1054.472444 0.154631 -1054.486802 
radical 6.18’ 
 




-1667.736890 0.197628 -1667.755171 
radical 6.65’ 
 




-1322.201434 0.220542 -1322.221439 
TS 6.68 
 




Start-point    TS    End-point 
 
 
Figure D7. Intrinsic Reaction Coordinate (IRC) plot at the UwB97XD/def2TZVP level of theory 






Start-point    TS    End-point 
 
 
Figure D8. Intrinsic Reaction Coordinate (IRC) plot at the UwB97XD/def2TZVP level of theory 









Electronic energy,         
gas phase 
IRC (reverse) 
Electronic energy,          
gas phase 
0 (TS) 0.000000 -1322.201434 0.000000 -1322.201434 
1 0.103100 -1322.202289 -0.103120 -1322.202265 
2 0.206020 -1322.204363 -0.206210 -1322.204302 
3 0.308480 -1322.206533 -0.309220 -1322.206636 
4 0.410230 -1322.208235 -0.411430 -1322.208374 
5 0.513250 -1322.209769 -0.511280 -1322.209361 
6 0.616330 -1322.211201 -0.614180 -1322.210171 
7 0.719410 -1322.212540 -0.717160 -1322.210888 
8 0.822490 -1322.213790 -0.820170 -1322.211530 
9 0.925580 -1322.214962 -0.923220 -1322.212120 
10 1.028660 -1322.216060 -1.026260 -1322.212666 
11 1.131740 -1322.217079 -1.129270 -1322.213173 
12 1.234750 -1322.218015 -1.232230 -1322.213651 
13 1.337680 -1322.218859 -1.335100 -1322.214093 
14 1.440460 -1322.219613 -1.438020 -1322.214523 
15 1.543320 -1322.220296 -1.540970 -1322.214923 
16 1.646250 -1322.220916 -1.644020 -1322.215310 
17 1.749270 -1322.221473 -1.747100 -1322.215672 
18 1.852320 -1322.221982 -1.850210 -1322.216016 
19 1.955400 -1322.222451 -1.953320 -1322.216343 
20 2.058490 -1322.222887 -2.056450 -1322.216655 
21 2.161590 -1322.223295 -2.159570 -1322.216953 
22 2.264700 -1322.223678 -2.262700 -1322.217238 
23 2.367820 -1322.224038 -2.365830 -1322.217510 
24 2.470940 -1322.224378 -2.468960 -1322.217770 
25 2.574070 -1322.224700 -2.572090 -1322.218019 
307 
26 2.677190 -1322.225004 -2.675230 -1322.218257 
27 2.780320 -1322.225292 -2.778360 -1322.218486 
28 2.883450 -1322.225564 -2.881490 -1322.218705 
29 2.986570 -1322.225823 -2.984620 -1322.218914 
30 3.089700 -1322.226067 -3.087750 -1322.219115 
31 3.192820 -1322.226299 -3.190890 -1322.219307 
32 3.295930 -1322.226518 -3.294020 -1322.219491 
33 3.399030 -1322.226726 -3.397150 -1322.219668 
34 3.502090 -1322.226922 -3.500280 -1322.219839 
35 3.605110 -1322.227107 -3.603410 -1322.220002 
36 3.708040 -1322.227282 -3.706530 -1322.220159 
37 3.810850 -1322.227445 -3.809650 -1322.220310 
38 3.913750 -1322.227604 -3.912760 -1322.220455 
39 4.016750 -1322.227750 -4.015850 -1322.220593 
40 4.119810 -1322.227889 -4.118920 -1322.220727 
41 4.222830 -1322.228020 -4.221940 -1322.220854 
42 4.325840 -1322.228144 -4.324910 -1322.220977 
43 4.428820 -1322.228262 -4.427840 -1322.221092 
44 4.531770 -1322.228374 -4.530770 -1322.221205 
45 4.634690 -1322.228480 -4.633720 -1322.221312 
46 4.737590 -1322.228581 -4.736740 -1322.221416 
47 4.840450 -1322.228677 -4.839780 -1322.221514 
48 4.943280 -1322.228769 -4.942840 -1322.221609 
49 5.046200 -1322.228858 -5.045860 -1322.221698 
50 5.149220 -1322.228940 -5.148770 -1322.221783 
51 5.252290 -1322.229020 -5.251700 -1322.221866 
52 5.355280 -1322.229094 -5.354670 -1322.221943 
53 5.458160 -1322.229165 -5.457660 -1322.222018 
54 5.561130 -1322.229233 -5.560460 -1322.222087 
55 5.664090 -1322.229296 -5.663360 -1322.222156 
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56 5.767120 -1322.229357 -5.766310 -1322.222219 
57 5.870010 -1322.229413 -5.869310 -1322.222281 
58 5.973010 -1322.229469 -5.972160 -1322.222338 
59 6.075980 -1322.229521 -6.075110 -1322.222394 
60 6.179020 -1322.229572 -6.178110 -1322.222445 
61 6.281960 -1322.229621 -6.281140 -1322.222495 
62 6.384780 -1322.229668 -6.384070 -1322.222541 
63 6.487680 -1322.229715 -6.486900 -1322.222584 
64 6.590650 -1322.229758 -6.589820 -1322.222627 
65 6.693690 -1322.229801 -6.692800 -1322.222667 
66 6.796650 -1322.229842 -6.795840 -1322.222706 
67 6.899530 -1322.229881 -6.898780 -1322.222742 
68 7.002520 -1322.229919 -7.001610 -1322.222776 
69 7.105490 -1322.229955 -7.104560 -1322.222810 
70 7.208560 -1322.229991 -7.207520 -1322.222842 
 




Electronic energy,         
gas phase 
IRC (reverse) 
Electronic energy,          
gas phase 
0 (TS) 0.000000 -1935.468302 0.000000 -1935.468302 
1 0.107340 -1935.469029 -0.107740 -1935.469341 
2 0.214130 -1935.470409 -0.215500 -1935.472441 
3 0.320360 -1935.471708 -0.323270 -1935.476863 
4 0.428050 -1935.473009 -0.431050 -1935.481641 
5 0.535770 -1935.474294 -0.538750 -1935.485679 
6 0.643500 -1935.475510 -0.644400 -1935.487874 
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7 0.751220 -1935.476608 -0.748790 -1935.488819 
8 0.858890 -1935.477555 -0.855830 -1935.489550 
9 0.966450 -1935.478346 -0.963290 -1935.490187 
10 1.073960 -1935.479010 -1.070840 -1935.490750 
11 1.181520 -1935.479581 -1.178490 -1935.491263 
12 1.289170 -1935.480087 -1.286200 -1935.491739 
13 1.396860 -1935.480544 -1.393930 -1935.492184 
14 1.504570 -1935.480961 -1.501690 -1935.492605 
15 1.612310 -1935.481346 -1.609460 -1935.493003 
16 1.720070 -1935.481706 -1.717230 -1935.493382 
17 1.827830 -1935.482045 -1.825000 -1935.493743 
18 1.935600 -1935.482364 -1.932770 -1935.494088 
19 2.043370 -1935.482667 -2.040540 -1935.494417 
20 2.151120 -1935.482953 -2.148300 -1935.494732 
21 2.258730 -1935.483223 -2.256030 -1935.495032 
22 2.366390 -1935.483482 -2.363700 -1935.495320 
23 2.474010 -1935.483725 -2.471250 -1935.495594 
24 2.581750 -1935.483960 -2.578840 -1935.495860 
25 2.689410 -1935.484179 -2.686490 -1935.496112 
26 2.797010 -1935.484388 -2.794230 -1935.496356 
27 2.904530 -1935.484585 -2.901920 -1935.496588 
28 3.012020 -1935.484774 -3.009590 -1935.496811 
29 3.119510 -1935.484955 -3.117220 -1935.497024 
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30 3.227070 -1935.485129 -3.224820 -1935.497230 
31 3.334680 -1935.485296 -3.332390 -1935.497426 
32 3.442340 -1935.485455 -3.439970 -1935.497615 
33 3.550040 -1935.485607 -3.547580 -1935.497797 
34 3.657750 -1935.485752 -3.655210 -1935.497972 
35 3.765450 -1935.485891 -3.762880 -1935.498140 
36 3.873120 -1935.486023 -3.870580 -1935.498302 
37 3.980710 -1935.486150 -3.978290 -1935.498457 
38 4.088350 -1935.486272 -4.086010 -1935.498607 
39 4.196030 -1935.486388 -4.193730 -1935.498751 
40 4.303770 -1935.486500 -4.301420 -1935.498890 
41 4.411470 -1935.486607 -4.409110 -1935.499023 
42 4.519160 -1935.486709 -4.516780 -1935.499153 
43 4.626810 -1935.486806 -4.624440 -1935.499277 
44 4.734420 -1935.486899 -4.732120 -1935.499397 
45 4.842010 -1935.486988 -4.839810 -1935.499512 
46 4.949580 -1935.487072 -4.947510 -1935.499624 
47 5.057160 -1935.487153 -5.055230 -1935.499730 
48 5.164740 -1935.487230 -5.162960 -1935.499833 
49 5.272370 -1935.487304 -5.270680 -1935.499932 
50 5.380010 -1935.487373 -5.378410 -1935.500027 
51 5.487680 -1935.487439 -5.486120 -1935.500119 
52 5.595360 -1935.487502 -5.593820 -1935.500207 
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53 5.703050 -1935.487562 -5.701500 -1935.500291 
54 5.810720 -1935.487618 -5.809150 -1935.500371 
55 5.918350 -1935.487670 -5.916760 -1935.500448 
56 6.025880 -1935.487720 -6.024320 -1935.500521 
57 6.133500 -1935.487768 -6.131850 -1935.500592 
58 6.241130 -1935.487812 -6.239350 -1935.500658 
59 6.348830 -1935.487854 -6.346830 -1935.500722 
60 6.456430 -1935.487893 -6.454300 -1935.500783 
61 6.563890 -1935.487929 -6.561770 -1935.500840 
62 6.671430 -1935.487965 -6.669250 -1935.500896 
63 6.779020 -1935.487997 -6.776740 -1935.500948 
64 6.886690 -1935.488029 -6.884290 -1935.500999 
65 6.994230 -1935.488058 -6.991880 -1935.501047 
66 7.101860 -1935.488086 -7.099520 -1935.501093 
67 7.209490 -1935.488112 -7.207210 -1935.501138 
68 7.317170 -1935.488137 -7.314910 -1935.501180 
69 7.424710 -1935.488161 -7.422590 -1935.501221 





Figure D9. Spin density plots for TS structures 6.67 (top) and 6.68 (bottom) as from the 
calculations at the SMD(CH2Cl2)-U B97XD/def2TZVP//U B97XD/def2TZVP level of theory.  
313 
Optimized Structures 
   propanoic acid (absolute minimum) 
 
 C                  0.56205700    0.10314200    0.00006800 
 O                  0.61148400    1.30194100    0.00006900 
 C                 -0.68997200   -0.73228900    0.00017200 
 H                 -0.64048900   -1.39163600   -0.87015400 
 H                 -0.64061700   -1.39112000    0.87090200 
 O                  1.66958600   -0.66228800   -0.00013100 
 H                  2.42522400   -0.06232800   -0.00018100 
 C                 -1.96168400    0.09659900   -0.00014100 
 H                 -2.00949000    0.73858700   -0.87928700 
 H                 -2.83603900   -0.55457600    0.00001600 
 H                 -2.00956400    0.73912600    0.87860500 
 
   propanoic acid (relative minimum) 
 
 C                  0.57837700    0.15095000    0.00011900 
 O                  0.55942600    1.34378800   -0.00003400 
 C                 -0.65136500   -0.73576700   -0.00001400 
 H                 -0.59283200   -1.38993600   -0.87552600 
314 
 H                 -0.59291000   -1.39010100    0.87537600 
 O                  1.75859500   -0.50604800   -0.00002000 
 H                  1.61687700   -1.45617100   -0.00003700 
 C                 -1.95049100    0.04899700   -0.00000200 
 H                 -2.01546000    0.68936000   -0.87817400 
 H                 -2.80339300   -0.62930300   -0.00013300 
 H                 -2.01557000    0.68915400    0.87831400 
 
   carboxyl radical 
 
 C                  0.61396200   -0.01946700    0.00000200 
 O                  1.73070500   -0.59082700    0.00005200 
 C                 -0.69279200   -0.74252900   -0.00006500 
 H                 -0.68954800   -1.39993300    0.87318600 
 H                 -0.68955500   -1.39969800   -0.87349500 
 O                  0.75442200    1.21783700   -0.00003500 
 C                 -1.90002700    0.18447500    0.00004900 
 H                 -2.81778400   -0.40269200    0.00069900 
 H                 -1.90511900    0.82606400    0.88082800 
 H                 -1.90586900    0.82530400   -0.88127500 
 
315 
  amide D10 
 
 C                 -2.28268200    1.27322300    0.00436900 
 C                 -3.06451400    0.14439800    0.18541500 
 C                 -2.48658800   -1.11494400    0.14820600 
 C                 -1.12578700   -1.23289000   -0.07662800 
 C                 -0.32384800   -0.11893400   -0.26118300 
 C                 -0.92279500    1.12763600   -0.21254800 
 C                  1.14708200   -0.27717900   -0.59695100 
 O                  1.48397700   -0.68784700   -1.68456600 
 C                  3.44622900    0.07570200    0.34824300 
 C                  3.92432100    0.57184500    1.71063800 
 C                  3.95897000   -1.34346000    0.09938400 
 H                  5.01353600    0.59404600    1.73539200 
 H                  3.58285500   -0.08868900    2.51114900 
 H                  3.56283900    1.58360800    1.90960300 
 H                  5.05026800   -1.34515300    0.09530500 
 H                  3.61609900   -2.01799700    0.88589100 
 H                  3.60656700   -1.71827200   -0.85983600 
 N                  1.97421200    0.07421300    0.40604600 
 C                  3.92340700    1.02616800   -0.75112400 
316 
 H                  3.57526400    0.69281100   -1.72720100 
 H                  3.55043200    2.03620500   -0.57255100 
 H                  5.01416100    1.05810600   -0.76283900 
 F                 -0.19027500    2.22457200   -0.38707500 
 F                 -0.59109800   -2.44601100   -0.09723500 
 F                 -3.23711200   -2.19013200    0.33326300 
 F                 -4.36324700    0.26819600    0.39789400 
 F                 -2.83750000    2.47560800    0.03987600 
 H                  1.54700300    0.40914000    1.25186400 
 
  radical 6.18’ 
 
 C                  2.30168600   -1.19135200    0.06799800 
 C                  2.91734500    0.03125500    0.28284000 
 C                  2.20433600    1.20836700    0.11974700 
 C                  0.87634500    1.14929200   -0.26364700 
 C                  0.23732900   -0.06246800   -0.48007500 
 C                  0.96871800   -1.22780500   -0.30436700 
 C                 -1.20830800   -0.07873500   -0.91282900 
 O                 -1.56573900    0.36012300   -1.97951200 
 C                 -3.21304500   -0.07054900    0.52627300 
317 
 C                 -3.55312400   -0.78465500    1.83415000 
 C                 -3.03150800    1.43164100    0.75845300 
 H                 -4.48690900   -0.39267700    2.24018600 
 H                 -2.76581800   -0.63132700    2.57355800 
 H                 -3.66392600   -1.85593600    1.66663400 
 H                 -3.94469000    1.85102700    1.18244900 
 H                 -2.21735100    1.61768100    1.46157600 
 H                 -2.81596200    1.95450800   -0.17306900 
 N                 -2.01822500   -0.70190900   -0.00459400 
 C                 -4.32908000   -0.32318500   -0.50990500 
 H                 -4.10592400    0.17839100   -1.44937300 
 H                 -4.44450100   -1.39069000   -0.69637200 
 H                 -5.26477500    0.06668200   -0.10461400 
 F                  0.41112700   -2.40899800   -0.52237800 
 F                  0.20838900    2.28755500   -0.39830700 
 F                  2.79470100    2.37373100    0.33510800 
 F                  4.18716900    0.07523000    0.64324300 
 F                  2.99185600   -2.31153100    0.21516200 
 
 sulfonamide D11 
 
318 
 C                 -2.31159800    0.05597100   -0.17264500 
 C                 -1.69831700   -1.16232600    0.02992600 
 C                 -0.38578400   -1.22411300    0.48742500 
 C                  0.29593500   -0.05258500    0.73249700 
 C                 -0.30931800    1.18330000    0.54131300 
 C                 -1.61032600    1.23008900    0.08771800 
 O                  2.32701900   -1.49678400    1.37948900 
 C                  3.40076200    0.10128800   -1.05376100 
 C                  2.35812700   -0.72837300   -1.79950400 
 H                  2.06886500   -1.61301900   -1.23266100 
 H                  2.78135700   -1.06502900   -2.74625400 
 N                  2.81203200    0.67528000    0.17761100 
 H                  3.31571800    1.44844700    0.58636700 
 H                 -3.33071700    0.10111600   -0.53133900 
 H                  1.46653300   -0.13732800   -2.01445400 
 C                  4.63153600   -0.74687100   -0.72838700 
 H                  5.37692700   -0.15219700   -0.19630200 
 H                  4.36113900   -1.59799500   -0.10542100 
 H                  5.08635000   -1.11672400   -1.64916600 
 C                  3.80124800    1.30352000   -1.90773800 
 H                  4.25707600    0.96329700   -2.83798100 
 H                  2.93120100    1.91559100   -2.14912800 
 H                  4.53283900    1.92772100   -1.38853000 
319 
 H                  0.23824800    2.09266400    0.74596800 
 H                  0.10585800   -2.17438100    0.64852800 
 S                  1.97348100   -0.11323700    1.32359900 
 O                  2.04935000    0.71742500    2.48364400 
 C                 -2.42195700   -2.45554400   -0.24975500 
 C                 -2.30604600    2.54720100   -0.14668400 
 F                 -3.67683500   -2.25553000   -0.66044200 
 F                 -1.79577100   -3.16112900   -1.20251600 
 F                 -2.47311200   -3.22999400    0.84051400 
 F                 -1.52784600    3.59111000    0.14731200 
 F                 -3.41630100    2.65003000    0.59493500 
 F                 -2.67989500    2.67420100   -1.42846700 
 
 radical 6.65’ 
 
 C                 -2.50819200    0.07815500    0.17831500 
 C                 -1.76797300    1.23837400   -0.01647700 
 C                 -0.43163200    1.16959200   -0.35696700 
 C                  0.16093900   -0.07736100   -0.49595700 
 C                 -0.55873100   -1.24024400   -0.31253900 
 C                 -1.90265000   -1.15383600    0.02757000 
320 
 O                  2.21137600    1.01767600   -1.64526600 
 C                  3.99111900    0.00456600    0.73370500 
 C                  4.20073900    1.52132500    0.94076000 
 H                  3.96219500    2.07081500    0.03154000 
 H                  5.24846400    1.68878000    1.19540400 
 N                  2.55324900   -0.15999200    0.56069200 
 H                 -3.55478400    0.14109200    0.44294200 
 H                  3.57911200    1.89030100    1.75646000 
 C                  4.86304300   -0.49440300   -0.42177300 
 H                  4.69613000   -1.55471700   -0.60817900 
 H                  4.66927800    0.05451000   -1.34266800 
 H                  5.91098500   -0.35135400   -0.15489100 
 C                  4.34052100   -0.74164700    2.02446300 
 H                  5.39052300   -0.57762900    2.27149900 
 H                  3.72401000   -0.38911200    2.85116000 
 H                  4.17798700   -1.81304100    1.90273100 
 H                 -0.07780900   -2.20086600   -0.44262300 
 H                  0.14862700    2.06601400   -0.52424200 
 S                  1.87640400   -0.17669800   -0.92970000 
 O                  2.11056500   -1.46333500   -1.51104900 
 C                 -2.46304600    2.56820100    0.13812300 
 C                 -2.67923100   -2.43251000    0.22332400 
 F                 -3.95130600   -2.20460000    0.55956600 
321 
 F                 -2.13626500   -3.18450300    1.18985600 
 F                 -2.68368700   -3.17189600   -0.89271800 
 F                 -3.04610200    2.67250400    1.34015600 
 F                 -1.62239900    3.59635800    0.00896600 
 F                 -3.42856300    2.71950500   -0.77844300 
 
 TS 6.67 
 
 C                 -0.01954400    1.37536500   -1.68960500 
 O                 -1.07757900    1.49767500   -2.25873500 
 C                 -2.26200200   -1.48342100   -0.49632600 
 C                 -3.01848100   -0.52358100    0.15721500 
 C                 -2.42911100    0.31316200    1.09139400 
 C                 -1.08026000    0.18136500    1.36456200 
 C                 -0.29977200   -0.76036000    0.71121300 
 C                 -0.91226400   -1.58886000   -0.21675500 
 C                  1.17192000   -0.83599100    1.00007400 
 O                  1.59744600   -1.14097100    2.08947600 
 C                  3.39914300   -0.25195900    0.01581900 
 C                  3.85733500    0.20091700   -1.36960300 
322 
 C                  3.67625500    0.83858200    1.05294900 
 H                  4.93141000    0.38396000   -1.35255700 
 H                  3.35387100    1.12194000   -1.66567500 
 H                  3.64443900   -0.55906400   -2.12183100 
 H                  4.74567800    1.05131000    1.06623800 
 H                  3.15415300    1.75945200    0.78884200 
 H                  3.37300300    0.53127600    2.05115900 
 N                  1.98015800   -0.58066100   -0.08563700 
 C                  4.13480900   -1.55831600    0.39023800 
 H                  3.85293300   -1.88722800    1.38760500 
 H                  3.90687200   -2.34632800   -0.32746600 
 H                  5.20739400   -1.36162500    0.36377600 
 H                  1.40894000   -0.22569300   -1.06259700 
 C                  0.52596000    2.40925800   -0.72259700 
 H                  0.90560300    1.90239300    0.16672700 
 H                  1.40198400    2.85440400   -1.20490600 
 O                  0.74594600    0.33264700   -1.94214600 
 F                 -0.20184800   -2.51167700   -0.84880700 
 F                 -0.52574900    1.01120600    2.24044800 
 F                 -3.15290500    1.23529400    1.70535900 
 F                 -4.30407900   -0.40787200   -0.10755200 
 F                 -2.83180900   -2.28548500   -1.37727800 
 C                 -0.48990700    3.47207400   -0.34759100 
323 
 H                 -1.34885700    3.03075100    0.15852400 
 H                 -0.04171900    4.20719100    0.32156900 
 H                 -0.86027400    3.98447100   -1.23415000 
 
 TS 6.68 
 
 C                  0.47428300   -1.66475000    1.85789000 
 O                 -0.12922900   -2.68209200    2.11183700 
 C                 -1.87325500    1.41766600   -0.24853000 
 C                 -2.53547400    0.20789100   -0.33613200 
 C                 -1.86576500   -0.91692700   -0.80136800 
 C                 -0.53698200   -0.83982500   -1.17115400 
 C                  0.11290500    0.38130100   -1.06410100 
 C                 -0.53935800    1.51424600   -0.61820600 
 O                  2.13146500    1.83633500   -1.82861700 
 C                  3.91927300    0.17715300    0.32455500 
 C                  4.06754000    0.24929300    1.84422100 
 C                  4.47276800   -1.16106100   -0.19446600 
 H                  5.12203000    0.18415000    2.11358900 
 H                  3.54586800   -0.58004700    2.32493800 
324 
 H                  3.66781000    1.18891100    2.22713800 
 H                  5.52332200   -1.23393100    0.09027000 
 H                  3.93181300   -1.99820200    0.24570400 
 H                  4.39652300   -1.22668800   -1.27786600 
 N                  2.46480500    0.27985800    0.07743000 
 C                  4.66606800    1.34211000   -0.33308900 
 H                  4.64278600    1.28002800   -1.41955000 
 H                  4.24468000    2.30072100   -0.03318400 
 H                  5.70627300    1.29736300   -0.00886500 
 H                  1.92213900   -0.57608100    0.60830400 
 C                  0.19807400   -0.33156800    2.50466500 
 H                  1.01403300   -0.15363100    3.21247600 
 H                  0.28680400    0.45325300    1.75050000 
 O                  1.44845900   -1.75346100    0.98087100 
 S                  1.83538500    0.49069400   -1.45321000 
 O                  2.17620400   -0.58888000   -2.32202100 
 H                 -0.00880800    2.45542500   -0.55467600 
 H                 -0.00072000   -1.71168200   -1.51757700 
 H                 -3.57328300    0.13462100   -0.04082800 
 C                 -2.62741100   -2.21723000   -0.90385600 
 C                 -2.56312600    2.64739300    0.28668100 
 F                 -3.26467600   -2.49266100    0.23883800 
 F                 -1.83415100   -3.24481400   -1.19175100 
325 
 F                 -3.56111700   -2.14333000   -1.86553100 
 F                 -2.01010100    3.03640000    1.44618600 
 F                 -2.45639100    3.67543300   -0.56167800 
 F                 -3.86133400    2.44087400    0.51306900 
 C                 -1.15045800   -0.27191800    3.20374300 
 H                 -1.21617800   -1.01903300    3.99299300 
 H                 -1.30346200    0.71433900    3.64149700 
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